{"text_format":"3","workbook":"xlsx","n_sheets":101,"sheets":["Cover","Audit Information","Consolidated Balance Sheets","Consolidated Balance Sheets (Pa","Consolidated Statements of Oper","Consolidated Statements of Stoc","Consolidated Statement of Cash ","Nature of Business and Organiza","Liquidity and Capital Resources","Inventory, net","Deposits and Other Current Asse","Property, Plant, and Equipment,","Accrued Expenses and Other Curr","Notes Payable","Related Party Transactions","Other Financing Liabilities","Leases","Commitments and Contingencies","Stockholders_ Equity","Stock-Based Compensation","Fair Value of Financial Instrum","Income Taxes","Net Loss per Share","Subsequent Events","Pay vs Performance Disclosure","Insider Trading Arrangements","Insider Trading Policies and Pr","Cybersecurity Risk Management a","Nature of Business and Organi_2","Nature of Business and Organi_3","Inventory, net (Tables)","Deposits and Other Current As_2","Property, Plant, and Equipmen_2","Accrued Expenses and Other Cu_2","Notes Payable (Tables)","Related Party Transactions (Tab","Other Financing Liabilities (Ta","Leases (Tables)","Stockholders_ Equity (Tables)","Stock-Based Compensation (Table","Fair Value of Financial Instr_2","Income Taxes (Tables)","Net Loss per Share (Tables)","Nature of Business and Organi_4","Nature of Business and Organi_5","Nature of Business and Organi_6","Nature of Business and Organi_7","Liquidity and Capital Resourc_2","Inventory, net - Schedule of In","Inventory, net - Narrative (Det","Deposits and Other Current As_3","Property, Plant, and Equipmen_3","Property, Plant, and Equipmen_4","Accrued Expenses and Other Cu_3","Notes Payable - Schedule of Not","Notes Payable - Schedule of N_2","Notes Payable - Schedule of Mat","Notes Payable - Secured SPA Not","Notes Payable - 2023 Unsecured ","Notes Payable - Unsecured Conve","Notes Payable - Junior Secured ","Notes Payable - 2024 Unsecured ","Notes Payable - Notes Payable, ","Notes Payable - Auto Loans Narr","Related Party Transactions - Sc","Related Party Transactions - _2","Related Party Transactions - Na","Other Financing Liabilities - N","Other Financing Liabilities - F","Leases - Narrative (Details)","Leases - Total Lease Costs (Det","Leases - Future Lease Payments ","Leases - Supplemental Informati","Commitments and Contingencies (","Stockholders_ Equity - Schedule","Stockholders_ Equity - Amendmen","Stockholders_ Equity - Series A","Stockholders' Equity - Common S","Stockholders_ Equity - Schedu_2","Stockholders_ Equity - Weighted","Stockholders_ Equity - Warrants","Stockholders_ Equity - Insuffic","Stockholders_ Equity - Salary D","Stock-Based Compensation - Narr","Stock-Based Compensation - Summ","Stock-Based Compensation - Weig","Stock-Based Compensation - Sche","Stock-Based Compensation - Stoc","Fair Value of Financial Instr_3","Fair Value of Financial Instr_4","Fair Value of Financial Instr_5","Income Taxes - Schedule of Prov","Income Taxes - Schedule of Comp","Income Taxes - Schedule of Effe","Income Taxes - Schedule of Defe","Income Taxes - Narrative (Detai","Income Taxes - Valuation Allowa","Income Taxes - Schedule of Unre","Net Loss per Share - Schedule o","Net Loss per Share - Potentiall","Subsequent Events (Details)"],"cells_cut":5,"read":"whole","date_system":"1900"}

{"sheet":"Cover","index":0,"n_rows":49,"n_cols":4,"rows_kept":49,"merged":[[0,0,1,0]]}
["Cover - USD ($)","12 Months Ended"]
[null,"Dec. 31, 2024","Mar. 28, 2025","Jun. 30, 2024"]
["Document Information [Line Items]"," "," "," "]
["Document Type","10-K"," "," "]
["Document Annual Report","true"," "," "]
["Document Period End Date","Dec. 31,  2024"," "," "]
["Current Fiscal Year End Date","--12-31"," "," "]
["Document Transition Report","false"," "," "]
["Entity File Number","001-39395"," "," "]
["Entity Registrant Name","Faraday Future Intelligent Electric Inc."," "," "]
["Entity Incorporation, State or Country Code","DE"," "," "]
["Entity Tax Identification Number","84-4720320"," "," "]
["Entity Address, Address Line One","18455 S. Figueroa Street"," "," "]
["Entity Address, City or Town","Gardena"," "," "]
["Entity Address, State or Province","CA"," "," "]
["Entity Address, Postal Zip Code","90248"," "," "]
["City Area Code","424"," "," "]
["Local Phone Number","276-7616"," "," "]
["Entity Well-known Seasoned Issuer","No"," "," "]
["Entity Voluntary Filers","No"," "," "]
["Entity Current Reporting Status","Yes"," "," "]
["Entity Interactive Data Current","Yes"," "," "]
["Entity Filer Category","Non-accelerated Filer"," "," "]
["Entity Small Business","true"," "," "]
["Entity Emerging Growth Company","true"," "," "]
["Entity Ex Transition Period","false"," "," "]
["ICFR Auditor Attestation Flag","false"," "," "]
["Document Financial Statement Error Correction","false"," "," "]
["Entity Shell Company","false"," "," "]
["Entity Public Float"," "," ",{"v":223500520,"d":"$ 223,500,520"}]
["Entity Central Index Key","0001805521"," "," "]
["Amendment Flag","false"," "," "]
["Document Fiscal Year Focus","2024"," "," "]
["Document Fiscal Period Focus","FY"," "," "]
["Auditor Location","Melville, New York"," "," "]
["Class A Common Stock"," "," "," "]
["Document Information [Line Items]"," "," "," "]
["Title of 12(b) Security","Class A Common Stock, par value $0.0001 per share"," "," "]
["Trading Symbol","FFAI"," "," "]
["Security Exchange Name","NASDAQ"," "," "]
["Entity Common Stock, Shares Outstanding"," ",{"v":85092832,"d":"85,092,832 "}," "]
["Redeemable Warrants"," "," "," "]
["Document Information [Line Items]"," "," "," "]
["Title of 12(b) Security","Redeemable warrants, exercisable for shares of Class A Common Stock at an exercise price of $2,760.00 per share"," "," "]
["Trading Symbol","FFAIW"," "," "]
["Security Exchange Name","NASDAQ"," "," "]
["Class B Common Stock"," "," "," "]
["Document Information [Line Items]"," "," "," "]
["Entity Common Stock, Shares Outstanding"," ",{"v":6667,"d":"6,667 "}," "]

{"sheet":"Audit Information","index":1,"n_rows":6,"n_cols":2,"rows_kept":6,"merged":[[0,0,1,0]]}
["Audit Information","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Audit Information [Abstract]"," "]
["Auditor Firm ID","324"]
["Auditor Name","Macias Gini & O’Connell LLP"]
["Auditor Location","Melville, New York"]

{"sheet":"Consolidated Balance Sheets","index":2,"n_rows":52,"n_cols":3,"rows_kept":52}
["Consolidated Balance Sheets - USD ($) $ in Thousands","Dec. 31, 2024","Dec. 31, 2023"]
["Current assets"," "," "]
["Cash",{"v":7144,"d":"$ 7,144"},{"v":1898,"d":"$ 1,898"}]
["Restricted cash",{"v":30,"d":"30 "},{"v":2127,"d":"2,127 "}]
["Accounts receivable",{"v":0,"d":"0 "},{"v":7,"d":"7 "}]
["Inventory, net",{"v":27486,"d":"27,486 "},{"v":34229,"d":"34,229 "}]
["Deposits",{"v":31094,"d":"31,094 "},{"v":31382,"d":"31,382 "}]
["Other current assets",{"v":6127,"d":"6,127 "},{"v":21721,"d":"21,721 "}]
["Total current assets",{"v":71881,"d":"71,881 "},{"v":91364,"d":"91,364 "}]
["Property, plant and equipment, net",{"v":348587,"d":"348,587 "},{"v":417812,"d":"417,812 "}]
["Operating lease right-of-use assets, net",{"v":1761,"d":"1,761 "},{"v":16486,"d":"16,486 "}]
["Other non-current assets",{"v":3171,"d":"3,171 "},{"v":4877,"d":"4,877 "}]
["Total assets",{"v":425400,"d":"425,400 "},{"v":530539,"d":"530,539 "}]
["Current liabilities"," "," "]
["Accounts payable",{"v":71414,"d":"71,414 "},{"v":93170,"d":"93,170 "}]
["Accrued expenses and other current liabilities",{"v":56754,"d":"56,754 "},{"v":62391,"d":"62,391 "}]
["Other financing liabilities, current portion",{"v":761,"d":"761 "},{"v":0,"d":"0 "}]
["Operating lease liabilities, current portion",{"v":2128,"d":"2,128 "},{"v":3621,"d":"3,621 "}]
["Total current liabilities",{"v":192707,"d":"192,707 "},{"v":261176,"d":"261,176 "}]
["Other financing liabilities, long term portion",{"v":38698,"d":"38,698 "},{"v":25483,"d":"25,483 "}]
["Operating lease liabilities, long term portion",{"v":14,"d":"14 "},{"v":14306,"d":"14,306 "}]
["Derivative call options",{"v":29709,"d":"29,709 "},{"v":0,"d":"0 "}]
["Other liabilities",{"v":1287,"d":"1,287 "},{"v":1338,"d":"1,338 "}]
["Total liabilities",{"v":310433,"d":"310,433 "},{"v":302303,"d":"302,303 "}]
["Stockholders’ equity"," "," "]
["Preferred stock",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Additional paid-in capital",{"v":4421563,"d":"4,421,563 "},{"v":4180873,"d":"4,180,873 "}]
["Accumulated other comprehensive income",{"v":7744,"d":"7,744 "},{"v":5862,"d":"5,862 "}]
["Accumulated deficit",{"v":-4314346,"d":"(4,314,346)"},{"v":-3958499,"d":"(3,958,499)"}]
["Total stockholders’ equity",{"v":114967,"d":"114,967 "},{"v":228236,"d":"228,236 "}]
["Total liabilities and stockholders’ equity",{"v":425400,"d":"425,400 "},{"v":530539,"d":"530,539 "}]
["Related Party"," "," "]
["Current liabilities"," "," "]
["Accounts payable",{"v":300,"d":"300 "},{"v":200,"d":"200 "}]
["Accrued expenses and other current liabilities",{"v":11077,"d":"11,077 "},{"v":7282,"d":"7,282 "}]
["Warrant liabilities",{"v":0,"d":"0 "},{"v":21,"d":"21 "}]
["Accrued interest",{"v":23227,"d":"23,227 "},{"v":753,"d":"753 "}]
["Notes payable",{"v":5310,"d":"5,310 "},{"v":9760,"d":"9,760 "}]
["Notes payable, long-term portion",{"v":2754,"d":"2,754 "},{"v":0,"d":"0 "}]
["Nonrelated Party"," "," "]
["Current liabilities"," "," "]
["Accrued expenses and other current liabilities",{"v":45677,"d":"45,677 "},{"v":55109,"d":"55,109 "}]
["Warrant liabilities",{"v":28864,"d":"28,864 "},{"v":285,"d":"285 "}]
["Accrued interest",{"v":25,"d":"25 "},{"v":25,"d":"25 "}]
["Notes payable",{"v":4224,"d":"4,224 "},{"v":91150,"d":"91,150 "}]
["Notes payable, long-term portion",{"v":45264,"d":"45,264 "},{"v":0,"d":"0 "}]
["Class A Common Stock"," "," "]
["Stockholders’ equity"," "," "]
["Common stock",{"v":6,"d":"6 "},{"v":0,"d":"$ 0"}]
["Class B Common Stock"," "," "]
["Stockholders’ equity"," "," "]
["Common stock",{"v":0,"d":"$ 0"}," "]

{"sheet":"Consolidated Balance Sheets (Pa","index":3,"n_rows":16,"n_cols":3,"rows_kept":16}
["Consolidated Balance Sheets (Parenthetical) - $ / shares","Dec. 31, 2024","Dec. 31, 2023"]
["Common stock, shares authorized (in shares)",{"v":104245313,"d":"104,245,313 "}," "]
["Preferred stock, par value (in dollars per share)",{"v":0.0001,"d":"$ 0.0001"},{"v":0.0001,"d":"$ 0.0001"}]
["Preferred stock, shares authorized (in shares)",{"v":10000000,"d":"10,000,000 "},{"v":10000000,"d":"10,000,000 "}]
["Preferred stock, shares issued (in shares)",{"v":1,"d":"1 "},{"v":0,"d":"0 "}]
["Preferred stock, shares outstanding (in shares)",{"v":1,"d":"1 "},{"v":0,"d":"0 "}]
["Class A Common Stock"," "," "]
["Common stock, par value (in dollars per share)",{"v":0.0001,"d":"$ 0.0001"},{"v":0.0001,"d":"$ 0.0001"}]
["Common stock, shares authorized (in shares)",{"v":99815625,"d":"99,815,625 "},{"v":1232292,"d":"1,232,292 "}]
["Common stock, shares issued (in shares)",{"v":65919127,"d":"65,919,127 "},{"v":1060833,"d":"1,060,833 "}]
["Common stock, shares outstanding (in shares)",{"v":65919127,"d":"65,919,127 "},{"v":1060833,"d":"1,060,833 "}]
["Class B Common Stock"," "," "]
["Common stock, par value (in dollars per share)",{"v":0.0001,"d":"$ 0.0001"},{"v":0.0001,"d":"$ 0.0001"}]
["Common stock, shares authorized (in shares)",{"v":4429688,"d":"4,429,688 "},{"v":54688,"d":"54,688 "}]
["Common stock, shares issued (in shares)",{"v":6667,"d":"6,667 "},{"v":6667,"d":"6,667 "}]
["Common stock, shares outstanding (in shares)",{"v":6667,"d":"6,667 "},{"v":6667,"d":"6,667 "}]

{"sheet":"Consolidated Statements of Oper","index":4,"n_rows":47,"n_cols":3,"rows_kept":47,"merged":[[0,0,1,0],[0,1,0,2]]}
["Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands","12 Months Ended"]
[null,"Dec. 31, 2024","Dec. 31, 2023"]
["Revenue",{"v":539,"d":"$ 539"},{"v":784,"d":"$ 784"}]
["Cost of revenue",{"v":84029,"d":"84,029 "},{"v":42607,"d":"42,607 "}]
["Gross profit",{"v":-83490,"d":"(83,490)"},{"v":-41823,"d":"(41,823)"}]
["Operating expenses"," "," "]
["Research and development",{"v":25227,"d":"25,227 "},{"v":132021,"d":"132,021 "}]
["Sales and marketing",{"v":9278,"d":"9,278 "},{"v":22836,"d":"22,836 "}]
["General and administrative",{"v":43164,"d":"43,164 "},{"v":82888,"d":"82,888 "}]
["Settlement on accrued research and development expenses",{"v":-14935,"d":"(14,935)"},{"v":0,"d":"0 "}]
["Lease impairment, net",{"v":1847,"d":"1,847 "},{"v":0,"d":"0 "}]
["Loss on disposal on property, plant, and equipment",{"v":1667,"d":"1,667 "},{"v":4453,"d":"4,453 "}]
["Change in fair value of earnout liability",{"v":0,"d":"0 "},{"v":2033,"d":"2,033 "}]
["Total operating expenses",{"v":66248,"d":"66,248 "},{"v":244231,"d":"244,231 "}]
["Loss from operations",{"v":-149738,"d":"(149,738)"},{"v":-286054,"d":"(286,054)"}]
["Other expense, net",{"v":-1448,"d":"(1,448)"},{"v":-2437,"d":"(2,437)"}]
["Loss before income taxes",{"v":-356114,"d":"(356,114)"},{"v":-431635,"d":"(431,635)"}]
["Income tax benefit (expense)",{"v":267,"d":"267 "},{"v":-109,"d":"(109)"}]
["Net loss",{"v":-355847,"d":"(355,847)"},{"v":-431744,"d":"(431,744)"}]
["Total comprehensive loss"," "," "]
["Net loss",{"v":-355847,"d":"(355,847)"},{"v":-431744,"d":"(431,744)"}]
["Foreign currency translation adjustment",{"v":1882,"d":"1,882 "},{"v":2357,"d":"2,357 "}]
["Total comprehensive loss",{"v":-353965,"d":"$ (353,965)"},{"v":-429387,"d":"$ (429,387)"}]
["Class A Common Stock"," "," "]
["Net loss per share of Class A and B Common Stock attributable to common stockholders:"," "," "]
["Basic (in dollars per share)",{"v":-19.61,"d":"$ (19.61)"},{"v":-1792.44,"d":"$ (1,792.44)"}]
["Diluted (in dollars per share)",{"v":-19.61,"d":"$ (19.61)"},{"v":-1792.44,"d":"$ (1,792.44)"}]
["Weighted average common shares used in computing net loss per share of Class A and Class B Common Stock:"," "," "]
["Basic (in shares)",{"v":18529525,"d":"18,529,525 "},{"v":240869,"d":"240,869 "}]
["Diluted (in shares)",{"v":18529525,"d":"18,529,525 "},{"v":240869,"d":"240,869 "}]
["Class B Common Stock"," "," "]
["Net loss per share of Class A and B Common Stock attributable to common stockholders:"," "," "]
["Basic (in dollars per share)",{"v":-19.61,"d":"$ (19.61)"},{"v":-1792.44,"d":"$ (1,792.44)"}]
["Diluted (in dollars per share)",{"v":-19.61,"d":"$ (19.61)"},{"v":-1792.44,"d":"$ (1,792.44)"}]
["Weighted average common shares used in computing net loss per share of Class A and Class B Common Stock:"," "," "]
["Basic (in shares)",{"v":18529525,"d":"18,529,525 "},{"v":240869,"d":"240,869 "}]
["Diluted (in shares)",{"v":18529525,"d":"18,529,525 "},{"v":240869,"d":"240,869 "}]
["Nonrelated Party"," "," "]
["Operating expenses"," "," "]
["Change in fair value of notes payable, warrant liabilities, and derivative call options",{"v":-12556,"d":"$ (12,556)"},{"v":89860,"d":"$ 89,860"}]
["Loss on settlement of notes payable",{"v":-161725,"d":"(161,725)"},{"v":-217019,"d":"(217,019)"}]
["Interest expense",{"v":-7895,"d":"(7,895)"},{"v":-2288,"d":"(2,288)"}]
["Related Party"," "," "]
["Operating expenses"," "," "]
["Change in fair value of notes payable, warrant liabilities, and derivative call options",{"v":253,"d":"253 "},{"v":7101,"d":"7,101 "}]
["Loss on settlement of notes payable",{"v":-14295,"d":"(14,295)"},{"v":-20045,"d":"(20,045)"}]
["Interest expense",{"v":-8710,"d":"$ (8,710)"},{"v":-753,"d":"$ (753)"}]

{"sheet":"Consolidated Statements of Stoc","index":5,"n_rows":45,"n_cols":16,"rows_kept":45}
["Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands","Total","February 28, 2023","April 21, 2023","August 25, 2023","Notes Payable","Additional \u2028Paid-in \u2028Capital","Additional \u2028Paid-in \u2028Capital February 28, 2023","Additional \u2028Paid-in \u2028Capital April 21, 2023","Additional \u2028Paid-in \u2028Capital August 25, 2023","Additional \u2028Paid-in \u2028Capital Notes Payable","Accumulated \u2028Other \u2028Comprehensive Income (Loss)","Accumulated Deficit","Class A Common Stock Common Stock","Class A Common Stock Common Stock Notes Payable","Class B Common Stock Common Stock"]
["Beginning balance (in shares) at Dec. 31, 2022"," "," "," "," "," "," "," "," "," "," "," "," ",{"v":58682,"d":"58,682 "}," ",{"v":6667,"d":"6,667 "}]
["Beginning balance at Dec. 31, 2022",{"v":200992,"d":"$ 200,992"}," "," "," "," ",{"v":3724242,"d":"$ 3,724,242"}," "," "," "," ",{"v":3505,"d":"$ 3,505"},{"v":-3526755,"d":"$ (3,526,755)"},{"v":0,"d":"$ 0"}," ",{"v":0,"d":"$ 0"}]
["Increase (Decrease) in Stockholders' Equity [Roll Forward]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Conversion of notes payable and accrued interest into Class A Common Stock (in shares)"," "," "," "," "," "," "," "," "," "," "," "," "," ",{"v":625650,"d":"625,650 "}," "]
["Conversion of notes payable and accrued interest into Class A Common Stock"," "," "," "," ",{"v":360668,"d":"$ 360,668"}," "," "," "," ",{"v":360668,"d":"$ 360,668"}," "," "," "," "," "]
["Change in classification of warrants from Additional paid-in capital to liability pursuant to the Warrant Exchange",{"v":-6811,"d":"(6,811)"}," "," "," "," ",{"v":-6811,"d":"(6,811)"}," "," "," "," "," "," "," "," "," "]
["Reclassification of earnout shares liability to equity due to authorized share increase"," ",{"v":5014,"d":"$ 5,014"}," ",{"v":1381,"d":"$ 1,381"}," "," ",{"v":5014,"d":"$ 5,014"}," ",{"v":1381,"d":"$ 1,381"}," "," "," "," "," "," "]
["Reclassification of stock-based awards liability to equity due to authorized share increase"," ",{"v":8978,"d":"$ 8,978"}," ",{"v":2043,"d":"$ 2,043"}," "," ",{"v":8978,"d":"$ 8,978"}," ",{"v":2043,"d":"$ 2,043"}," "," "," "," "," "," "]
["Reclassification of earnout shares from equity to liability on April 21, 2023 due to insufficient authorized shares"," "," ",{"v":-2112,"d":"$ (2,112)"}," "," "," "," ",{"v":-2112,"d":"$ (2,112)"}," "," "," "," "," "," "," "]
["Reclassification of stock-based awards from equity to liability on April 21, 2023 due to insufficient authorized shares"," "," ",{"v":-2979,"d":"$ (2,979)"}," "," "," "," ",{"v":-2979,"d":"$ (2,979)"}," "," "," "," "," "," "," "]
["Issuance of common stock (in shares)"," "," "," "," "," "," "," "," "," "," "," "," ",{"v":368803,"d":"368,803 "}," "," "]
["Issuance of common stock",{"v":34492,"d":"34,492 "}," "," "," "," ",{"v":34492,"d":"34,492 "}," "," "," "," "," "," "," "," "," "]
["Reverse Stock split related round up share issuances (in shares)"," "," "," "," "," "," "," "," "," "," "," "," ",{"v":2040,"d":"2,040 "}," "," "]
["Stock-based compensation",{"v":5101,"d":"$ 5,101"}," "," "," "," ",{"v":5101,"d":"5,101 "}," "," "," "," "," "," "," "," "," "]
["Exercise of warrants (in shares)",{"v":6292,"d":"6,292 "}," "," "," "," "," "," "," "," "," "," "," ",{"v":5326,"d":"5,326 "}," "," "]
["Exercise of warrants",{"v":51276,"d":"$ 51,276"}," "," "," "," ",{"v":51276,"d":"51,276 "}," "," "," "," "," "," "," "," "," "]
["Exercise of stock options (in shares)"," "," "," "," "," "," "," "," "," "," "," "," ",{"v":6,"d":"6 "}," "," "]
["Exercise of stock options",{"v":44,"d":"44 "}," "," "," "," ",{"v":44,"d":"44 "}," "," "," "," "," "," "," "," "," "]
["Issuance of shares for RSU vesting net of tax withholdings (in shares)"," "," "," "," "," "," "," "," "," "," "," "," ",{"v":352,"d":"352 "}," "," "]
["Issuance of shares for RSU vesting net of tax withholdings",{"v":-464,"d":"(464)"}," "," "," "," ",{"v":-464,"d":"(464)"}," "," "," "," "," "," "," "," "," "]
["Cancellations (in shares)"," "," "," "," "," "," "," "," "," "," "," "," ",{"v":-26,"d":"(26)"}," "," "]
["Foreign currency translation adjustment",{"v":2357,"d":"2,357 "}," "," "," "," "," "," "," "," "," ",{"v":2357,"d":"2,357 "}," "," "," "," "]
["Net loss",{"v":-431744,"d":"(431,744)"}," "," "," "," "," "," "," "," "," "," ",{"v":-431744,"d":"(431,744)"}," "," "," "]
["Ending balance (in shares) at Dec. 31, 2023"," "," "," "," "," "," "," "," "," "," "," "," ",{"v":1060833,"d":"1,060,833 "}," ",{"v":6667,"d":"6,667 "}]
["Ending balance at Dec. 31, 2023",{"v":228236,"d":"228,236 "}," "," "," "," ",{"v":4180873,"d":"4,180,873 "}," "," "," "," ",{"v":5862,"d":"5,862 "},{"v":-3958499,"d":"(3,958,499)"},{"v":0,"d":"$ 0"}," ",{"v":0,"d":"$ 0"}]
["Increase (Decrease) in Stockholders' Equity [Roll Forward]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Conversion of notes payable and accrued interest into Class A Common Stock (in shares)"," "," "," "," "," "," "," "," "," "," "," "," "," ",{"v":62101798,"d":"62,101,798 "}," "]
["Conversion of notes payable and accrued interest into Class A Common Stock"," "," "," "," ",{"v":226341,"d":"$ 226,341"}," "," "," "," ",{"v":226335,"d":"$ 226,335"}," "," ",{"v":6,"d":"$ 6"}," "," "]
["Reclassification of SPA Warrants from liability to equity",{"v":160,"d":"160 "}," "," "," "," ",{"v":160,"d":"160 "}," "," "," "," "," "," "," "," "," "]
["Issuance of common stock and warrants",{"v":10,"d":"10 "}," "," "," "," ",{"v":10,"d":"10 "}," "," "," "," "," "," "," "," "," "]
["Settlement of Palantir dispute with issuance of Class A Common Stock (in shares)"," "," "," "," "," "," "," "," "," "," "," "," ",{"v":1080294,"d":"1,080,294 "}," "," "]
["Settlement of Palantir dispute with issuance of Class A Common Stock",{"v":4800,"d":"$ 4,800"}," "," "," "," ",{"v":4800,"d":"4,800 "}," "," "," "," "," "," "," "," "," "]
["Purchase of Class A Common Stock under Salary Deduction and Stock Purchase Agreements (in shares)",{"v":49659,"d":"49,659 "}," "," "," "," "," "," "," "," "," "," "," ",{"v":49659,"d":"49,659 "}," "," "]
["Purchase of Class A Common Stock under Salary Deduction and Stock Purchase Agreements",{"v":102,"d":"$ 102"}," "," "," "," ",{"v":102,"d":"102 "}," "," "," "," "," "," "," "," "," "]
["Grow Fandor Contribution",{"v":250,"d":"250 "}," "," "," "," ",{"v":250,"d":"250 "}," "," "," "," "," "," "," "," "," "]
["Chongqing related party debt restructuring",{"v":661,"d":"661 "}," "," "," "," ",{"v":661,"d":"661 "}," "," "," "," "," "," "," "," "," "]
["Reverse Stock split related round up share issuances (in shares)"," "," "," "," "," "," "," "," "," "," "," "," ",{"v":306779,"d":"306,779 "}," "," "]
["Stock-based compensation",{"v":8382,"d":"8,382 "}," "," "," "," ",{"v":8382,"d":"8,382 "}," "," "," "," "," "," "," "," "," "]
["Issuance of shares for RSU vesting net of tax withholdings (in shares)"," "," "," "," "," "," "," "," "," "," "," "," ",{"v":1319764,"d":"1,319,764 "}," "," "]
["Issuance of shares for RSU vesting net of tax withholdings",{"v":-10,"d":"(10)"}," "," "," "," ",{"v":-10,"d":"(10)"}," "," "," "," "," "," "," "," "," "]
["Foreign currency translation adjustment",{"v":1882,"d":"1,882 "}," "," "," "," "," "," "," "," "," ",{"v":1882,"d":"1,882 "}," "," "," "," "]
["Net loss",{"v":-355847,"d":"(355,847)"}," "," "," "," "," "," "," "," "," "," ",{"v":-355847,"d":"(355,847)"}," "," "," "]
["Ending balance (in shares) at Dec. 31, 2024"," "," "," "," "," "," "," "," "," "," "," "," ",{"v":65919127,"d":"65,919,127 "}," ",{"v":6667,"d":"6,667 "}]
["Ending balance at Dec. 31, 2024",{"v":114967,"d":"$ 114,967"}," "," "," "," ",{"v":4421563,"d":"$ 4,421,563"}," "," "," "," ",{"v":7744,"d":"$ 7,744"},{"v":-4314346,"d":"$ (4,314,346)"},{"v":6,"d":"$ 6"}," ",{"v":0,"d":"$ 0"}]

{"sheet":"Consolidated Statement of Cash ","index":6,"n_rows":90,"n_cols":3,"rows_kept":90,"merged":[[0,0,1,0],[0,1,0,2]]}
["Consolidated Statement of Cash Flows - USD ($) $ in Thousands","12 Months Ended"]
[null,"Dec. 31, 2024","Dec. 31, 2023"]
["Cash flows from operating activities"," "," "]
["Net loss",{"v":-355847,"d":"$ (355,847)"},{"v":-431744,"d":"$ (431,744)"}]
["Adjustments to reconcile net loss to net cash used in operating activities:"," "," "]
["Depreciation and amortization expense",{"v":71442,"d":"71,442 "},{"v":42473,"d":"42,473 "}]
["Amortization of operating lease right-of-use assets and intangible assets",{"v":2588,"d":"2,588 "},{"v":2992,"d":"2,992 "}]
["Non-cash interest expense",{"v":1929,"d":"1,929 "},{"v":0,"d":"0 "}]
["Stock-based compensation",{"v":8382,"d":"8,382 "},{"v":9167,"d":"9,167 "}]
["Reserve on inventory",{"v":476,"d":"476 "},{"v":0,"d":"0 "}]
["Loss on disposal on property, plant, and equipment",{"v":1667,"d":"1,667 "},{"v":4453,"d":"4,453 "}]
["Loss from failed sale leaseback arrangement",{"v":0,"d":"0 "},{"v":5173,"d":"5,173 "}]
["Loss on lease impairment",{"v":1847,"d":"1,847 "},{"v":0,"d":"0 "}]
["Gain on foreign exchange",{"v":0,"d":"0 "},{"v":-2068,"d":"(2,068)"}]
["Gain on settlement on accrued research and development expenses",{"v":-14935,"d":"(14,935)"},{"v":0,"d":"0 "}]
["Change in fair value of notes payable, warrant liabilities, and derivative call options",{"v":15058,"d":"15,058 "},{"v":-90518,"d":"(90,518)"}]
["Change in fair value of related party notes payable and related party warrant liabilities",{"v":-253,"d":"(253)"},{"v":-7101,"d":"(7,101)"}]
["Other",{"v":963,"d":"963 "},{"v":1075,"d":"1,075 "}]
["Changes in operating assets and liabilities:"," "," "]
["Deposits",{"v":-706,"d":"(706)"},{"v":14337,"d":"14,337 "}]
["Inventory",{"v":6267,"d":"6,267 "},{"v":-29772,"d":"(29,772)"}]
["Other current and non-current assets",{"v":16907,"d":"16,907 "},{"v":-2884,"d":"(2,884)"}]
["Accounts payable",{"v":-8804,"d":"(8,804)"},{"v":13785,"d":"13,785 "}]
["Accrued expenses and other current and non-current liabilities",{"v":-1573,"d":"(1,573)"},{"v":-42481,"d":"(42,481)"}]
["Financial obligations on lease back transaction",{"v":2876,"d":"2,876 "},{"v":0,"d":"0 "}]
["Operating lease liabilities",{"v":-3200,"d":"(3,200)"},{"v":-2717,"d":"(2,717)"}]
["Net cash used in operating activities",{"v":-70186,"d":"(70,186)"},{"v":-278178,"d":"(278,178)"}]
["Cash flows from investing activities"," "," "]
["Proceeds from the sale of equipment",{"v":198,"d":"198 "},{"v":0,"d":"0 "}]
["Payments for property and equipment",{"v":-7580,"d":"(7,580)"},{"v":-31109,"d":"(31,109)"}]
["Net cash used in investing activities",{"v":-7382,"d":"(7,382)"},{"v":-31109,"d":"(31,109)"}]
["Cash flows from financing activities"," "," "]
["Payments of notes payable and other financing obligations",{"v":-428,"d":"(428)"},{"v":0,"d":"0 "}]
["Payments of notes payable issuance costs",{"v":-2087,"d":"(2,087)"},{"v":-2503,"d":"(2,503)"}]
["Capital contributions",{"v":250,"d":"250 "},{"v":0,"d":"0 "}]
["Proceeds from other financial obligations",{"v":11812,"d":"11,812 "},{"v":24897,"d":"24,897 "}]
["Payments of finance lease obligations",{"v":0,"d":"0 "},{"v":-1016,"d":"(1,016)"}]
["Proceeds from exercise of stock options",{"v":0,"d":"0 "},{"v":44,"d":"44 "}]
["Proceeds from exercise of warrants",{"v":0,"d":"0 "},{"v":4074,"d":"4,074 "}]
["Proceeds from issuance of Class A Common Stock",{"v":0,"d":"0 "},{"v":34492,"d":"34,492 "}]
["Net cash (used in) provided by financing activities",{"v":80733,"d":"80,733 "},{"v":291446,"d":"291,446 "}]
["Effect of exchange rate changes on cash and restricted cash",{"v":-16,"d":"(16)"},{"v":3352,"d":"3,352 "}]
["Net (decrease) increase in cash and restricted cash",{"v":3149,"d":"3,149 "},{"v":-14489,"d":"(14,489)"}]
["Cash and restricted cash, beginning of period",{"v":4025,"d":"4,025 "},{"v":18514,"d":"18,514 "}]
["Cash and restricted cash, end of period",{"v":7174,"d":"7,174 "},{"v":4025,"d":"4,025 "}]
["Cash and restricted cash"," "," "]
["Cash",{"v":7144,"d":"7,144 "},{"v":1898,"d":"1,898 "}]
["Restricted cash",{"v":30,"d":"30 "},{"v":2127,"d":"2,127 "}]
["Cash, cash equivalents, restricted cash, and restricted cash equivalents",{"v":7174,"d":"7,174 "},{"v":4025,"d":"4,025 "}]
["Supplemental disclosure of cash flow information"," "," "]
["Cash paid for interest",{"v":4865,"d":"4,865 "},{"v":465,"d":"465 "}]
["Supplemental disclosure of noncash investing and financing activities"," "," "]
["Additions of property and equipment included in accounts payable and accrued expenses",{"v":44540,"d":"44,540 "},{"v":48037,"d":"48,037 "}]
["Write off of a finance lease pursuant to lease back transaction",{"v":0,"d":"0 "},{"v":6917,"d":"6,917 "}]
["Obtaining right-of-use asset in exchange for operating lease liabilities",{"v":30,"d":"30 "},{"v":0,"d":"0 "}]
["Issuance of Class A Common Stock under the Salary Deduction and Stock Purchase Agreements",{"v":102,"d":"102 "},{"v":0,"d":"0 "}]
["Shares Withheld for RSU tax obligations",{"v":10,"d":"10 "},{"v":0,"d":"0 "}]
["Issuance of Exchange Note",{"v":0,"d":"0 "},{"v":16500,"d":"16,500 "}]
["Conversion of notes payable, related party notes payable and accrued interest into Class A Common Stock",{"v":67113,"d":"67,113 "},{"v":123460,"d":"123,460 "}]
["Conversion of related party notes payable and related party accrued interest into Class A Common Stock",{"v":0,"d":"0 "},{"v":12662,"d":"12,662 "}]
["Reclassification of stock-based awards from equity to liability on April 21, 2023 due to insufficient authorized shares",{"v":0,"d":"0 "},{"v":2979,"d":"2,979 "}]
["Issuance of warrants with the SPA Portfolio Notes",{"v":34440,"d":"34,440 "},{"v":34269,"d":"34,269 "}]
["Reduction in warrants pursuant to the Exchange Agreement",{"v":0,"d":"0 "},{"v":16506,"d":"16,506 "}]
["Reclassification of warrants from equity to liability",{"v":0,"d":"0 "},{"v":6811,"d":"6,811 "}]
["Reclassification of earnout shares from equity to liability on April 21, 2023 due to insufficient authorized shares",{"v":0,"d":"0 "},{"v":2112,"d":"2,112 "}]
["De-recognition of right-of-use assets and lease liabilities due to lease modifications",{"v":3394,"d":"3,394 "},{"v":0,"d":"0 "}]
["Supplemental disclosure of noncash operating activities"," "," "]
["Settlement of Palantir dispute with issuance of Class A Common Stock",{"v":4800,"d":"4,800 "},{"v":0,"d":"0 "}]
["August 25, 2023"," "," "]
["Supplemental disclosure of noncash investing and financing activities"," "," "]
["Reclassification of August 25, 2023 stock-based awards liability to equity due to authorized share increase",{"v":0,"d":"0 "},{"v":2043,"d":"2,043 "}]
["Reclassification of earnout shares liability to equity due to authorized share increase",{"v":0,"d":"0 "},{"v":1381,"d":"1,381 "}]
["February 28, 2023"," "," "]
["Supplemental disclosure of noncash investing and financing activities"," "," "]
["Reclassification of August 25, 2023 stock-based awards liability to equity due to authorized share increase",{"v":0,"d":"0 "},{"v":8978,"d":"8,978 "}]
["Reclassification of earnout shares liability to equity due to authorized share increase",{"v":0,"d":"0 "},{"v":5014,"d":"5,014 "}]
["Nonrelated Party"," "," "]
["Adjustments to reconcile net loss to net cash used in operating activities:"," "," "]
["Loss on settlement of notes payable",{"v":161725,"d":"161,725 "},{"v":217019,"d":"217,019 "}]
["Changes in operating assets and liabilities:"," "," "]
["Accrued interest expense",{"v":0,"d":"0 "},{"v":588,"d":"588 "}]
["Cash flows from financing activities"," "," "]
["Proceeds from notes payable, net of original issuance discount",{"v":68111,"d":"68,111 "},{"v":210450,"d":"210,450 "}]
["Related Party"," "," "]
["Adjustments to reconcile net loss to net cash used in operating activities:"," "," "]
["Loss on settlement of notes payable",{"v":14295,"d":"14,295 "},{"v":20045,"d":"20,045 "}]
["Changes in operating assets and liabilities:"," "," "]
["Accrued interest expense",{"v":8710,"d":"8,710 "},{"v":0,"d":"0 "}]
["Cash flows from financing activities"," "," "]
["Proceeds from notes payable, net of original issuance discount",{"v":3075,"d":"$ 3,075"},{"v":21008,"d":"$ 21,008"}]

{"sheet":"Nature of Business and Organiza","index":7,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Nature of Business and Organization, Basis of Presentation, and Summary of Significant Accounting Policies","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Organization, Consolidation and Presentation of Financial Statements [Abstract]"," "]
["Nature of Business and Organization, Basis of Presentation and Summary of Significant Accounting Policies",{"$cut":{"chars":32767,"head":"Nature of Business and Organization, Basis of Presentation, and Summary of Significant Accounting Policies Nature of Business and Organization Unless otherwise stated or the context requires otherwise, references herein to the “Company,” “FFIE,” “FFAI,” “Faraday” “we,” “us,” and “our” mean Faraday Future Intelligent Electric Inc. and its wholly-owned subsidiaries, and controlled and managed entities. The Company is a holding company incorporated in the State of Delaware on February 11, 2020, conducts its operations through its subsidiaries and is headquartered in 18455 S. Figueroa Street, Gardena, CA 90248. The Company operates in a single operating segment and designs and engineers next-generation, intelligent, electric vehicles. The Company manufactures its vehicles at its production facility in Hanford, California, known as “FF ieFactory California” and has additional engineering, sales, and operations capabilities in China. The Company has created innovations in technology, products, and a user-centered business model that are being incorporated into its planned electric vehicle platform. Principles of Consolidation The Consolidated Financial Statements have been prepared in conformity with accounting principles generally accepted in the U.S. (“GAAP”) and include the accounts of the Company, its wholly-owned subsidiaries and all other entities in which the Company has a controlling financial interest, including the accounts of any variable interest entity, in which the Company has a controlling financial interest and for which it is the primary beneficiary in accordance with Accounting Standards Codification (“ASC”) 810, Consolidation (“ASC 810”). All intercompany transactions and balances have been eliminated upon consolidation. Basis of Presentation Use of Estimates The preparation of the Consolidated Financial Statements in conformity with GAAP and in accordance with the rules and regulations of the U.S Securities and Exchange Commission (“SEC”) requires management to make estimates and assumptions which affect the reported amounts in the Consolidated Financial Statements. Estimates are based on historical experience, where applicable, and other assumptions which management believes are reasonable under the circumstances. On an ongoing basis management evaluates its estimates, including those related to the: (i) recognition and disclosure of contingent liabilities, including litigation reserves; (ii) fair value of related party notes payable and notes payable; (iii) calculations for evaluating potential long-term asset impairment; and (iv) valuation of warrants and other derivative instruments. Such estimates often require the selection of appropriate valuation methodologies and financial models and may involve significant judgment in evaluating ranges of assumptions and financial inputs. Actual results may differ from those estimates under different assumptions, financial inputs, or circumstances. Given the global economic climate, estimates are subject to additional volatility. As of the date the Company’s Consolidated Financial Statements were issued, the Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or to revise the carrying value of its assets or liabilities. However, these estimates and judgments may change as new events occur and additional information is obtained, which may result in changes being recognized in the Company’s Consolidated Financial Statements in future periods. Actual results could differ from those estimates and any such differences may have a material impact on the Company’s Consolidated Financial Statements. Foreign Currency The Company determines the functional and reporting currency of each of its international subsidiaries based on the primary currency in which they operate. The functional currency of the Company’s foreign subsidiaries in China is their local currency, Chinese Yuan (“CNY”). For foreign subsidiaries where the functional currency is their local currency, assets and liabilities are translated into U."}}]

{"sheet":"Liquidity and Capital Resources","index":8,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Liquidity and Capital Resources and Going Concern","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Organization, Consolidation and Presentation of Financial Statements [Abstract]"," "]
["Liquidity and Capital Resources and Going Concern","Liquidity and Capital Resources and Going Concern The Company has evaluated whether there are certain conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the Consolidated Financial Statements are issued. Based on its recurring losses from operations since inception and continued cash outflows from operating activities (all as described below), the Company has concluded that there is substantial doubt about its ability to continue as a going concern for a period of one year from the date that these Consolidated Financial Statements were issued. Preparation of Financial statements The Consolidated Financial Statements do not include any adjustments that might result from the outcome of this uncertainty. Accordingly, the Consolidated Financial Statements have been prepared on a basis that assumes the Company will continue as a going concern and which contemplates the realization of assets and satisfaction of liabilities and commitments in the ordinary course of business. Capital Investment, SPA Portfolio Debt, and Future Equity Plans The Company has and will continue to devote subs tantial effort and, to the extent available, capital resources, to strategic planning, engineering, design, and development of its electric vehicle platform, development of vehicle models, finalizing the build out of the FF ieFactory California manufacturing facility, and capital raising. The Company incurred cumulative losses from operations, negative cash flows from operating activities, and has an accumulated deficit of $4,314.3 million, an unrestricted cash balance of $7.1 million and a negative working capital position of $120.9 million as of December 31, 2024. The Company delivered its first vehicles during 2023 and plans to launch its FX Series of vehicles, but expects to continue to generate significant operating losses for the foreseeable future. The Company has funded its operations and capital needs primarily through the issuance of notes payable and related party notes payable convertible notes (see Note 7, Notes Payable and Note 8, Related Party Transactions ), and the sale of common stock. Debt Commitments under SPA Portfolio Notes and Other Notes SPA Portfolio Notes: The Company has issued various financing arrangements collectively known as the SPA Portfolio Notes. These are categorized as follows: (i) Secured SPA Notes; (ii) 2023 Unsecured SPA Notes; (iii) Junior Secured SPA Notes; (iv) and 2024 Unsecured SPA Notes. As of December 31, 2024, the SPA Portfolio Notes were in good standing. Pursuant to the SPA Portfolio Notes commitments (collectively the “SPA Commitments”) (see Note 7, Notes Payable and Note 8, Related Party Transactions ), the Company obtained commitments from several investors. As of December 31, 2024, the SPA Commitments totaled $614.5 million, of which $405.3 million was funded, $209.2 million remained to be funded, and $46.4 million in principal was outstanding. On December 31, 2024, Optional Commitments under the SPA Commitments totaled $426.0 million, of which $50.9 million was funded, $375.1 million remained to be funded, and $3.1 million was outstanding. The remaining amounts to be funded as of December 31, 2024, are subject to the achievement of delivery milestones, satisfaction of closing conditions, resolving disputes with investors, and satisfaction or waiver of other conditions, including for a portion of such financing an effective registration statement for the shares underlying the applicable notes. Other Financing Arrangements and Related Party Notes: Additional financing is provided via convertible debt instruments, equipment financing arrangements, and related party notes that support the Company’s operations and capital expenditures. As of December 31, 2024, the Company was in good standing on all of its other financing arrangements and Related Party Notes. The Company may be unable to satisfy the closing conditions under the SPA Commitments or obt ain additional incremental investors under the SPA Commitments or other debt or equity financing in a timely manner, on acceptable terms, or at all. Standby Equity Purchase Agreement, At-The-Market Offerin g , and Equity Issuance Constraints The Company has implemented a series of financing arrangements, including a Standby Equity Purchase Agreement with Yorkville and an At-The-Market offering. These initiatives are accompanied by equity issuance constraints, such as limitations imposed by authorized share counts and the impact of convertible securities and related provisions. Together, these elements define the Company’s approach to capital raising and its management of associated regulatory and contractual obligations . Standby Equity Purchase Agreement (“SEPA”) On November 11, 2022, the Company entered into the SEPA, which expires in November 2025. Under the terms of the SEPA, the Company may, at its option, issue and sell from time to time up to $200.0 million (which can be increased up to $350.0 million in the aggregate under the Company’s option) of Class A Common Stock to YA II PN Ltd. (“Yorkville”) , subject to certain limitations. As of December 31, 2024, the Company had the right to issue and sell up to an additional $192.5 million, or $342.5 million if the Company exercises its option under the SEPA. At-The-Market Offerin g On September 26, 2023, the Company entered into a sales agreement with Stifel, Nicolaus & Company, Incorporated, B. Riley Securities, Inc., A.G.P./Alliance Global Partners, Wedbush Securities Inc. and Maxim Group LLC, as sales agents, to sell shares of Class A Common Stock, from time to time, with aggregate gross sales proceeds of up to $90.0 million pursuant to the Registration Statement as an “at-the-market” offering under the Securities Act (the “ATM Program”). Under applicable SEC rules and regulations, because the Company failed to timely file its Form 10-K for the year ended December 31, 2023, as well as its Form 10-Q for the quarter ended March 31, 2024, the Company will not be eligible to access the ATM Program until August 1, 2025, at the earliest. Equity Issuance Constraints The Company’s ability to issue and sell additional shares of Common Stock or warrants to support ongoing capital needs is further constrained by the number of authorized shares. In addition to outstanding shares, the Company must also consider shares reserved for issuance under convertible debt, warrants or other obligations with equity rights. In addition, equity issuances can potentially trigger various anti-dilution features in the Company’s debt and equity instruments that increase the number of shares to be issued and/or reduce the exercise price. This could result in the Company having inadequate authorized shares to meet its outstanding commitments. Capital Needs, FX Series Production, and Bankruptcy Risk The Company projects that it will require substantial additional funds to continue operations and support production of the FF 91, and it also plans to initiate production of its FX Series of vehicles. If additional capital is not secured, it will not have sufficient resources to meet its obligations and continue operations, which could result in bankruptcy protection and asset liquidation, with equity holders receiving little to no recovery. The anticipated start of FX Series production is expected to generate new revenue streams and enhance operational performance, partially mitigating near-term cash flow pressures; however, if additional capital is not secured, the Company will not have sufficient resources to meet its obligations or continue operations, potentially resulting in bankruptcy protection, asset liquidation, and minimal or no recovery for equity holders. Funding Alternatives and Risks The Company continues to explore various funding and financing alternatives to fund its ongoing operations and to ramp up production. The particular funding and financing mechanisms, terms, timing, and amounts depend on the Company’s assessment of opportunities available in the marketplace and the circumstances of the business at the relevant time. However, there have been delays in securing additional funding commitments, which have exacerbated supply chain pressures, among other things. If the Company’s ongoing capital raising efforts are unsuccessful or significantly delayed, or if the Company experiences prolonged material adverse trends in its business, production will be delayed or decreased, and actual use of cash, production volume and revenue for 2025 will vary from the Company’s previously disclosed forecasts, and such variances may be material. While the Company is actively engaged in negotiations with potential financing sources, it may be unable to raise additional capital on terms acceptable to it or at all. In addition to the risk that the Company’s assumptions and analyses may prove incorrect, the projections may underestimate the professional fees and other costs to be incurred related to the pursuit of various financing options currently being considered and ongoing legal risks. Capital needed to fund the development of the Company’s remaining product portfolio will largely depend on market success and profitability of the FF 91 and the launch of the FX series, and the Company’s ability to accurately estimate and control costs. Apart from the FF 91 series and FX series, substantial additional capital would be required to fund operations, research, development, and design efforts for future vehicles. Going Concern and Future Capital Strategy"]

{"sheet":"Inventory, net","index":9,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Inventory, net","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Inventory Disclosure [Abstract]"," "]
["Inventory, net","Inventory, net Inventory, net, consists of the following as of: (in thousands) December 31, 2024 December 31, 2023 Raw materials (net of reserves) $ 27,440 $ 33,345 Work in progress 46 572 Finished goods — 312 $ 27,486 $ 34,229 The inventory reserve was $3.3 million and $2.8 million as of December 31, 2024, and 2023, respectively."]

{"sheet":"Deposits and Other Current Asse","index":10,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Deposits and Other Current Assets","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]"," "]
["Deposits and Other Current Assets","Deposits and Other Current Assets Deposits and other current assets consists of the following as of: (in thousands) December 31, 2024 December 31, 2023 Deposits Deposits for research and development, prototype and production parts, and other $ 29,318 $ 28,609 Deposits for goods and services yet to be received (“Future Work”) 1,776 2,773 $ 31,094 $ 31,382 Other current assets December 31, 2024 December 31, 2023 Prepaid expenses $ 4,832 $ 13,309 Other current assets 1,295 $ 8,412 $ 6,127 $ 21,721 Deposits for R&D, prototype and production parts, and other are recognized and reported as R&D expenses in the Consolidated Statements of Operations and Comprehensive Loss when services are provided or as prototype parts are received. In addition, during the years ended December 31, 2024 and 2023, the Company made deposits for inventory and property and equipment items which are classified as Deposits for goods and services yet to be received (“Future Work”). Prepaid expenses primarily consist of software subscriptions and insurance, and Other current assets includes certain deferred expenses. As of December 31, 2024, and 2023, Other current assets also includes an insurance receivable relating to a legal settlement with a corresponding liability recognized in Accrued expenses and other current liabilities."]

{"sheet":"Property, Plant, and Equipment,","index":11,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Property, Plant, and Equipment, Net","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Property, Plant and Equipment [Abstract]"," "]
["Property, Plant, and Equipment, Net","Property, Plant, and Equipment, Net Property, plant, and equipment, net, consists of the following as of : (in thousands) December 31, 2024 December 31, 2023 Land, buildings and leasehold improvements $ 111,443 $ 103,522 Computer hardware 2,397 2,195 Tooling, machinery and equipment 319,313 318,301 Vehicles 245 669 Lease vehicles 3,121 1,873 Computer software 4,339 4,301 Construction in process 27,563 36,491 468,421 467,352 Less: Accumulated depreciation (119,834) (49,540) $ 348,587 $ 417,812 The Company’s CIP is primarily related to the construction of tooling, machinery and equipment for the FF ieFactory California. Tooling, machinery, and equi pment are either held at Company facilities, primarily the FF ieFactory California, or at the vendor’s location until the tooling, machinery and equipment is completed. The Company recognized Loss on disposal on property, plant, and equipment of $1.7 million, which included the derecognition of approximately $1.0 million in accumulated depreciation, and $4.5 million for the years ended December 31, 2024, and 2023, respectively. Depreciation and amortization expe nse totale d $71.4 million and $42.5 million for the years ended December 31, 2024, and 2023, respectively. During 2024 and 2023, the Company disposed of $5.3 million and $9.6 million, respectively, of CIP relating to the abandonment of certain FF 91 program assets, including vendor tooling, machinery, and equipment. These disposals were primarily driven by the redesign of FF 91 components and the implementation of the Company’s cost reduction program. In addition, the Company wrote off costs with the construction of a sales office and warehousing equipment as part of its operational restructuring. Disposals of CIP of $5.3 million and $3.7 million were charged to operating expenses in the Consolidated Statements of Operations and Comprehensive Loss during the years ended December 31, 2024, and 2023, respectively. Asset Retirement Obligation Due to the build out of the FF ieFactory California, the Company has an asset retirement obligation (“ARO”) totaling $0.8 million and $0.7 million for the years ended December 31, 2024, and 2023, respectively. The ARO is recorded to Other liabilities with a corresponding ARO asset within Land, buildings and leasehold improvements and Tooling, machinery, and equipment. The ARO asset is depreciated to operating expense over the remaining term of the lease through December 2027."]

{"sheet":"Accrued Expenses and Other Curr","index":12,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Accrued Expenses and Other Current Liabilities","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Payables and Accruals [Abstract]"," "]
["Accrued Expenses and Other Current Liabilities","Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities—which include both third-party and related-party balances—comprise the following items as of: (in thousands) December 31, 2024 December 31, 2023 Accrued payroll and benefits $ 27,713 $ 28,037 Accrued legal contingencies 9,091 21,590 Customer deposits 3,027 3,246 Other current liabilities 16,923 9,518 $ 56,754 $ 62,391 "]

{"sheet":"Notes Payable","index":13,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Notes Payable","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Debt Disclosure [Abstract]"," "]
["Notes Payable",{"$cut":{"chars":29534,"head":"Notes Payable The Company has entered into notes payable agreements with third parties. The tables below summarize these agreements as of December 31, 2024, and 2023, providing details on contractual maturity dates, contractual interest rates, unpaid principal balances, fair value adjustments, original issue discounts, including proceeds allocated to warrants, and net carrying values. December 31, 2024 (in thousands) Contractual Contractual Unpaid Principal Fair Value Original Issue Discount and Proceeds Allocated to Warrants Net Secured SPA Notes Various 10 % - 15% $ 3,118 $ 2,651 $ (312) $ 5,457 2023 Unsecured SPA Notes Various dates in 2029 10 % - 15% 4,380 2,844 (508) 6,716 Junior Secured SPA Notes September 2029 10% 28,840 13,163 (15,944) 26,059 2024 Unsecured SPA Notes December 2029 10% 10,015 8,741 (11,724) 7,032 Notes payable – China other Due on Demand —% 4,173 — — 4,173 Auto loans October 2026 7% 51 — — 51 $ 50,577 $ 27,399 $ (28,488) $ 49,488 Notes payable, current portion $ 4,224 Notes payable, long-term portion $ 45,264 December 31, 2023 (in thousands) Contractual Contractual Unpaid Principal Fair Value Original Issue Discount and Proceeds Allocated to Warrants Net Secured SPA Notes Various 10 % - 15% $ 100,052 $ (15,501) $ (10,319) $ 74,232 2023 Unsecured SPA Notes Various dates in 2029 10 % - 15% 13,219 1,262 (2,543) 11,938 (1) Notes payable – China other Due on Demand —% 4,898 — — 4,898 Auto loans October 2026 7% 82 — — 82 $ 118,251 $ (14,239) $ (12,862) $ 91,150 Notes payable, current portion $ 91,150 Notes payable, long-term portion $ — _____________________ (1) The 2023 Unsecured SPA Notes line item values above were updated to exclude related party balance of $542 thousand for comparability of the presentation with the current year. (See Note 8, Related Party Transactions. ) Roll Forward of the Fair Value of Notes payable by Transaction Type The following table presents a roll forward of the Company’s Notes payable balances from December 31, 2023 to December 31, 2024. The table summarizes beginning and ending balances by debt category and details changes during the period, including repayments, conversions, reclassifications, fair value adjustments, and other significant transactions. Categories of Debt (in thousands) Secured 2023 Unsecured Junior 2024 Notes Auto Total Balance as of December 31, 2023 (a) $ 74,232 $ 11,938 $ — $ — $ — $ 4,898 $ 82 $ 91,150 New Issuances (b) 10,701 — 34,885 9,950 1,755 — 57,291 Repayment of Debt (c) — — — — — — (31) (31) Conversion of Debt to Equity (d) (50,691) (14,931) — (1,056) — — — (66,678) Extinguishments of Debt (e) 5,158 (2,394) (65) — — — — 2,699 Fair Value Adjustments of Debt (f) (33,943) (10,268) 328 9,665 — — — (34,218) Reclassification of Debt Between Debt Categories (g) — 22,371 (35,148) 7,500 5,277 — — — Other Adjustments (h) — — — — — (725) — (725) Balance as of December 31, 2024 (i) $ 5,457 $ 6,716 $ — $ 26,059 $ 7,032 $ 4,173 $ 51 $ 49,488 (a) The carrying value for each note category, fair value or amortized cost depending on the election, as of December 31, 2023. (b) Debt instruments issued during the period, recorded at fair value upon issuance if the fair value option is elected, or at principal balance net of discounts. (c) Cash repayments of principal amounts during the period. (d) Fair value of debt converted into equity during the period. (e) Adjustments from amendments, modifications, or extinguishment of existing debt, in accordance with ASC 470-50, and presented as a component of 'Loss on settlement of notes payable' in the Consolidated Statements of Operations. (f) Adjustments to debt fair value due to the fair value option election, embedded derivatives, or anti-dilution provisions. These adjustments are presented as a component of 'Change in fair value of notes payable, warrant liabilities, and call option derivatives' in the Consolidated Statements of Operations. (g) Transfers of amounts between debt categories, such as from secured to unsecured classifications. (h) Miscellaneous changes not captured in other columns, such as currency ad"}}]

{"sheet":"Related Party Transactions","index":14,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Related Party Transactions","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Related Party Transactions [Abstract]"," "]
["Related Party Transactions",{"$cut":{"chars":20668,"head":"Related Party Transactions The Company has entered into notes payable agreements with related parties. The Company receives funding via notes payable from various parties, including related parties. These related parties include employees as well as affiliates of employees, affiliates, and other companies controlled or previously controlled by the Company’s founder and Chief Product and User Ecosystem Officer. The tables below summarize the related party note payable agreements as of December 31, 2024 and December 31, 2023, providing details on contractual maturity dates, contractual interest rates, and net carrying values. December 31, 2024 (in thousands) Contractual Contractual Net Carrying Unsecured Convertible Note April 2024 (1) 4.27% $ 1,364 Notes Payable — China April 2027 18.0% 4,382 Notes Payable on Demand — China Due on Demand —% 417 FFGP Note Various 2024 (1) 4.27% 1,576 Convertible FFGP Note 'May 2024 (1) 4.27% 250 Other Notes Due on Demand 12.0% 75 $ 8,064 Related party notes payable, current $ 5,310 Related party notes payable, long-term $ 2,754 _______________ (1) The term was extended upon receipt of waivers of enforcement rights and remedies under the loan agreements, as described below, with the expected settlement in 2025. December 31, 2023 (in thousands) Contractual Contractual Net Carrying Value 2023 Unsecured SPA Notes August 2029 10% - 15% $ 542 Notes Payable — China December 2023 18.0% 5,103 Notes Payable on Demand — China Due on Demand —% 3,789 FFGP Note Various 5.27% 326 $ 9,760 Related party notes payable, current $ 9,760 Related party notes payable, long-term $ — Schedule of Principal Maturities of Related Party Notes Payable The future scheduled principal maturities of Related party notes payable as of December 31, 2024, are as follows: (in thousands) Due on demand $ 492 2025 4,954 2026 2,003 2027 751 Thereafter — $ 8,200 The Company has issued various financing arrangements with related parties, categorized as follows: (i) 2023 Unsecured SPA Notes ; (ii) Unsecured Convertible Note ; (iii) Notes Payable — China ; (iv) Notes Payable on Demand — China ; (v) FFGP Note ; and (vi) Convertible FFGP Note . 2023 Unsecured SPA Notes In May 2023, June 2023, and October 2023, the Company issued unsecured convertible notes to MHL, a related party, under the 2023 Unsecured SPA Notes as the anchor investor. (For information on the terms of this note, see Note 7, Notes Payable 2023 Unsecured SPA Notes issued to third-parties.) The Company elected the fair value o ption under ASC 825, Financial Instruments , for the 2023 Unsecured SPA Notes because the notes include features such as a contingently exercisable put option, which meets the definition of an embedded derivative. Transaction costs were expensed under “Change in fair value of related party notes payable and related party warrant liabilities” in the Consolidated Statements of Operations and Comprehensive Loss. MHL converted $0.7 million and $22.3 million of gross principal balances in exchange for 33,107 and 125,267 Class A Common Stock shares during years ended December 31, 2024, and 2023, respectively. During the years ended December 31, 2024, and 2023, the Company recognized losses of $0.2 million and $20.0 million on the settlement (conversion) of related party notes payable into shares of Class A Common stock and losses of $0.1 million and $5.9 million , due to fair value adjustments under ASC 825. As of December 31, 2024, there were no related party notes payable outstanding pursuant to the 2023 Unsecured SPA Notes, compared to $0.5 million as of December 31, 2023 . Unsecured Convertible Note In January 2024, the Company issued an unsecured convertible note to MHL, a related party, in a principal amount of $1.5 million. The note was due three months from the date of issuance ( April 2024 ), accrues interest at an annual rate of 4.27% per annum, and is convertible at the option of the holder into either Class A Common Stock or into a 2023 Unsecured SPA Note. If conversion into Class A Common Stock was elected, the conversion price would be base"}}]

{"sheet":"Other Financing Liabilities","index":15,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Other Financing Liabilities","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Organization, Consolidation and Presentation of Financial Statements [Abstract]"," "]
["Other Financing Liabilities","Other Financing Liabilities FF ieFactory California (“Hanford”) Financing Arrangement On October 19, 2023, the Company entered into a sale leaseback transaction whereby it has exercised its option to purchase its FF ieFactory California manufacturing facility located in Hanford California (the “Property”) and simultaneously completed a sale leaseback to Ocean West Capital Partners (“Landlord”) pursuant to that certain Lease Agreement, dated as of October 19, 2023, by and between the Tenant and 10701 Idaho Owner, LLC (the “Lease Agreement”). This Lease Agreement also allows the Tenant access to up to $12.0 million of tenant improvement allowance for the Property. The Lease Agreement is for a term of five years, with a monthly lease rate of $355,197, with a five Due to the inclusion of the purchase option in the lease agreement, the Company was considered to have continuing involvement and, thus, accounted for the transaction as a failed sale lease back, with the HQ assets subject to the sale leaseback remaining on the balance sheet and the sale proceeds recorded as a liability in accordance with the financing method. The Company recognized a $13.1 million financing obligation at the completion of the transaction, which was recorded to the Other financing liabilities, long term portion on its Consolidated Balance Sheets. No gain or loss was record on the failed sale and lease back. On March 14, 2024, the Company entered into the First Amendment to the Lease Agreement (the “First Amendment). The First Amendment established a repayment plan requiring the Company to pay an aggregate amount of $1.7 million of past due rent by March 31, 2024. The Company has an original Security Deposit balance of $1.5 million. In December 2024, the Landlord applied $0.6 million of the original Security Deposit to past due rent. In January 2025, the Company paid the Landlord $0.6 million that reinstated the Security Deposit balance. On August 27, 2024, the Company entered into the Second Amendment to the Lease Agreement (the “Second Amendment”). Under the terms of the original lease agreement, the Company expected to receive $12.0 million in tenant improvement allowance, the repayment of which was included in the scheduled financing obligation payments. In the Second Amendment, the Landlord agreed to fund up to $10.0 million of the costs associated with the replacement of the Property’s roof and the remaining $2.0 million for other improvement costs. The $2.0 million may be reduced by incremental actual costs incurred for the roof replacement and the remaining amount will be contingent on the Company funding up to 66.67% of the other improvement costs. As of December 31, 2024, the Company recognized $6.9 million of leasehold improvement costs funded through the tenant improvement allowance in Property, plant and equipment, net on the Consolidated Balance Sheets. The repayment of the tenant improvement allowance are included in the scheduled financing obligation payments. For the years ended December 31, 2024, and 2023, the Company recorded interest expense of $3.0 million and $0.5 million, respectively. The financial liability as of December 31, 2024, and 2023 was $35.2 million and $25.5 million, respectively. Collateralized Loan Overview and T erms The Collateralized Loan was entered into on July 11, 2024, with Utica Leaseco, LLC. The loan is secured by machinery and equipment owned by the Company. It bears an effective interest rate of 23% and requires 51 monthly payments of $0.1 million, concluding with a $0.5 million balloon payment in October 2028. The loan terms include provisions for adjusting monthly payments based on fluctuations in the prime rate. Summary of Collateralized Loan Activity As of December 31, 2024, the carrying value of the Collateralized Loan was $4.3 million, of which $0.8 million is included in Other financing liabilities, current portion and $3.5 million is included in Other financing liabilities, long term portion in the Consolidated Balance Sheets . For the year ended December 31, 2024, the Company repaid $0.3 million of Collateralized Loan principal. The future scheduled principal maturities of financing obligations as of December 31, 2024 are as follows (in thousands): Years Ending December 31, 2025 $ 761 2026 951 2027 1,189 2028 60,455 $ 63,356 "]

{"sheet":"Leases","index":16,"n_rows":5,"n_cols":2,"rows_kept":5,"merged":[[0,0,1,0]]}
["Leases","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Leases [Abstract]"," "]
["Leases","Leases The Company determines if an arrangement is a lease at its commencement if the Company is both able to identify an asset and conclude the Company has the right to control the identified asset. Leases are classified as finance or operating based on the principle of whether or not the lease is effectively a financed purchase by the lessee. An ROU asset represents the Company’s right to use an underlying asset for the lease term and a lease liability represents the Company’s obligation to make lease payments related to the lease. The Company recognizes operating and finance lease ROU assets and liabilities at the commencement date based on the present value of lease payments over the lease term. The lease term includes renewal options when it is reasonably certain that the option will be exercised and excludes termination options. The Company’s leases do not provide an implicit rate therefore, the Company uses its incremental borrowing rate based on information available at the commencement date to determine the present value of lease payments. The incremental borrowing rate used is estimated based on what the Company would be required to pay for a collateralized loan for a similar asset over a similar term. The Company’s leases do not include any material residual value guarantees, or bargain purchase options. To the extent that the Company’s agreements have variable lease payments, the Company includes variable lease payments that depend on an index or a rate in the measurement and classification of a lease and exclude those that depend on facts or circumstances occurring after the commencement date, other than the passage of time. Lease expense for operating leases is recognized on a straight-line basis over the lease term and is recorded in operating expenses in the Consolidated Statements of Operations and Comprehensive Loss. Amortization of ROU assets on finance leases is recorded on a straight-line basis within operating expenses in the Consolidated Statements of Operations and Comprehensive Loss. Interest expense incurred on finance lease liabilities is recorded in Interest expense in the Consolidated Statements of Operations and Comprehensive Loss. The Company has elected not to recognize ROU assets and lease liabilities that arise from short-term (12 months or less) leases for any class of underlying asset. Additionally, the Company does not separate lease and non-lease components. Operating leases are included in Operating lease right-of-use assets, net, Operating lease liabilities, current portion and Operating lease liabilities, long term portion in the Company's Consolidated Balance Sheets. Finance leases are included in Property, plant and equipment, net, Other financing liabilities, current portion, and Other financing liabilities, long term portion in the Company's Consolidated Balance Sheets. The Company’s lease arrangements primarily consist of corporate office, store, and vehicle lease agreements. The leases expire on various dates through 2032, some of which include options to extend the lease term for additional five ASC 842 Disclosures During 2024, the Company moved out of its leased facilities and office spaces, resulting in a write-down of right-of-use assets and lease liabilities in an aggregate amount of $8.8 million and $7.0 million, respectively. The Company also recognized less than $0.1 million in lease termination costs during 2024. The net impact of the right-of-use asset write down and lease termination costs of $1.8 million is reported in Lease impairment, net on the Consolidated Statements of Operations and Comprehensive Loss for the year ended December 31, 2024. There were no lease impairments for the year ended December 31, 2023. Lease cost includes both the fixed and variable expenses recorded for leases. The components of lease cost for the were as follows: Years Ended December 31, (in thousands) 2024 2023 Finance lease cost Amortization of ROU assets $ — $ 273 Interest on lease liabilities — 275 Total finance lease cost — 548 Operating lease cost 4,389 5,915 Variable lease cost 398 257 Total lease cost $ 4,787 $ 6,720 The following table summarizes future lease payments: (in thousands) Years Ending December 31, Operating Leases 2025 $ 2,243 2026 12 2027 2 Total 2,257 Less: Imputed Interest 115 Present value of net lease payments $ 2,142 Lease liability, current portion $ 2,128 Lease liability, net of current portion 14 Total lease liability $ 2,142 Supplemental information and non-cash activities related to operating and finance leases are as follows: Years Ended December 31, (in thousands) 2024 2023 Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases $ 3,230 $ 5,709 Operating cash flows from finance leases — 275 Financing cash flows from finance leases — 1,016 $ 3,230 $ 7,000 Lease assets obtained in exchange for operating lease liabilities $ 30 $ — Years Ended December 31, 2024 2023 Weighted average remaining lease term (in years) Operating leases 0.70 5.70 Finance leases 0.00 5.00 Weighted average discount rate Operating leases 16.4 % 15.6 % Finance leases — % 9.2 %"]
["Leases","Leases The Company determines if an arrangement is a lease at its commencement if the Company is both able to identify an asset and conclude the Company has the right to control the identified asset. Leases are classified as finance or operating based on the principle of whether or not the lease is effectively a financed purchase by the lessee. An ROU asset represents the Company’s right to use an underlying asset for the lease term and a lease liability represents the Company’s obligation to make lease payments related to the lease. The Company recognizes operating and finance lease ROU assets and liabilities at the commencement date based on the present value of lease payments over the lease term. The lease term includes renewal options when it is reasonably certain that the option will be exercised and excludes termination options. The Company’s leases do not provide an implicit rate therefore, the Company uses its incremental borrowing rate based on information available at the commencement date to determine the present value of lease payments. The incremental borrowing rate used is estimated based on what the Company would be required to pay for a collateralized loan for a similar asset over a similar term. The Company’s leases do not include any material residual value guarantees, or bargain purchase options. To the extent that the Company’s agreements have variable lease payments, the Company includes variable lease payments that depend on an index or a rate in the measurement and classification of a lease and exclude those that depend on facts or circumstances occurring after the commencement date, other than the passage of time. Lease expense for operating leases is recognized on a straight-line basis over the lease term and is recorded in operating expenses in the Consolidated Statements of Operations and Comprehensive Loss. Amortization of ROU assets on finance leases is recorded on a straight-line basis within operating expenses in the Consolidated Statements of Operations and Comprehensive Loss. Interest expense incurred on finance lease liabilities is recorded in Interest expense in the Consolidated Statements of Operations and Comprehensive Loss. The Company has elected not to recognize ROU assets and lease liabilities that arise from short-term (12 months or less) leases for any class of underlying asset. Additionally, the Company does not separate lease and non-lease components. Operating leases are included in Operating lease right-of-use assets, net, Operating lease liabilities, current portion and Operating lease liabilities, long term portion in the Company's Consolidated Balance Sheets. Finance leases are included in Property, plant and equipment, net, Other financing liabilities, current portion, and Other financing liabilities, long term portion in the Company's Consolidated Balance Sheets. The Company’s lease arrangements primarily consist of corporate office, store, and vehicle lease agreements. The leases expire on various dates through 2032, some of which include options to extend the lease term for additional five ASC 842 Disclosures During 2024, the Company moved out of its leased facilities and office spaces, resulting in a write-down of right-of-use assets and lease liabilities in an aggregate amount of $8.8 million and $7.0 million, respectively. The Company also recognized less than $0.1 million in lease termination costs during 2024. The net impact of the right-of-use asset write down and lease termination costs of $1.8 million is reported in Lease impairment, net on the Consolidated Statements of Operations and Comprehensive Loss for the year ended December 31, 2024. There were no lease impairments for the year ended December 31, 2023. Lease cost includes both the fixed and variable expenses recorded for leases. The components of lease cost for the were as follows: Years Ended December 31, (in thousands) 2024 2023 Finance lease cost Amortization of ROU assets $ — $ 273 Interest on lease liabilities — 275 Total finance lease cost — 548 Operating lease cost 4,389 5,915 Variable lease cost 398 257 Total lease cost $ 4,787 $ 6,720 The following table summarizes future lease payments: (in thousands) Years Ending December 31, Operating Leases 2025 $ 2,243 2026 12 2027 2 Total 2,257 Less: Imputed Interest 115 Present value of net lease payments $ 2,142 Lease liability, current portion $ 2,128 Lease liability, net of current portion 14 Total lease liability $ 2,142 Supplemental information and non-cash activities related to operating and finance leases are as follows: Years Ended December 31, (in thousands) 2024 2023 Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases $ 3,230 $ 5,709 Operating cash flows from finance leases — 275 Financing cash flows from finance leases — 1,016 $ 3,230 $ 7,000 Lease assets obtained in exchange for operating lease liabilities $ 30 $ — Years Ended December 31, 2024 2023 Weighted average remaining lease term (in years) Operating leases 0.70 5.70 Finance leases 0.00 5.00 Weighted average discount rate Operating leases 16.4 % 15.6 % Finance leases — % 9.2 %"]

{"sheet":"Commitments and Contingencies","index":17,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Commitments and Contingencies","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Commitments and Contingencies Disclosure [Abstract]"," "]
["Commitments and Contingencies",{"$cut":{"chars":32767,"head":"Commitments and Contingencies The Company is, from time to time, subject to claims and disputes arising in the normal course of business. In the opinion of management, the outcome of any such claims and disputes cannot be predicted with certainty. Legal Proceedings Against the Company As of December 31, 2024 and December 31, 2023, the Company had accrued legal contingencies of $9.1 million and $21.6 million, respectively, recorded within Accrued expenses and other current liabilities and Accounts payable for potential financial exposure related to ongoing legal matters, primarily related to breach of contracts and employment matters, which are deemed both probable of loss and reasonably estimable. Class and Derivative Actions Zhou v. Faraday Future Intelligent Electric Inc. f/k/a Property Solutions Acquisition Corp. et al., Case No. 2:21-cv-009914 (U.S. District Court – Central District of California). On December 23, 2021, a putative class action lawsuit alleging violations of the Exchange Act was filed in the United States District Court, Central District of California, against the Company and its former Chief Executive Officer and Chief Financial Officer, and its current Chief Product and User Ecosystem Officer, as well as the Co-CEOs of Property Solutions Acquisition Corp. (“PSAC”). On May 6, 2022, the appointed lead plaintiffs in the Zhou putative class action filed an amended complaint alleging violations of Sections 10(b), 14(a) and 20(a) of the Exchange Act, Sections 11 and 15 of the Securities Act , and related “control” person claims for secondary liability under those statutes, seeking unspecified damages. Following motion to dismiss briefing which resulted in the dismissal of several of the plaintiffs’ claims, answers were filed and the parties agreed to participate in mediation. On April 27, 2023, the court granted the parties’ joint motion for a temporary stay pending mediation. The parties thereafter participated in a private mediation on June 29, 2023. After further discussions and negotiations, the parties reached an agreement-in-principle to settle the Zhou putative class action. Although denying all allegations, the Company nevertheless agreed to settle the Zhou putative class action for a non-reversionary cash payment of $7.5 million for the benefit of the settlement class and to be funded entirely by the Company’s insurers, in exchange for the release of all claims asserted against the Company. The court granted preliminary approval of the settlement on November 7, 2023, and scheduled a hearing for final approval of the settlement to take place on March 18, 2024. On January 23, 2024, the ostensible lead plaintiff in the Consolidated Delaware Class Action discussed below, filed an Objection to final approval of the settlement (the “Objection”) to which the Company and the other defendants responded on March 11, 2024. On March 18, 2024, the court overruled the Objection in its entirety and entered an Order finally approving the Zhou putative class action settlement. Farazmand v. Breitfeld et al. , Case No. 2:22-cv-01570 (U.S. District Court – Central District of California). Zhou v Breitfeld et al. , Case No. 2:22-cv-01852 (U.S. District Court – Central District of California). Moubarak v. Breitfeld et al. , Case No. 1:22-cv-00467 (U.S. District Court – District of Delaware). Wang v. Breitfeld et al. , Case No. 1:22-cv-00525 (U.S. District Court – District of Delaware). Wallace v. Breitfeld et al. , Case No. 2023-0639-KSJM (Delaware Court of Chancery). Ashkan Farazmand and Wangjun Zhou v. Breitfeld, et al., Case No. 2023-1283 (Delaware Court of Chancery). On March 8 (Farazmand) and March 21 (Zhou), 2022, putative stockholder derivative lawsuits were respectively filed in the United States District Court, Central District of California and were subsequently consolidated in an action entitled In re Faraday Future Intelligent Electric Inc. Case No. 2:22-cv-1570 (the “California Federal Derivative Action”). The California Federal Derivative Action was stayed pending resolution of certain proceedings in the"}}]

{"sheet":"Stockholders_ Equity","index":18,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Stockholders’ Equity","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Equity [Abstract]"," "]
["Stockholders’ Equity",{"$cut":{"chars":24915,"head":"Stockholders’ Equity The number of authorized, issued and outstanding stock, were as follows: December 31, 2024 Authorized Issued Shares Preferred Stock 10,000,000 1 Class A Common Stock 99,815,625 65,919,127 Class B Common Stock 4,429,688 6,667 114,245,313 65,925,795 December 31, 2023 Authorized Issued Shares Preferred Stock 10,000,000 — Class A Common Stock 1,232,292 1,060,833 Class B Common Stock 54,688 6,667 11,286,980 1,067,500 Amendments to the Company’s Certificate of Incorporation On the Closing Date of the Business Combination, the Company’s shareholders adopted the Company’s Second Amended and Restated Certificate of Incorporation. The amendment set forth the rights, privileges, and preferences of the Common Stock. The amendment authorizes the issuance of 10,000,000 shares of Preferred Stock with such designations, rights and preferences as may be determined from time to time by the Board. The Board is empowered, without stockholder approval, to issue the Preferred Stock with dividend, liquidation, conversion, voting or other rights which could adversely affect the voting power or other rights of the holders of Common Stock; provided that any issuance of preferred stock with more than one vote per share will require the prior approval of the holders of a majority of the outstanding shares of Class B Common Stock. Increase in Authorized Shares (February 2023) A special meeting of the Company’s stockholders held on February 28, 2023, the Company’s stockholders approved a further increase to the number of the Company’s authorized shares of Class A Common Stock from 84,896 to 176,042, increasing the Company’s total number of authorized shares of Common Stock and preferred stock from 342,709 to 433,855. On March 1, 2023, the Company filed an amendment to its Second Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware to reflect such amendment. Reverse Stock Split (August 2023) Additionally, at a special meeting of the Company’s stockholders held on August 16, 2023, the Company’s stockholders approved a proposal authorizing the Board to effect a reverse stock split of the outstanding Common Stock at a range between 1-for-2 and 1-for-90 shares of outstanding Common Stock, and a proposal stating that a reverse stock split is implemented at a ratio of 1-for-8 or greater. On August 22, 2023, the Board approved the Reverse Stock Split ratio (1-for-80). Accordingly, on August 24, 2023, the Company filed the Third Amended and Restated Certificate of Incorporation of the Company to effect the Reverse Stock Split and to set the number of authorized shares of Common Stock to 1,286,980. As a result, effective August 25, 2023, every 80 shares of the issued and outstanding Common Stock were converted into one share of Common Stock, without any change in par value per share, and the authorized shares of Common Stock were reduced to 1,286,980, composed of (i) 1,232,292 shares of Class A Common Stock and (ii) 54,688 shares of Class B Common Stock. No fractional shares of Common Stock were issued as a result of the Reverse Stock Split. Stockholders who would otherwise have received a fractional share were instead issued a full share in lieu of such fractional share. The Class A Common Stock began trading on The Nasdaq Capital Market on a split-adjusted basis at the opening of trading on August 28, 2023, under the symbol \"FFIE\" with a new CUSIP number (307359 505); meanwhile, the Company’s Public Warrants traded under the symbol \"FFIEW\" with the CUSIP number unchanged. Increase in Authorized Shares and Reverse Stock Split (February 2024) On February 5, 2024, the Company filed an amendment to the Company’s Third Amended and Restated Certificate of Incorporation, as amended, with the office of the Secretary of the State of Delaware to effect an increase in the authorized shares of Common Stock from 3,860,938 to 34,748,438. At a special meeting of the Company’s stockholders held on February 5, 2024, the Company’s stockholders approved an amendment to the Company’s Third Amended and Restat"}}]

{"sheet":"Stock-Based Compensation","index":19,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Stock-Based Compensation","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Share-Based Payment Arrangement [Abstract]"," "]
["Stock-Based Compensation","Stock-Based Compensation 2021 Plan In July 2021, the Company adopted the 2021 Stock Incentive Plan (“2021 Plan”). The 2021 Plan allows the Board of Directors to grant up to 5,164 incentive and nonqualified stock options, restricted shares, unrestricted shares, restricted share units, and other stock-based awards for the Class A Common Stock to employees, directors, and non-employees. The number of shares of Class A Common Stock available under the 2021 Plan will increase annually on the first day of each calendar year, beginning with the calendar year ending December 31, 2023, and continuing until (and including) the calendar year ending December 31, 2031. Annual increases are equal to the lesser of (i) 5 percent of the number of shares of Class A Common Stock issued and outstanding on December 31 of the immediately preceding fiscal year and (ii) an amount determined by the Board. As of the effective date of the 2021 Plan, no further stock awards have been or will be granted under the EI Plan or STI Plan (defined below). At the annual meeting of stockholders held on July 31, 2024, the Company’s stockholders approved (among other proposals) an amendment to the 2021 Plan to increase the number of shares of Class A Common Stock available for issuance under the 2021 Plan by an additional 2,206,324 shares, subject to proportionate adjustment for stock splits and similar events as provided in the 2021 Plan. As of December 31, 2024, and 2023 the Company had 530,131 and 2,527 shares of Class A Common Stock available for future issuance under the 2021 SI Plan. Option Awards A summary of the Company’s stock option activity under the 2021Plan is as follows: (dollars in thousands except weighted average exercise price) Number of Weighted Weighted Aggregate Outstanding as of December 31, 2022 693 $ 26,496.00 8.97 $ — Granted 313 $ 10,368.00 Exercised (6) $ 8,544.00 Expired/forfeited (202) $ 28,020.00 Outstanding as of December 31, 2023 798 $ 19,885.20 8.74 $ 5,351 Expired/forfeited (390) $ 20,794.36 Outstanding as of December 31, 2024 408 $ 21,156.47 7.59 $ 8,317 Exercisable as of December 31, 2024 286 $ 21,480.84 7.58 $ 5,940 As of December 31, 2024, the total unrecognized stock-based compensation expense for stock options granted under the 2021 Plan was less than $0.1 million, which is expected to be recognized over a weighted average period of 2.26 years. There were no options granted under the 2021 Plan during the year ended December 31, 2024. The weighted-average assumptions used in the Black-Scholes option pricing model for awards granted during the year ended December 31, 2023 are as follows: 2023 Risk-free interest rate: 3.53 % Expected term (in years): 8.71 Expected volatility: 89.62 % Dividend yield: 0 % The total grant date fair value of options vested during the years ended December 31, 2024 and 2023 was $2.0 million and $2.5 million, respectively. Restricted Stock Units A summary of the Company’s RSU activity under the 2021 Plan is as follows: (dollars in thousands except weighted average fair value) Shares Weighted Average Fair Value Outstanding as of December 31, 2022 (1) 1,862 $ 10,464.00 Granted 2,551 $ 2,702.00 Released (650) $ 10,329.60 Forfeited (878) $ 9,817.60 Outstanding as of December 31, 2023 2,885 $ 3,784.80 Granted 1,797,111 $ 3.72 Released (1,322,382) $ 1.31 Forfeited (37,207) $ 2.32 Outstanding as of December 31, 2024 440,407 $ 3.61 (1) The Company’s subsidiaries in China have employees who are citizens of the PRC. Pursuant to the regulation Circular 78 and Circular 7 issued by the Central State Administration of Foreign Exchange of PRC (“SAFE”), we cannot release vested RSUs to it’s PRC citizen employees before they have completed the required SAFE registration with a dedicated account set up for each of them to repatriate proceeds back to China under the SAFE. As a result, 151 RSUs of the Company’s PRC citizens employees vested in 2022 were included in the outstanding RSUs at December 31, 2022 as unreleased RSUs because those employees did not complete the SAFE registration process. As of December 31, 2024, the total unrecognized stock-based compensation expense for RSUs granted under the 2021 Plan was $0.8 million which is expected to be recognized over a weighted average period of 1.71 years. The total fair value of RSUs vested during the years ended December 31, 2024 and 2023 was $8.4 million and $4.4 million, respectively. EI Plan On February 1, 2018, the Board adopted the Equity Incentive Plan (“EI Plan”), under which the Board authorized the grant of up to 4,416 incentive and nonqualified stock options, restricted stock, unrestricted stock, restricted stock units, and other stock-based awards for Legacy FF’s Class A Ordinary Stock to employees, directors and non-employees. On the closing date and in connection with the Business Combination, each of the Legacy FF’s outstanding options under the EI Plan immediately prior to the closing of the Business Combination remained outstanding and converted into the right to purchase the Company’s Class A Common Stock based on the Exchange Ratio. A summary of the Company’s stock option activity under the EI Plan is as follows: (dollars in thousands except weighted average exercise price) Number of Weighted Weighted Aggregate Outstanding as of December 31, 2022 2,440 $ 27,168.00 6.92 $ 22 Expired/forfeited (409) $ 31,130.40 Outstanding as of December 31, 2023 2,031 $ 26,408.80 5.92 $ 31,743 Expired/forfeited (82) $ 28,973.01 Outstanding as of December 31, 2024 1,949 $ 26,237.95 4.84 $ 50,054 Exercisable as of December 31, 2024 1,931 $ 26,077.74 4.83 $ 49,283 The total grant date fair value of options vested during the years ended December 31, 2024 and 2023 was $2.3 million and $9.3 million, respectively. As of December 31, 2024, the total unrecognized stock-based compensation expense for stock options granted under the EI Plan was less than $0.1 million which is expected to be recognized over a weighted average period of 1.69 years. STI Plan On May 2, 2019, the Company adopted its Special Talent Incentive Plan (“STI Plan”) under which the Board may grant up to 1,472 incentive and nonqualified stock options, restricted shares, unrestricted shares, restricted share units, and other stock-based awards for Legacy FF’s Class A Ordinary Stock to employees, directors, and non-employees. The STI Plan does not specify a limit on the number of stock options that can be issued under the plan. Per the terms of the STI Plan the Company must reserve and keep available a sufficient number of shares to satisfy the requirements of the STI Plan. A summary of the Company’s stock option activity under the STI Plan is as follows: (dollars in thousands except weighted average exercise price) Number of Weighted Weighted Aggregate Outstanding as of December 31, 2022 586 $ 60,864.00 6.94 $ — Expired/forfeited (22) $ 78,722.80 Outstanding as of December 31, 2023 564 $ 60,169.20 6.64 $ 16,318 Expired/forfeited (77) $ 95,528.84 Outstanding as of December 31, 2024 487 $ 52,893.32 5.50 $ 25,481 Exercisable as of December 31, 2024 374 $ 41,906.97 5.23 $ 15,448 The total grant date fair value of options vested during the years ended December 31, 2024 and 2023 was $7.8 million and $1.7 million, respectively. As of December 31, 2024, the total unrecognized stock-based compensation expense for stock options granted under the STI Plan was less than $0.1 million, which is expected to be recognized over a weighted average period of approximately 1.78 years. Stock-based compensation expense The following table presents stock-based compensation expense for all of the Company’s 2021 Plan, EI Plan, STI Plan and Common Units of FF Global included in each respective expense category in the Consolidated Statements of Operations and Comprehensive Loss is as follows: Years Ended December 31, (in thousands) 2024 2023 Research and development $ 2,670 $ 6,812 Sales and marketing 915 807 General and administrative 4,797 1,548 $ 8,382 $ 9,167 Included in stock-based compensation expense for the year ended December 31, 2023 is $4.1 million related to when the Company’s share-based payment awards were classified as liabilities from time to time during the year ended December 31, 2023."]

{"sheet":"Fair Value of Financial Instrum","index":20,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Fair Value of Financial Instruments","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Fair Value Disclosures [Abstract]"," "]
["Fair Value of Financial Instruments","Fair Value of Financial Instruments Cash Equivalents The fair value of the Company’s money market funds is based on the closing price of these assets as of the reporting date, which are included in cash equivalents. The Company’s money market funds are classified within Level 1 of the fair value hierarchy because they are valued using quoted prices for identical instruments in active markets. The Company had no cash equivalents on December 31, 2024 and 2023. Notes Payable & Related Party Notes Payable The Company has elected to measure certain notes payable and related party notes payable at fair value. Specifically, the SPA Portfolio Notes or notes convertible into SPA Portfolio Notes as they contain embedded liquidation premiums with conversion rights that represent embedded derivatives (see Note 7, Notes Payable and Note 8, Related Party Transactions ). The Company used a binomial lattice model and discounted cash flow methodology to value the notes carried at fair value. The significant assumptions used in the models include the volatility of the Class A Common Stock, the Company’s expectations around the full ratchet anti-dilution trigger, the Company’s debt discount rate based on a CCC rating, annual dividend yield, and the expected life of the instrument. Fair value measurements associated with the notes payable and related party notes payable represent Level 3 valuations under the fair value hierarchy. The fair value adjustments related to notes payables and related party notes payable were recorded in Change in fair value of notes payable, warrant liabilities, and derivative call options or Change in fair value of related party notes payable and related party warrant liabilities, respectively, in the Consolidated Statements of Operations and Comprehensive Loss. For notes payable and related party notes payable where the Company did not elect the fair value option pursuant to ASC 825, Financial Instruments, the carrying value approximates the fair value of the obligation. SPA Portfolio Note Warrants The Company is required to measure certain SPA Portfolio Note warrants at fair value. The Company uses a Monte Carlo simulation model to measure the fair value of the liability classified SPA Warrants, where the significant assumptions used include the volatility of the Company’s Class A Common Stock, the Company’s expectations around the full ratchet anti-dilution trigger, the contractual term of the warrant, the risk-free rate and annual dividend yield. Fair value measurements associated with the liability-classified warrants represent Level 3 valuations under the fair value hierarchy. The fair value adjustments related to the liability classified warrants were recorded in Change in fair value of notes payable, warrant liabilities, and derivative call options or Change in fair value of related party notes payable and related party warrant liabilities, in the Consolidated Statements of Operations and Comprehensive Loss Public and Private Warrants Upon the closing of the Business Combination, the Company assumed 2,394 Public Warrants and 62 Private Warrants from PSAC. The Company also issued 9 Private Warrants to settle related party notes of PSAC. The Public Warrants are indexed to the Company’s own stock and, as such, meet the scope exception in accordance with ASC 815-40 to be classified in equity. The Private Warrants are classified as liabilities and the fair value is included in Warrant liabilities in the Consolidated Balance Sheets. The Company valued the Private Warrants using a binomial lattice model. Inherent in a binomial lattice model are assumptions related to risk free rate, annual dividend yield, expected warrant life, and volatility of the Company's stock. The Company estimated the fair value of the Private Warrants to be zero and $0.1 million as of December 31, 2024, and 2023, respectively. Changes in the fair value of the Private Warrants are recorded in Change in fair value of notes payable, warrant liabilities, and derivative call options in the Company’s Consolidated Statements of Operations and Comprehensive Loss. Fair value measurements associated with the Private Warrants liabilities represent Level 3 valuations under the fair value hierarchy. Derivative Call Options The Junior Secured SPA investors and the 2024 Unsecured SPA investors were issued Incremental Warrants to purchase additional Junior Secured SPA Notes and 2024 Unsecured SPA Notes, respectively, up to the amounts originally funded under their commitments. The Company estimates the fair value of the Incremental Warrants using a Monte Carlo simulation model where the significant assumptions used include the volatility of the Company’s Class A Common Stock, the Company’s expectations around the full ratchet trigger, the contractual term of the Incremental Warrants, the risk-free rate and annual dividend yield. The underlying convertible notes and the warrants issuable upon the exercise of the Incremental Warrant were assumed to be exercisable up to the maximum allowable amount. Additionally, the terms of these instruments were presumed to be consistent with those of the convertible notes and warrants issued in connection with the Incremental Warrants. Fair value measurements associated with the liability-classified derivatives represent Level 3 valuations under the fair value hierarchy. The fair value adjustments related to the Incremental Warrants were recorded in Change in fair value of notes payable, warrant liabilities, and derivative call options in the Consolidated Statements of Operations and Comprehensive Loss Liabilities due to Insufficient Authorized Shares From time to time, certain of the Company’s equity-linked financial instruments may be classified as derivative liabilities under ASC 815, Derivatives and Hedging, due to the Company having insufficient authorized shares to fully settle the equity-linked financial instruments in shares. See Note 12, Stockholders' Equity . As of December 31, 2024, the Company did not have any instruments classified as a liability due to insufficient authorized shares. Recurring Fair Value Measurements Financial assets and financial liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The following tables present financial assets and liabilities remeasured on a recurring basis by level within the fair value hierarchy: December 31, 2024 (in thousands) Level 1 Level 2 Level 3 Liabilities: Warrant liabilities 1 $ — $ — $ 28,864 Derivative call options $ — $ — $ 29,709 Notes payable 1 $ — $ — $ 46,628 1 Includes both related party and non-related party balances for the Company’s notes payable and warrant liabilities. December 31, 2023 (in thousands) Level 1 Level 2 Level 3 Liabilities: Warrant liabilities 1 $ — $ — $ 306 Notes payable 1 — — 86,712 1 Includes both related party and non-related party balances for the Company’s notes payable and warrant liabilities. There were not any transfers of assets and liabilities between Level 1, Level 2 and Level 3 of the fair value measurement hierarchy during the year ended December 31, 2024. The carrying amounts of the Company’s financial assets and liabilities, including cash, restricted cash, deposits, accounts payable, accrued liabilities and notes payable, other than the SPA Portfolio Notes, approximate fair value because of their short-term nature or contractually defined value. The following table summarizes the activity of Level 3 fair value measurements: (in thousands) Warrant Liabilities 1 Derivative Call Option Notes Payable 1 Balance as of December 31, 2023 $ 306 $ — $ 86,712 Additions 34,441 14,267 58,789 Debt extinguishments — — 2,699 Change in fair value measurements (5,723) 15,442 (34,460) Reclassification of liability classified warrants to equity (160) — — Conversions of notes to Class A Common Stock — — (67,112) Balance as of December 31, 2024 $ 28,864 $ 29,709 $ 46,628 1 Includes both related party and non-related party balances for the Company’s notes payable and warrant liabilities."]

{"sheet":"Income Taxes","index":21,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Income Taxes","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Income Tax Disclosure [Abstract]"," "]
["Income Taxes","Income Taxes The provision for income tax consisted of the following: (in thousands) 2024 2023 Current: Federal $ — $ — State (4) 2 Foreign (263) 107 (267) 109 Deferred: Federal (21,218) (48,499) State (10,013) (22,277) Foreign (504) 6,577 (31,735) (64,199) Valuation allowance 31,735 64,199 — — $ (267) $ 109 The components of losses before income taxes, by taxing jurisdiction, were as follows for the years ended December 31,: (in thousands) 2024 2023 U.S. $ (324,929) $ (411,790) Foreign (31,185) (19,845) $ (356,114) $ (431,635) Reconciliation of Statutory Federal Tax Rate to Effective Tax Rate The provision for income taxes for the years ended December 31, 2024, and 2023 differs from the amount computed by applying the statutory federal corporate income tax rate of 21% to losses before income taxes. The following adjustments account for these differences for the years ended December 31, 2024, and 2023: 2024 2023 Federal income tax expense 21.0 % 21.0 % State income taxes (net of federal benefit) 2.3 % 4.1 % Other permanent differences (1.4) % (0.7) % Fair value debt adjustments (10.3) % (5.8) % Disallowed interest (1.8) % (1.2) % Foreign tax rate difference 0.1 % 0.2 % Prior year true-up on deferred taxes (0.2) % (0.1) % Return-to-provision adjustment (1.3) % — % Uncertain tax benefit 0.8 % (1.0) % Expiration of tax attributes (0.3) % (1.8) % Valuation allowance (9.0) % (14.7) % 0.1 % 0.0 % These adjustments result in an effective tax rate of 0.1% in 2024 compared to 0.0% in 2023. The main changes in permanent differences related to fair value adjustments on convertible related party notes payable and notes payable and disallowed interest expense. The main changes in foreign tax rate difference and valuation allowance related to lower foreign losses incurred in 2024. Deferred Tax Assets & Liabilities and Valuation Allowance The tax effects of temporary differences for the years ended December 31, 2024, and 2023 that give rise to significant portions of the deferred tax assets and deferred tax liabilities are provided below: (in thousands) 2024 2023 Deferred Tax Assets: Net operating losses (“NOL”) $ 411,244 $ 353,839 Research and development credits 4,239 4,239 Accrued liabilities 25,581 16,646 Capital loss — 3,420 Amortization 8,803 9,921 Capitalized R&D expense 53,125 74,835 Stock-based compensation 450 418 Transaction costs 35 45 Other 379 594 Gross deferred tax assets 503,856 463,957 Valuation allowance (457,738) (426,003) Deferred tax assets, net of valuation allowance 46,118 37,954 Deferred Tax Liabilities: Depreciation (20,174) (14,113) State taxes (25,944) (23,841) Gross deferred tax liabilities (46,118) (37,954) Net deferred tax assets (liabilities) $ — $ — The Company has recognized a full valuation allowance as of December 31, 2024, and 2023 since, in the judgment of management given the Company’s history of losses, the realization of these deferred tax assets was not considered more likely than not. The valuation allowance was $457.7 million and $426.0 million as of December 31, 2024, and 2023, respectively, with increases attributable to the current year’s provision. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the period in which those temporary differences become deductible. Management considers projected future taxable income and tax planning strategies in making this assessment. During December 31, 2024 and 2023, the Company evaluated the realizability of its net deferred tax assets based on available positive and negative evidence and concluded that the likelihood of realization of the benefits associated with its net deferred tax assets does not reach the level of more likely than not due to the Company’s history of cumulative pre-tax losses and risks associated with the generation of future income given the current stage of the Company’s business. The following table summarizes the valuation allowance: (in thousands) 2024 2023 Beginning balance $ 426,003 $ 361,804 Increase related to current year tax positions 31,735 64,199 Ending balance $ 457,738 $ 426,003 Net Operating Loss Carryforwards and R&D tax credit carryforward As of December 31, 2024, the Company has U.S. federal net operating loss carryforwards of $1,328.5 million, which will begin to expire in 2034, and foreign net operating loss carryforwards of $48.0 million, began expiring in 2024. The U.S. federal net operating loss carryforwards of $1,247.5 million generated post the Tax Cuts and Jobs Act may be carried forward indefinitely, subject to the 80% taxable income limitation on the utilization of the carryforwards. The U.S. federal net operating loss carryforwards of $80.5 million generated prior to December 31, 2017 may be carried forward for twenty years. As of December 31, 2024, the Company has California net operating loss carryforwards of $1,360.2 million, which will begin to expire in 2034. The Company has 2035 U.S. federal R&D tax credit carryforwards and a state R&D tax credit carryforward of $4.2 million as of December 31, 2024 which will begin to expire in 2035. The U.S. state tax credits do not expire and can be carried forward indefinitely. In accordance with Internal Revenue Code Section 382 (“Section 382”) and Section 383 (“Section 383”), a corporation that undergoes an “ownership change” (generally defined as a cumulative change (by value) of more than 50% in the equity ownership of certain stockholders over a rolling three-year period) is subject to limitations on its ability to utilize its pre-change NOLs and R&D tax credits to offset post-change taxable income and post-change tax liabilities, respectively. The Company’s existing NOLs and R&D credits may be subject to limitations arising from previous ownership changes, and the ability to utilize NOLs could be further limited by Section 382 and Section 383 of the Code. In addition, future changes in the Company’s stock ownership, some of which may be outside of the Company’s control, could result in an ownership change under Section 382 and Section 383 of the Code. Reinvestment of Earnings The Company’s intention is to indefinitely reinvest earnings in all jurisdictions outside the United States. As of December 31, 2024, and 2023, there was no material cumulative earnings outside the United States due to net operating losses and the Company has no earnings and profits in any jurisdiction, that if distributed, would give rise to a material unrecorded liability. Tax Jurisdictions The Company is subject to taxation and files income tax returns with the U.S. federal government, the state of California, , as well as under the tax laws of the People’s Republic of China. As of December 31, 2024, the 2020 through 2024 federal income tax returns and 2019 through 2024 state income tax returns are open to exam. Th e Company is not under any income tax audits. All of the prior year income tax returns, from 2018 through 2024, are open under China tax law. Uncertain Income Tax Position The aggregate change in the balance of unrecognized tax benefits for the years ended December 31, 2024, and 2023 is as follows: (in thousands) 2024 2023 Beginning balance $ 12,972 $ 8,807 Increase related to current year tax positions 389 4,165 Decrease related to prior year positions (3,274) — Ending balance $ 10,087 $ 12,972 In accordance with ASC 740-10, Income Taxes — Overall , the impact of an uncertain income tax position on the income tax return must be recognized at the largest amount that is more likely than not to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. No interest and penalties related to the Company’s unrecognized tax benefits was accrued as of December 31, 2024, and 2023, as the uncertain tax benefit only reduced the net operating losses. The Company does not expect its uncertain income tax positions to have a material impact on its consolidated financial statements within the next twelve months. As of December 31, 2024 and 2023, the realization of uncertain tax positions were not expected to impact the effective rate due to a full valuation allowance on federal and state deferred taxes."]

{"sheet":"Net Loss per Share","index":22,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Net Loss per Share","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Earnings Per Share [Abstract]"," "]
["Net Loss per Share","Net Loss per Share Net Loss Per Share Attributable to Common Stockholders Basic net loss per share attributable to common stockholders is calculated by dividing net loss attributable to common stockholders by the weighted-average number of shares issued and shares to be issued under the commitment to issue shares, as these shares are issuable for no consideration. Diluted net loss per share attributable to common stockholders adjusts the basic net loss per share attributable to common stockholders and the weighted-average number of shares issued and shares to be issued under the commitment to issue shares for potentially dilutive instruments. The following data shows the amounts used in computing net loss per share and the effect on net loss and the weighted-average number of shares for the years ended December 31, 2024, and 2023: (in thousands, except share and per share amounts) 2024 2023 Net loss $ (355,847) $ (431,744) Less: Deemed Dividend (7,576) — Net loss available to common stockholders $ (363,423) $ (431,744) Weighted average shares used in computing net loss per share of Class A and B Common Stock: Basic 18,529,525 240,869 Diluted 18,529,525 240,869 Net loss per share of Class A and B Common Stock attributable to common stockholders: Basic $ (19.61) $ (1,792.44) Diluted $ (19.61) $ (1,792.44) The net loss per common share was the same for the Class A Common Stock and Class B Common Stock because they are entitled to the same liquidation and dividend rights and are therefore combined in the Consolidated Statements of Operations and Comprehensive Loss. Potentially Dilutive Shares The Company reported net losses for all periods presented, resulting in all potentially dilutive Common Stock equivalents being considered antidilutive and excluded from the calculation of net loss per share. The table below presents the potentially dilutive shares that were excluded from the computation of diluted net loss per share of Common Stock attributable to Common Stock stockholders due to their antidilutive effect as of December 31,: 2024 2023 Shares issuable upon conversion of SPA Portfolio Notes 41,054,586 1,069,202 Shares issuable upon conversion of Unsecured Convertible Notes 749,866 — Shares issuable upon exercise of equity classified SPA Portfolio Note warrants 15,238 13,906 Shares issuable upon exercise of liability classified SPA Portfolio Note warrants 16,720,384 — Other warrants 5,776,657 228,482 Stock-based compensation awards – Options 2,591 798 Stock-based compensation awards – RSUs 161,225 2,885 Public warrants 2,453 2,453 Private warrants 12 12 64,483,012 1,317,738 "]

{"sheet":"Subsequent Events","index":23,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Subsequent Events","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Subsequent Events [Abstract]"," "]
["Subsequent Events","Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that t he Consolidated Financial Statements were issued. Subsequent SPA Portfolio Notes Activity Subsequent to December 31, 2024, the Company issued 2024 Unsecured convertible notes to a third party totaling $20.0 million with due dates ranging from December 31, 2029 through January 22, 2030 at 10.00% interest. Principal and accrued interest are convertible at the option of the holder into Common Stock of the Company at a conversion price per share equal to the lower of a) stated conversion price or b) lowest VWAP of the five trading days immediately prior to the day on which lender provides conversion notice. Additionally, $18.6 million of principal and $1.1 million of interest of the Company’s SPA Portfolio Notes were conver ted into 17,034,826 shares of the Company’s Class A Common Stock. Related Parties Unsecured Convertible Note On February 11, 2025, $1.5 million of principal and $0.1 million of interest under Unsecured Convertible Note held by MHL were converted into 1,352,766 shares of Class A Common Stock pursuant to the terms of the agreement. Letter Agreements On January 28, 2025, the Company entered into a letter agreement (“September Letter Agreement”) with certain Junior Secured SPA Investors. Before stockholder approval, these investors agreed not to convert outstanding notes below the initial $5.24 conversion price. In return, the Company agreed to issue “True-Up Shares” after approval to adjust for any pre-approval conversions, based on a formula considering accrued interest and market pricing. On the same date, the Company entered into a similar letter agreement (“December Letter Agreement”) with certain 2024 Unsecured SPA Investors, modifying terms related to their previously disclosed investment. These investors agreed not to convert outstanding notes below the initial $1.16 conversion price before stockholder approval. The Company agreed to issue True-Up Shares post-approval using a similar adjustment formula. Additionally, if a resale registration statement becomes effective, and the conversion price exceeds the prior day's closing bid price, the conversion price will be adjusted downward. Both Letter Agreements include a provision preventing the issuance of shares if the Company's available authorized stock is insufficient. However, the Company must deliver the shares once sufficient stock becomes available. Settlement and Release Agreement On January 17, 2025, the Company entered into a Settlement and Release Agreement with HSL s.r.l. (“HSL”) to resolve outstanding claims with HSL. As part of the Settlement and Release Agreement, Faraday agreed to issue €1.15 million (approximately $1.185 million) worth of Class A Common Stock (the “Compensated Shares”) to HSL, with the number of shares based on a per share price of $1.53, which was the closing price of the Class A Common Stock on January 16, 2025, the trading day prior to the signing of the Settlement and Release Agreement. On January 17, 2025 the Company issued 774,183 shares of Class A common stock in lieu of the settlement. These shares remain restricted until the Registration Statement becomes effective. The settlement also included the cancellation of purchase orders and the resolution of claims related to item s without associated purchase orders. Additionally, the Company may issue extra shares or provide additional cash to HSL if the market value decreases by more than 5% between January 17, 2025, the issuance date of the Compensated Shares and the date when the Registration Statement is effective. Second Series A Preferred Stock On January 28, 2025, in connection with a purchase agreement entered into with Mr. Aydt, the Company’s Global CEO, the Company filed a Series A Certificate of Designation with the Secretary of State of the State of Delaware. The Series A Certificate of Designation designated one share of the Company’s Preferred Stock as the Second Series A Preferred and established the preferences, rights and limitations thereof. The closing of the sale and purchase of the share of the Second Series A Preferred was completed on January 28, 2025 for a purchase price of $100.00. See Note 12, Stockholders’ Equity. 2025 Senior Unsecured SPA Notes On March 21, 2025, the Company entered into a Securities Purchase Agreement with institutional investors for the sale of $41.0 million in senior unsecured convertible notes (“2025 Senior Unsecured SPA Notes”), of which approximately $39.5 million will be paid in cash and $1.5 million will convert from a prior loan. The financing includes common stock purchase warrants, Series B Preferred Stock, and incremental note purchase warrants, with closings expected to occur in four tranches subject to certain conditions. The Company may issue up to an additional $10.0 million in notes if additional investors join before the first closing. Faraday Future also agreed to register for resale the shares underlying the convertible notes and warrants within 45 days and maintain an effective registration. Uni vest Securities, LLC is acting as placement agent and will receive a cash fee of up to 8.0% of gross proceeds and warrants equal to 7.0% of the shares underlying the issued notes. The placement agent warrants have a five-year term and exercise prices ranging from $1.548 to 120% of the prior day’s closing stock price, depending on the tranche. The Company agreed to reimburse up to $0.2 million in expenses related to the transaction. Increase in Authorized Shares and Elimination of Preferred Stock On March 10, 2025, the Company amended its Certificate of Incorporation to increase authorized shares to 139,245,313, consisting of 129,245,313 shares of Common Stock and 10,000,000 shares of Preferred Stock. Additionally, the Company eliminated the previously designated Second Series A Preferred Stock following the redemption of its sole outstanding share on March 7, 2025. The eliminated share was returned to authorized but unissued Preferred Stock. See Note 12, "]

{"sheet":"Pay vs Performance Disclosure","index":24,"n_rows":4,"n_cols":3,"rows_kept":4,"merged":[[0,0,1,0],[0,1,0,2]]}
["Pay vs Performance Disclosure - USD ($) $ in Thousands","12 Months Ended"]
[null,"Dec. 31, 2024","Dec. 31, 2023"]
["Pay vs Performance Disclosure"," "," "]
["Net loss",{"v":-355847,"d":"$ (355,847)"},{"v":-431744,"d":"$ (431,744)"}]

{"sheet":"Insider Trading Arrangements","index":25,"n_rows":7,"n_cols":2,"rows_kept":7,"merged":[[0,0,1,0]]}
["Insider Trading Arrangements","3 Months Ended"]
[null,"Dec. 31, 2024"]
["Trading Arrangements, by Individual"," "]
["Rule 10b5-1 Arrangement Adopted","false"]
["Non-Rule 10b5-1 Arrangement Adopted","false"]
["Rule 10b5-1 Arrangement Terminated","false"]
["Non-Rule 10b5-1 Arrangement Terminated","false"]

{"sheet":"Insider Trading Policies and Pr","index":26,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Insider Trading Policies and Procedures","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Insider Trading Policies and Procedures [Line Items]"," "]
["Insider Trading Policies and Procedures Adopted","true"]

{"sheet":"Cybersecurity Risk Management a","index":27,"n_rows":18,"n_cols":2,"rows_kept":18,"merged":[[0,0,1,0]]}
["Cybersecurity Risk Management and Strategy Disclosure","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Cybersecurity Risk Management, Strategy, and Governance [Line Items]"," "]
["Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]","The Company recognizes the increasing complexity and significance of cybersecurity risks in safeguarding its technology, operations, and customer data. As an advanced electric vehicle manufacturer, the Company’s operations rely on interconnected digital infrastructure, cloud-based systems, and proprietary software platforms, making cybersecurity an essential component of its risk management framework. The Company has implemented a comprehensive cybersecurity program designed to identify, assess, mitigate, and respond to cybersecurity risks. This approach is informed by industry best practices, including the NIST Cybersecurity Framework (“CSF”) and Risk Management Framework (“RMF”). The program is designed to prevent disruptions to operations, protect critical assets, and ensure compliance with applicable regulations such as the California Consumer Privacy Act (“CCPA”), the General Data Protection Regulation (“GDPR”), and the Securities and Exchange Commission (“SEC”) cybersecurity disclosure requirements. The following disclosure outlines the Company’s cybersecurity risk management strategy, governance structure, incident response procedures, regulatory compliance efforts, and ongoing investments in cybersecurity. 1. Cybersecurity Risk Management The Company employs a structured cybersecurity risk management program that aligns with NIST CSF's five core functions: Identify, Protect, Detect, Respond, and Recover. The approach includes: • Risk Assessments: Regular evaluations of cyber risks across IT infrastructure, production systems, and cloud-based platforms. • Threat Detection and Monitoring: Deployment of Security Information and Event Management (SIEM) tools, intrusion detection systems, and endpoint security solutions to monitor cyber threats in real-time. • Third-Party Risk Management: Continuous evaluation of vendors and partners who have access to the Company’s sensitive data and operational networks. • Access Controls and Encryption: Implementation of multi-factor authentication (MFA), data encryption protocols, and network segmentation to reduce attack vectors. The Company integrates cybersecurity into its enterprise risk management (ERM) framework to ensure cyber threats are regularly evaluated as part of its business strategy and operational resilience efforts."]
["Cybersecurity Risk Management Processes Integrated [Flag]","true"]
["Cybersecurity Risk Management Processes Integrated [Text Block]","The Company has implemented a comprehensive cybersecurity program designed to identify, assess, mitigate, and respond to cybersecurity risks. This approach is informed by industry best practices, including the NIST Cybersecurity Framework (“CSF”) and Risk Management Framework (“RMF”). The program is designed to prevent disruptions to operations, protect critical assets, and ensure compliance with applicable regulations such as the California Consumer Privacy Act (“CCPA”), the General Data Protection Regulation (“GDPR”), and the Securities and Exchange Commission (“SEC”) cybersecurity disclosure requirements."]
["Cybersecurity Risk Management Third Party Engaged [Flag]","true"]
["Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]","true"]
["Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]","false"]
["Cybersecurity Risk Board of Directors Oversight [Text Block]","Cybersecurity oversight is a shared responsibility between the Company’s Board of Directors, senior management, and IT security leadership. The Board receives regular updates on cybersecurity risk exposure, incident response capabilities, and compliance efforts from management. The Company’s Senior Cybersecurity Engineer leads the execution of cybersecurity programs, including: • Developing and maintaining security policies. • Conducting periodic risk assessments and audits. • Managing incident response and recovery plans. • Providing reports to senior executives on security trends, vulnerabilities, and ongoing mitigation efforts. The Company enforces a top-down approach to cybersecurity governance, ensuring accountability and continuous risk monitoring at all levels of the organization."]
["Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]","Cybersecurity oversight is a shared responsibility between the Company’s Board of Directors, senior management, and IT security leadership. The Board receives regular updates on cybersecurity risk exposure, incident response capabilities, and compliance efforts from management."]
["Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]","o Board members currently hold formal cybersecurity certifications or direct experience in cybersecurity risk management. The Company continues to enhance Board education on cybersecurity trends and governance practices."]
["Cybersecurity Risk Role of Management [Text Block]","Management plays an active role in implementing cybersecurity policies, conducting risk evaluations, and ensuring compliance with regulatory requirements. The IT security team collaborates with third-party cybersecurity vendors, including Rapid7, Cisco, and Carbon Black, to enhance the Company’s security posture. Management is also responsible for employee training and awareness programs, ensuring that cybersecurity is embedded in the corporate culture. All employees complete mandatory cybersecurity training to recognize and mitigate phishing attempts, malware threats, and social engineering risks."]
["Cybersecurity Risk Management Positions or Committees Responsible [Flag]","true"]
["Cybersecurity Risk Management Positions or Committees Responsible [Text Block]","Management plays an active role in implementing cybersecurity policies, conducting risk evaluations, and ensuring compliance with regulatory requirements. The IT security team collaborates with third-party cybersecurity vendors, including Rapid7, Cisco, and Carbon Black, to enhance the Company’s security posture. Management is also responsible for employee training and awareness programs, ensuring that cybersecurity is embedded in the corporate culture. All employees complete mandatory cybersecurity training to recognize and mitigate phishing attempts, malware threats, and social engineering risks."]
["Cybersecurity Risk Management Expertise of Management Responsible [Text Block]","Management plays an active role in implementing cybersecurity policies, conducting risk evaluations, and ensuring compliance with regulatory requirements. The IT security team collaborates with third-party cybersecurity vendors, including Rapid7, Cisco, and Carbon Black, to enhance the Company’s security posture. Management is also responsible for employee training and awareness programs, ensuring that cybersecurity is embedded in the corporate culture. All employees complete mandatory cybersecurity training to recognize and mitigate phishing attempts, malware threats, and social engineering risks."]
["Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]","Management plays an active role in implementing cybersecurity policies, conducting risk evaluations, and ensuring compliance with regulatory requirements. The IT security team collaborates with third-party cybersecurity vendors, including Rapid7, Cisco, and Carbon Black, to enhance the Company’s security posture. Management is also responsible for employee training and awareness programs, ensuring that cybersecurity is embedded in the corporate culture. All employees complete mandatory cybersecurity training to recognize and mitigate phishing attempts, malware threats, and social engineering risks."]
["Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]","true"]

{"sheet":"Nature of Business and Organi_2","index":28,"n_rows":24,"n_cols":2,"rows_kept":24,"merged":[[0,0,1,0]]}
["Nature of Business and Organization, Basis of Presentation, and Summary of Significant Accounting Policies (Policies)","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Organization, Consolidation and Presentation of Financial Statements [Abstract]"," "]
["Principles of Consolidation","The Consolidated Financial Statements have been prepared in conformity with accounting principles generally accepted in the U.S. (“GAAP”) and include the accounts of the Company, its wholly-owned subsidiaries and all other entities in which the Company has a controlling financial interest, including the accounts of any variable interest entity, in which the Company has a controlling financial interest and for which it is the primary beneficiary in accordance with Accounting Standards Codification (“ASC”) 810, Consolidation (“ASC 810”). All intercompany transactions and balances have been eliminated upon consolidation."]
["Use of Estimates","Use of Estimates The preparation of the Consolidated Financial Statements in conformity with GAAP and in accordance with the rules and regulations of the U.S Securities and Exchange Commission (“SEC”) requires management to make estimates and assumptions which affect the reported amounts in the Consolidated Financial Statements. Estimates are based on historical experience, where applicable, and other assumptions which management believes are reasonable under the circumstances. On an ongoing basis management evaluates its estimates, including those related to the: (i) recognition and disclosure of contingent liabilities, including litigation reserves; (ii) fair value of related party notes payable and notes payable; (iii) calculations for evaluating potential long-term asset impairment; and (iv) valuation of warrants and other derivative instruments. Such estimates often require the selection of appropriate valuation methodologies and financial models and may involve significant judgment in evaluating ranges of assumptions and financial inputs. Actual results may differ from those estimates under different assumptions, financial inputs, or circumstances. Given the global economic climate, estimates are subject to additional volatility. As of the date the Company’s Consolidated Financial Statements were issued, the Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or to revise the carrying value of its assets or liabilities. However, these estimates and judgments may change as new events occur and additional information is obtained, which may result in changes being recognized in the Company’s Consolidated Financial Statements in future periods. Actual results could differ from those estimates and any such differences may have a material impact on the Company’s Consolidated Financial Statements."]
["Foreign Currency","Foreign Currency The Company determines the functional and reporting currency of each of its international subsidiaries based on the primary currency in which they operate. The functional currency of the Company’s foreign subsidiaries in China is their local currency, Chinese Yuan (“CNY”). For foreign subsidiaries where the functional currency is their local currency, assets and liabilities are translated into U.S. Dollars at exchange rates in effect at the balance sheet date, stockholders’ equity (deficit) is translated at the applicable historical exchange rate, and expenses are translated using the average exchange rates during the period. The effect of exchange rate changes resulting from the translation of the foreign subsidiary financial statements is accounted for as a component of accumulated other comprehensive income in the Consolidated Balance Sheets."]
["Concentration of Risk","Concentration of Risk Financial instruments, which subject the Company to concentrations of credit risk, consist primarily of cash, restricted cash, and deposits. Substantially all of the Company’s cash and restricted cash is held at financial institutions located in the United States of America and in the People’s Republic of China. The Company maintains its cash and restricted cash with major financial institutions. At times, cash and restricted cash account balances with any one financial institution may exceed Federal Deposit Insurance Corporation insurance limits ($250 thousand per depositor per institution) and China Deposit Insurance Regulations limits (CNY ¥500 thousand per depositor per institution). Management believes the financial institutions that hold the Company’s cash and restricted cash are financially sound and, accordingly, minimal credit risk exists with respect to cash and restricted cash. Cash and restricted cash held by the Company’s non-U.S. subsidiaries is subject to foreign currency fluctuations against the U.S. Dollar. If, however, the U.S. Dollar is devalued significantly against the Chinese Yuan, the Company’s cost to develop its business in China could exceed original estimates. The Company receives certain components from sole suppliers. The inability of a supplier to fulfill the Company’s supply requirements could materially impact future operating results."]
["Fair Value Measurements","Fair Value Measurements The Company applies the provisions of ASC 820, Fair Value Measurement , which defines a single authoritative definition of fair value, sets out a framework for measuring fair value, and expands on required disclosures about fair value measurements. The provisions of ASC 820 relate to financial assets and liabilities as well as other assets and liabilities carried at fair value on a recurring and nonrecurring basis. The standard clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. When determining the fair value measurements for assets and liabilities required or permitted to be either recorded or disclosed at fair value, the Company considers the principal or most advantageous market in which the Company would transact and assumptions that market participants would use when pricing the asset or liability. The accounting guidance for fair value measurement requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is as follows: Level 1 Valuations for assets and liabilities traded in active exchange markets, or interest in open-end mutual funds that allow a company to sell its ownership interest back at net asset value on a daily basis. Valuations are obtained from readily available pricing sources for market transactions involving identical assets, liabilities or funds. Level 2 Valuations for assets and liabilities traded in less active dealer, or broker markets, such as quoted prices for similar assets or liabilities or quoted prices in markets that are not active. Level 2 instruments typically include U.S. government and agency debt securities, and corporate obligations. Valuations are usually obtained through market data of the investment itself as well as market transactions involving comparable assets, liabilities or funds. Level 3 Valuations for assets and liabilities that are derived from other valuation methodologies, such as option pricing models, discounted cash flow models and similar techniques, and not based on market exchange, dealer, or broker-traded transactions. Level 3 valuations incorporate certain assumptions and projections in determining the fair value assigned to such assets or liabilities. Fair value estimates are made at a specific point in time based on relevant market information and information about the financial or nonfinancial asset or liability. ASC 825-10, Financial Instruments , allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (“fair value option”). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument are reported in earnings at each subsequent reporting date. The Company has elected to apply the fair value option to certain related party notes payable and notes payable with conversion features as discussed in Note 14, Fair Value of Financial Instruments. The Company did not separately report interest expense attributable to the notes payable accounted for pursuant to the fair value option in the Consolidated Statements of Operations and Comprehensive Loss because such interest was included in the determination of the fair value of the notes payable and changes thereto."]
["Reverse Stock Splits and Recasting of Per-Share Amounts","Reverse Stock Splits and Recasting of Per-Share Amounts On August 22, 2023, the Company's Board of Directors (the “Board”) approved the implementation of a 1-for-80 reverse stock split (the “Reverse Stock Split”) of the Common Stock and set the number of authorized shares of Common Stock to 3,860,938 (which is 308,875,000 divided by 80). The Reverse Stock Split was effected after market close on August 25, 2023, and shares of the Class A Common Stock and publicly traded warrants (the “Public Warrants”) began trading on a split-adjusted basis as of market open on August 28, 2023. As approved by the Company’s stockholders at a special meeting held on February 5, 2024, the Company filed an amendment to the Company’s Third Amended and Restated Certificate of Incorporation, as amended, with the office of the Secretary of the State of Delaware to effect an increase in the number of authorized shares of Common Stock from 3,860,938 to 34,748,438. On February 23, 2024, the Board approved the implementation of a 1-for-3 reverse stock split (the “Second Reverse Stock Split”) of the Common Stock and set the number of authorized shares of Common Stock to 11,582,813 (which is 34,748,438 divided by 3). The Second Reverse Stock Split was effected after market close on March 1, 2024, and shares of the Class A Common Stock par value $0.0001 per share and the Public Warrants began trading on a split-adjusted basis as of market open on July 31, 2024. On August 4, 2024, the Board approved the implementation of a 1-for-40 reverse stock split (the “Third Reverse Stock Split”) of the Common Stock and set the number of authorized shares of Common Stock to 104,245,313. The Third Reverse Stock Split was effected after market close on August 16, 2024, and shares of the Class A Common Stock par value $0.0001 per share and the Public Warrants began trading on a split-adjusted basis as of market open on August 19, 2024. "]
["Segments","Segments The Company operates in one operating segment and one reportable segment. T he Company’s Global CEO and Chief Product and User Ecosystem Officer, acting jointly serving as co-Chief Operating Decision Makers (“CODMs”), regularly evaluate the Company’s financial performance using consolidated financial information at the total-company level. The CODMs receive regular financial and operational reporting that focuses primarily on the Company's consolidated loss from operations, overall cash flows, liquidity, and strategic initiatives. For 2024, the Company adopted ASU 2023‑07 Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. Management has identified Loss from operations, as presented in the Company's Consolidated Statements of Operations and Comprehensive Loss, as the primary measure used by the CODMs to evaluate the performance of the business and allocate resources. This measure is critical for a going concern that must carefully manage its cash outflows, particularly given that the timing of its cash inflows is influenced by external investor decisions. The Company defines “significant segment expense” as controllable operating costs that are regularly provided to and reviewed by management, which include the expenses presented in the Consolidated Statements of Operations and Comprehensive Loss as Cost of revenue, Research and development, Sales and marketing, and General and administrative. Management closely tracks its expenditure on these key expense categories through regular reviews of cash balances, near‑term cash flow projections, monthly management reports, and project management reports. The CODMs, work in close collaboration with the Company’s business leaders to establish critical operational targets, set project timelines, and adjust spending plans. These leaders are responsible for implementing its strategic plans and revising targets and deadlines based on continuous internal communications and review meetings, thereby ensuring that any deviations from target spending or project timelines are promptly addressed. This rigorous oversight supports the Company’s strategic objectives to focus business activities the on the production, sales, and leasing of its FF 91 vehicles, and the planned launch of the FX Series vehicles. In addition, the Company defines “other segment items” as other operating expense adjustments that arise from lease or other impairments, gains and losses on the sale or disposition of its fixed assets, or other market‑driven factors that impact Loss from operations presented in the Consolidated Statements of Operations and Comprehensive Loss and are not part of the Company’s recurring and controllable operating costs . By segregating these “Other Segment Items” from “loss from operations,” the Company provides investors with a clear view of the expenses that management can directly influence versus those driven by external factors. Other potentially reportable items, such as separate automotive sales and leasing revenues (currently immaterial), geographic information, depreciation expense, interest expense, or other segment-specific activities, are not separately reviewed by the CODMs. Accordingly, these detailed segment components do not influence the CODMs’ decision-making or resource allocation processes and thus are not separately disclosed."]
["Reclassifications","Reclassifications In 2024, the Company reclassified $237.1 million of Loss on extinguishment of related party notes payable and notes payable into separate line items on the Consolidated Statements of Cash Flows to enhance financial reporting clarity. As a result, f or the year ended December 31, 2023, this amount was reclassified as $217.0 million in Loss on settlement of notes payable and $20.0 million in Loss on settlement of related party notes payable. In 2024, the Company reclassified $0.4 million from Loss (gain) on forgiveness of accounts payable and deposits, net to Other within the Consolidated Statements of Cash Flows for the year ended December 31, 2023. This reclassification increased the Other line item total from $0.7 million to $1.1 million in 2023. These reclassifications on the Consolidated Statements of Cash Flows had no impact on the Company's net cash provided by operating activities, investing activities, or financing activities. The previously reported 2023 amounts have been adjusted to conform to the 2024 presentation. Also in 2024, the Company reclassified $7.3 million of 2023 amounts from Accrued expenses and other current liabilities into Related party accrued expenses and other current liabilities to separately present the related party component within accrued expenses on the Consolidated Balance Sheets."]
["Cash and Cash Equivalents","Cash and Cash Equivalents The Company considers all highly liquid instruments with an original maturity of 90 days or less from the date of purchase to be cash equivalents. The Company holds cash balances and does not have any instruments classified as cash equivalents as of the reporting dates presented."]
["Inventory","Inventory Inventory is stated at the lower of cost or net realizable value and consists of raw materials, work in progress, and finished goods. The Company primarily computes cost using standard cost, which approximates cost on the first-in, first-out basis. Net realizable value is the estimated selling price of inventory in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. The Company assesses the valuation of inventory and periodically adjusts its value for estimated excess and obsolete inventory based upon expectations of future demand and market conditions, as well as damaged or otherwise impaired goods."]
["Property and Equipment, Net","Property, Plant and Equipment, Net Property, plant and equipment are stated at cost less accumulated depreciation and amortization. Expenditures for major renewals and betterments are capitalized, while minor replacements, maintenance and repairs, which do not extend the assets lives, are charged to operating expense as incurred. Upon sale or disposition, the cost and related accumulated depreciation or amortization are removed from the Consolidated Balance Sheets and any gain or loss is included in the Consolidated Statements of Operations and Comprehensive Loss. Depreciation and amortization on property and equipment is calculated using the straight-line method over the estimated useful lives of the assets and for leasehold improvements, over the term of the lease, if shorter. Useful Life Buildings 39 Building improvements 15 Computer hardware 5 Tooling, machinery, and equipment 5 to 10 Vehicles 5 Lease vehicles 7 Computer software 3 Leasehold improvements Shorter of 15 years or term of the lease Construction in process (“CIP”) consists of the construction activities related to the FF ieFactory California production facility in plant and tooling, machinery and equipment being built to serve the manufacturing of production vehicles. These assets are depreciated once put into service. The amounts capitalized in CIP that are held at vendor sites relate to the completed portion of work-in-progress of tooling, machinery and equipment built based on the Company’s specific needs. The Company may incur storage fees or interest fees related to CIP which are expensed as incurred. CIP is presented within Property, Plant, and Equipment, Net in the Consolidated Balance Sheets."]
["Impairment of Long-Lived Assets","Impairment of Long-Lived Assets The Company reviews its long-lived assets, consisting primarily of property and equipment and right-of-use assets (“ROU”), for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset (or asset groups) may not be recoverable. The Company performs impairment testing at the asset group level that represents the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. Recoverability of these assets is determined by comparing the forecasted undiscounted cash flows attributable to such assets, including any cash flows upon their eventual disposition, to the assets carrying values. If the carrying value of the assets exceeds the forecasted undiscounted cash flows, then the assets are written down to their fair value. Assets classified as held for sale are also assessed for impairment and such amounts are determined at the lower of the carrying amount or fair value, less costs to sell the asset. During 2024, the Company recorded an impairment charge related to its right-of-use assets. See Note 10, Leases"]
["Accumulated Other Comprehensive Income","Accumulated Other Comprehensive Income"]
["Revenue Recognition","Revenue Recognition The following table disaggregates our revenue by major source: (in thousands) 2024 2023 Automotive sales $ 495 $ 771 Automotive leasing 44 13 $ 539 $ 784 Automotive Sales Revenue The Company began the production of its first vehicle the FF 91 Futurist (the “FF 91,” “FF 91 Futurist”, or “FF 91 2.0 Futurist Alliance”) in March 2023 and started making deliveries to customers in August 2023. The Company recognizes automotive sales revenue in accordance with ASC Topic 606, Revenue from Contracts with Customers. Automotive sales revenue includes cash deliveries of new vehicles, and specific other features and services including home charger, charger installation, twenty-four-seven roadside assistance, over-the-air (“OTA”) software updates, internet connectivity and destination fees that meet the definition of a performance obligation under ASC 606. Revenue is recognized when control of the vehicle transfers upon delivery to the customer. Payments are typically received at the point control transfers or according to payment terms customary to the business as specified in the sales contract. Vehicle contracts do not contain a significant financing component. For obligations related to automotive sales, transaction prices are allocated among performance obligations based on relative standalone selling prices, determined using market prices, estimated internal costs, and comparable third-party offerings. The transaction price is allocated among the performance obligations in proportion to the standalone selling price of its performance obligations. Other features and services as discussed above are provisioned upon transfer of control of the vehicle and are required to be recognized on a straight-line basis over the performance period, as the Company has a stand-ready obligation to deliver such services to the customer. However, due to immateriality, revenue from other features and services are combined with the vehicle performance obligation and recognized upon the transfer of the vehicle. The Company provides certain customers with a residual value guarantee which may or may not be exercised in the future. Residual value guarantees provided to customers had an immaterial impact on revenue for the years ended December 31, 2024, and 2023. Automotive Leasing Revenue The Company accounts for its automotive leasing revenue program under ASC 606 and ASC Topic 842, Leases (“ASC 842”). Operating Leasing Program : The Company offers a vehicle operating leasing program in the U.S., allowing qualifying customers to lease a vehicle directly from the Company for a lease term of up to 36 months. At the end of the lease term, customers are generally required to return the vehicle to the Company, at which point the Company may either sell or re-lease the returned vehicle. Leasing revenue from operating leases is recognized on a straight-line basis over the lease term, as long as collectability is probable in accordance with ASC 842. If collectability of lease payments is not probable at lease commencement, lease income is recognized on a cash basis, meaning payments received are recorded as revenue only when collected. Depreciation expense related to leased vehicles is recorded in cost of automotive leasing revenue on a straight-line basis over the lease term, reflecting the expected residual value of the vehicles at lease termination. Upfront payments related to lease agreements are deferred and recognized as revenue on a straight-line basis over the respective lease term. Taxes collected from customers in connection with automotive leasing transactions are excluded from the transaction price and reported separately in accordance with ASC 606. Sales-Type Leasing Program : The Company enters into sales-type leases under ASC 842, in which customers have the right to purchase the leased vehicle at the end of the lease term, typically 36 months. A lease qualifies as a sales-type lease when the Company determines that the customer is reasonably certain to exercise the purchase option, and the Company therefore expects the customer to take title to the vehicle upon completion of all contractual payments. At lease commencement, if collectability of lease payments is probable, the Company derecognizes the leased vehicle and recognizes: • Automotive leasing revenue for the present value of lease payments and any guaranteed residual value. • Automotive leasing cost of revenue for the carrying value of the leased vehicle. If collectability is not probable at lease commencement, the Company defers revenue recognition and records lease payments received as a deposit liability. The leased vehicle remains on the Company's balance sheet until collectability becomes probable, at which point revenue is recognized. For the years ended December 31, 2024, and 2023, revenue recorded under this program was immaterial to the Company’s consolidated financial statements. Co-creation Arrangements As part of the Company’s Futurist Product Officers (“FPO”) Co-Creation Delivery program, which began in August 2023, the Company has entered into co-creation agreements with certain customers. This arrangement leverages select sales and leasing customers to provide valuable driving data, insights, marketing, and brand awareness for the FF 91 vehicle. In exchange for these services, the Company compensates customers through either a monthly consulting fee or a discount on their lease payments. The services provided are considered distinct and could be purchased separately from a third party. Management conducted a detailed evaluation of each customer’s services under the co-creation agreement, established relevant data points, and assigned a fair value to the services provided. Any payments exceeding the fair value of these services are treated as consideration paid to the customer and recorded as a reduction of revenue. For the years ended December 31, 2024, and 2023, the Company recognized $0.3 million and $0.4 million, respectively, in co-creation fees as a reduction of revenue in the Consolidated Statements of Operations and Comprehensive Loss. Additionally, the Company recorded $0.6 million and $0.4 million Customer Deposits The Company’s customers may reserve a vehicl e and preorder certain services by making a customer deposit, which is fully refundable at any time. Refundable deposits, for vehicle reservations and services, received from customers prior to an executed vehicle purchase agreement are recorded as customer deposits within Accrued expenses and other current liabilities on the Company’s Consolidated Balance Sheets. Customer deposits were $3.0 million and $3.2 million as of December 31, 2024, and 2023, respectively. Deferred Revenue When vehicle purchase agreements are executed, the consideration for the vehicle and any accompanying products and services must be paid in advance before the transfer of products or se rvices by the Company. Unlike customer deposits, which are refundable, these advance payments are non-refundable. The Company recognizes revenue when control of the vehicle or related services transfers to the customer and defers revenue only when payments are received for undelivered products or services. Deferred revenue represents the total transaction price allocated to performance obligations that remain unsatisfied or partially unsatisfied as of the balance sheet date. As of December 31, 2024, and 2023 d eferred revenue related to products and services w"]
["Cost of Revenue","Cost of Revenue Automotive Sales Revenue Cost of automotive sales revenue includes direct and indirect materials, labor costs, manufacturing overhead, including depreciation costs of tooling and machinery, shipping and logistic costs, vehicle connectivity costs, and reserves for estimated warranty expenses. Cost of automotive sales revenues also includes adjustments to warranty expense. Cost of services and other revenue includes costs associated with providing non-warranty after-sales services, costs for retail merchandise, and costs to provide vehicle insurance. Cost of services and other revenue also includes direct parts and material. Cost of services and other revenue was immaterial for the years ended December 31, 2024, and 2023. Automotive Leasing Program"]
["Warranties","Warranties The Company provides a manufacturer’s warranty on all vehicles sold. The warranty covers the rectification of reported defects via repair, replacement, or adjustment of faulty parts or components. The warranty does not cover any item that fails due to normal wear and tear. This assurance-type warranty does not create a performance obligation separate from the vehicle. Management tracks warranty claims by vehicle ID, owner, and date. As the Company continues to manufacture and sell more vehicles it will reassess and evaluate its warranty claims for purposes of its warranty accrual. (in thousands) 2024 2023 Accrued warranty- beginning of period $ 684 $ — Provision for warranty 34 731 Warranty costs incurred (173) (47) Accrued warranty- end of period $ 545 $ 684 "]
["Research and Development","Research and Development Research and Development (“R&D”) costs are expensed as incurred and are primarily comprised of personnel-related costs (including salaries, bonuses, benefits, and stock-based compensation) for employees focused on R&D activities, other related costs, license fees, and depreciation and amortization. The Company’s R&D efforts are focused on design and development of the Company’s electric vehicles and continuing to prepare the Company’s prototype electric vehicle to achieve industry standards. Advanced payments for items and services related to R&D activities have been classified as Deposits in the Consolidated Balance Sheets and are included in operating activities on the Company’s Consolidated Statements of Cash Flows. The Company expenses deposits as the services are provided and prototype parts are received."]
["Sales and Marketing","Sales and Marketing Sales and marketing expenses primarily consist of personnel-related costs, including salaries, bonuses, benefits, and stock-based compensation for employees engaged in sales and marketing activities. Additionally, these expenses include direct costs associated with promotional and marketing efforts. The Company’s marketing initiatives focus on increasing brand awareness for the FF Series and FX Series, with a particular emphasis on introducing the FF 91 to the market. Advertising costs—including media payments for ad placements in print, digital, TV, radio, and other channels, as well as production costs for creating ads (such as fees for hiring creative agencies, production crews, or purchasing creative services)—were immaterial for the years ended December 31, 2024 and 2023."]
["Stock-Based Compensation","Stock-Based Compensation The Company’s stock-based compensation awards consist of stock options and restricted stock units (“RSUs”) granted to employees, directors and non-employees for the purchase of Common Stock. The Company recognizes stock-based compensation expense in accordance with the provisions of ASC 718, Compensation — Stock Compensation (“ASC 718”) . ASC 718 requires the measurement and recognition of compensation expense for all stock-based compensation awards based on the grant date fair values of the awards. The Company estimates the fair value of stock options using the Black-Scholes option pricing model. For options with service conditions, the value of the award is recognized as expense over the requisite service period on a straight-line basis. For performance-based awards, stock-based compensation expense is recognized over the expected performance achievement period of individual performance milestones when the achievement of each individual performance milestone becomes probable. Determining the grant date fair value of the awards using the Black-Scholes option pricing model requires management to make assumptions and judgments, including, but not limited to the following: • Expected term: The estimate of the expected term of awards was determined in accordance with the simplified method, which estimates the term based on an averaging of the vesting period and contractual term of the option grant for employee awards. The Company uses the contractual term for non-employee awards. • Expected volatility: The Company determines the expected volatility by weighing the historical average volatilities of publicly traded industry peers and its own trading history. The Company intends to continue to consistently apply this methodology using the same or similar public companies until a sufficient amount of historical information regarding the volatility of the Company’s own Class A Common Stock price becomes available, unless circumstances change such that the identified companies are no longer similar to FF, in which case more suitable companies whose stock prices are publicly available would be utilized in the calculation. • Risk-free interest rate: The risk-free interest rate used to value awards is based on the United States Treasury yield in effect at the time of grant for a period consistent with the expected term of the award. • Dividend yield: The Company has never declared or paid any cash dividends and does not presently plan to pay cash dividends for the foreseeable future. • Forfeiture rate: Effective January 1, 2023, stock-based compensation expense is reduced for forfeitures only when they occur. This change of accounting policy resulted in the recognition of a cumulative increase of prior stock-based compensation expenses totaling $1.8 million , which was recorded in the Consolidated Statements of Operations and Comprehensive Loss for the year ended December 31, 2023. • Fair value of Common Stock: The closing price of the Company’s Class A Common Stock on Nasdaq is used as the fair value of the Common Stock."]
["Income Taxes","Income Taxes The Company accounts for its income taxes using the asset and liability method whereby deferred tax assets and liabilities are determined based on temporary differences between the basis used for financial reporting and income tax reporting purposes. Deferred income taxes are provided based on the enacted tax rates in effect at the time such temporary differences are expected to reverse. A valuation allowance is provided for deferred tax assets if it is more likely than not that the Company will not realize those tax assets through future operations. The carrying value of deferred tax assets reflects an amount that is more likely than not to be realized. As of December 31, 2024, and 2023, the Company had recorded a full valuation allowance on net deferred tax assets because the Company expects it is more likely than not that the net deferred tax assets will not be realized. The Company utilizes the guidance in ASC 740-10, Income Taxes , to account for uncertain tax positions. ASC 740-10 contains a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates it is more likely than not that the positions will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount which is more likely than not of being realized and effectively settled. The Company considers many factors when evaluating and estimating its tax positions and tax benefits, which may require periodic adjustments and may not accurately forecast actual outcomes. The Company recognizes interest and penalties on unrecognized tax benefits as a component of income tax expense. There were no material interest or penalties for the years ended December 31, 2024 and 2023."]
["Recent Accounting Pronouncements","Recent Accounting Pronouncements In early 2025, the Financial Accounting Standards Board (“FASB”) issued several ASUs to enhance financial reporting and provide clearer guidance on various accounting topics. As a December 31 year-end filer and a Smaller Reporting Company (“SRC”), the Company is required to adopt these ASUs in accordance with the effective dates applicable to SRCs. The Company is currently evaluating the impact of these ASUs on the Company’s financial statements and related disclosures. Below is a summary of these ASUs: Recently issued accounting pronouncements not yet adopted In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures . This ASU enhances the transparency of income tax disclosures by requiring more detailed information about the rate reconciliation and income taxes paid, disaggregated by jurisdiction. This update is effective for the Company beginning January 1, 2026, and will first apply to the Company’s December 31, 2026, Form 10-K, with early adoption permitted. In December 2024, the FASB issued ASU 2025-01, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40 ). This ASU requires public business entities to disclose additional details about certain expenses in the notes to financial statements, such as inventory purchases, employee compensation, depreciation, and intangible asset amortization. This standard is effective for the Company beginning January 1, 2027, and will first apply to the Company’s December 31, 2027, Form 10-K, with early adoption permitted. In January 2025, the FASB issued ASU 2025-04, Leases (Topic 842): Common Control Arrangements . This ASU provides new guidance on lease arrangements between entities under common control, clarifying the criteria for determining whether a lease exists and how to account for such transactions. This update is effective for the Company beginning January 1, 2026, and will first apply to the Company’s December 31, 2026, Form 10-K, with early adoption permitted."]

{"sheet":"Nature of Business and Organi_3","index":29,"n_rows":6,"n_cols":2,"rows_kept":6,"merged":[[0,0,1,0]]}
["Nature of Business and Organization, Basis of Presentation, and Summary of Significant Accounting Policies (Tables)","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Organization, Consolidation and Presentation of Financial Statements [Abstract]"," "]
["Schedule of Property, Plant and Equipment, Net","Depreciation and amortization on property and equipment is calculated using the straight-line method over the estimated useful lives of the assets and for leasehold improvements, over the term of the lease, if shorter. Useful Life Buildings 39 Building improvements 15 Computer hardware 5 Tooling, machinery, and equipment 5 to 10 Vehicles 5 Lease vehicles 7 Computer software 3 Leasehold improvements Shorter of 15 years or term of the lease Property, plant, and equipment, net, consists of the following as of : (in thousands) December 31, 2024 December 31, 2023 Land, buildings and leasehold improvements $ 111,443 $ 103,522 Computer hardware 2,397 2,195 Tooling, machinery and equipment 319,313 318,301 Vehicles 245 669 Lease vehicles 3,121 1,873 Computer software 4,339 4,301 Construction in process 27,563 36,491 468,421 467,352 Less: Accumulated depreciation (119,834) (49,540) $ 348,587 $ 417,812 "]
["Disaggregation of Revenue","The following table disaggregates our revenue by major source: (in thousands) 2024 2023 Automotive sales $ 495 $ 771 Automotive leasing 44 13 $ 539 $ 784 "]
["Schedule of Standard Product Warranty Accrual","(in thousands) 2024 2023 Accrued warranty- beginning of period $ 684 $ — Provision for warranty 34 731 Warranty costs incurred (173) (47) Accrued warranty- end of period $ 545 $ 684 "]

{"sheet":"Inventory, net (Tables)","index":30,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Inventory, net (Tables)","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Inventory Disclosure [Abstract]"," "]
["Schedule of Inventory, Current","Inventory, net, consists of the following as of: (in thousands) December 31, 2024 December 31, 2023 Raw materials (net of reserves) $ 27,440 $ 33,345 Work in progress 46 572 Finished goods — 312 $ 27,486 $ 34,229 "]

{"sheet":"Deposits and Other Current As_2","index":31,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Deposits and Other Current Assets (Tables)","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]"," "]
["Schedule of Deposits and Other Current Assets","Deposits and other current assets consists of the following as of: (in thousands) December 31, 2024 December 31, 2023 Deposits Deposits for research and development, prototype and production parts, and other $ 29,318 $ 28,609 Deposits for goods and services yet to be received (“Future Work”) 1,776 2,773 $ 31,094 $ 31,382 Other current assets December 31, 2024 December 31, 2023 Prepaid expenses $ 4,832 $ 13,309 Other current assets 1,295 $ 8,412 $ 6,127 $ 21,721 "]

{"sheet":"Property, Plant, and Equipmen_2","index":32,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Property, Plant, and Equipment, Net (Tables)","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Property, Plant and Equipment [Abstract]"," "]
["Schedule of Property and Equipment, Net","Depreciation and amortization on property and equipment is calculated using the straight-line method over the estimated useful lives of the assets and for leasehold improvements, over the term of the lease, if shorter. Useful Life Buildings 39 Building improvements 15 Computer hardware 5 Tooling, machinery, and equipment 5 to 10 Vehicles 5 Lease vehicles 7 Computer software 3 Leasehold improvements Shorter of 15 years or term of the lease Property, plant, and equipment, net, consists of the following as of : (in thousands) December 31, 2024 December 31, 2023 Land, buildings and leasehold improvements $ 111,443 $ 103,522 Computer hardware 2,397 2,195 Tooling, machinery and equipment 319,313 318,301 Vehicles 245 669 Lease vehicles 3,121 1,873 Computer software 4,339 4,301 Construction in process 27,563 36,491 468,421 467,352 Less: Accumulated depreciation (119,834) (49,540) $ 348,587 $ 417,812 "]

{"sheet":"Accrued Expenses and Other Cu_2","index":33,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Accrued Expenses and Other Current Liabilities (Tables)","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Payables and Accruals [Abstract]"," "]
["Schedule of Accrued Expenses and Other Current Liabilities","Accrued expenses and other current liabilities—which include both third-party and related-party balances—comprise the following items as of: (in thousands) December 31, 2024 December 31, 2023 Accrued payroll and benefits $ 27,713 $ 28,037 Accrued legal contingencies 9,091 21,590 Customer deposits 3,027 3,246 Other current liabilities 16,923 9,518 $ 56,754 $ 62,391 "]

{"sheet":"Notes Payable (Tables)","index":34,"n_rows":6,"n_cols":2,"rows_kept":6,"merged":[[0,0,1,0]]}
["Notes Payable (Tables)","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Debt Disclosure [Abstract]"," "]
["Schedule of Notes Payable","The Company has entered into notes payable agreements with third parties. The tables below summarize these agreements as of December 31, 2024, and 2023, providing details on contractual maturity dates, contractual interest rates, unpaid principal balances, fair value adjustments, original issue discounts, including proceeds allocated to warrants, and net carrying values. December 31, 2024 (in thousands) Contractual Contractual Unpaid Principal Fair Value Original Issue Discount and Proceeds Allocated to Warrants Net Secured SPA Notes Various 10 % - 15% $ 3,118 $ 2,651 $ (312) $ 5,457 2023 Unsecured SPA Notes Various dates in 2029 10 % - 15% 4,380 2,844 (508) 6,716 Junior Secured SPA Notes September 2029 10% 28,840 13,163 (15,944) 26,059 2024 Unsecured SPA Notes December 2029 10% 10,015 8,741 (11,724) 7,032 Notes payable – China other Due on Demand —% 4,173 — — 4,173 Auto loans October 2026 7% 51 — — 51 $ 50,577 $ 27,399 $ (28,488) $ 49,488 Notes payable, current portion $ 4,224 Notes payable, long-term portion $ 45,264 December 31, 2023 (in thousands) Contractual Contractual Unpaid Principal Fair Value Original Issue Discount and Proceeds Allocated to Warrants Net Secured SPA Notes Various 10 % - 15% $ 100,052 $ (15,501) $ (10,319) $ 74,232 2023 Unsecured SPA Notes Various dates in 2029 10 % - 15% 13,219 1,262 (2,543) 11,938 (1) Notes payable – China other Due on Demand —% 4,898 — — 4,898 Auto loans October 2026 7% 82 — — 82 $ 118,251 $ (14,239) $ (12,862) $ 91,150 Notes payable, current portion $ 91,150 Notes payable, long-term portion $ — _____________________ (1) The 2023 Unsecured SPA Notes line item values above were updated to exclude related party balance of $542 thousand for comparability of the presentation with the current year. (See Note 8, Related Party Transactions. ) The future scheduled principal maturities of Related party notes payable as of December 31, 2024, are as follows: (in thousands) Due on demand $ 492 2025 4,954 2026 2,003 2027 751 Thereafter — $ 8,200 "]
["Schedule of Notes Payable Rollforward","The following table presents a roll forward of the Company’s Notes payable balances from December 31, 2023 to December 31, 2024. The table summarizes beginning and ending balances by debt category and details changes during the period, including repayments, conversions, reclassifications, fair value adjustments, and other significant transactions. Categories of Debt (in thousands) Secured 2023 Unsecured Junior 2024 Notes Auto Total Balance as of December 31, 2023 (a) $ 74,232 $ 11,938 $ — $ — $ — $ 4,898 $ 82 $ 91,150 New Issuances (b) 10,701 — 34,885 9,950 1,755 — 57,291 Repayment of Debt (c) — — — — — — (31) (31) Conversion of Debt to Equity (d) (50,691) (14,931) — (1,056) — — — (66,678) Extinguishments of Debt (e) 5,158 (2,394) (65) — — — — 2,699 Fair Value Adjustments of Debt (f) (33,943) (10,268) 328 9,665 — — — (34,218) Reclassification of Debt Between Debt Categories (g) — 22,371 (35,148) 7,500 5,277 — — — Other Adjustments (h) — — — — — (725) — (725) Balance as of December 31, 2024 (i) $ 5,457 $ 6,716 $ — $ 26,059 $ 7,032 $ 4,173 $ 51 $ 49,488 (a) The carrying value for each note category, fair value or amortized cost depending on the election, as of December 31, 2023. (b) Debt instruments issued during the period, recorded at fair value upon issuance if the fair value option is elected, or at principal balance net of discounts. (c) Cash repayments of principal amounts during the period. (d) Fair value of debt converted into equity during the period. (e) Adjustments from amendments, modifications, or extinguishment of existing debt, in accordance with ASC 470-50, and presented as a component of 'Loss on settlement of notes payable' in the Consolidated Statements of Operations. (f) Adjustments to debt fair value due to the fair value option election, embedded derivatives, or anti-dilution provisions. These adjustments are presented as a component of 'Change in fair value of notes payable, warrant liabilities, and call option derivatives' in the Consolidated Statements of Operations. (g) Transfers of amounts between debt categories, such as from secured to unsecured classifications. (h) Miscellaneous changes not captured in other columns, such as currency adjustments and reclassification to accrued expenses. (i) The carrying value for each note category, fair value or amortized cost depending on the election, as of December 31, 2024. The following table presents a roll forward of the Company’s Notes payable balances from December 31, 2022 to December 31, 2023 with third parties. The table summarizes beginning and ending balances by debt category and details changes during the period, including repayments, conversions, reclassifications, fair value adjustments, and other significant transactions. Categories of Debt (in thousands) Secured 2023 Notes Auto Total Balance as of December 31, 2022 (a) $ 26,008 $ — $ 4,997 $ 100 $ 31,105 New Issuances (b) 173,730 20,936 — (18) 194,648 Repayment of Debt, including periodic interest on debt carried at fair value (c) (1,167) — — — (1,167) Conversion of Debt to Equity (d) (114,252) (9,135) — — (123,387) Extinguishments of Debt (e) 13,078 — — — 13,078 Fair Value Adjustments of Debt (f) (23,165) 137 — — (23,028) Other Adjustments (g) — — (99) — (99) Balance as of December 31, 2023 (h) $ 74,232 $ 11,938 $ 4,898 $ 82 $ 91,150 (a) The carrying value for each note category, fair value or amortized cost depending on the election, as of December 31, 2022. (b) Debt instruments issued during the period, recorded at fair value upon issuance if the fair value option is elected, or at principal balance net of discounts. (c) Cash repayments of principal amount and periodic interest, where fair value option is elected, during the period. (d) Fair value of debt converted into equity during the period. (e) Adjustments from amendments, modifications, or extinguishment of existing debt, in accordance with ASC 470-50, and presented as a component of Loss on settlement of notes payable in the Consolidated Statements of Operations. (f) Adjustments to debt fair value due to the fair value option election, embedded derivatives, or anti-dilution provisions. These adjustments are presented as a component of Change in fair value of notes payable, warrant liabilities, and call option derivatives' in the Consolidated Statements of Operations. (g) Miscellaneous changes not captured in other columns, such as currency adjustments. (h) The carrying value for each note category, fair value or amortized cost depending on the election, as of December 31, 2023."]
["Schedule of Maturities of Long-term Debt","The future scheduled principal maturities of Notes payable as of December 31, 2024, are as follows: (in thousands) Due on demand $ 4,173 2025 — 2026 51 2027 — 2028 — 2029 39,546 Thereafter 6,807 $ 50,577 "]

{"sheet":"Related Party Transactions (Tab","index":35,"n_rows":5,"n_cols":2,"rows_kept":5,"merged":[[0,0,1,0]]}
["Related Party Transactions (Tables)","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Related Party Transactions [Abstract]"," "]
["Schedule of Debt","The tables below summarize the related party note payable agreements as of December 31, 2024 and December 31, 2023, providing details on contractual maturity dates, contractual interest rates, and net carrying values. December 31, 2024 (in thousands) Contractual Contractual Net Carrying Unsecured Convertible Note April 2024 (1) 4.27% $ 1,364 Notes Payable — China April 2027 18.0% 4,382 Notes Payable on Demand — China Due on Demand —% 417 FFGP Note Various 2024 (1) 4.27% 1,576 Convertible FFGP Note 'May 2024 (1) 4.27% 250 Other Notes Due on Demand 12.0% 75 $ 8,064 Related party notes payable, current $ 5,310 Related party notes payable, long-term $ 2,754 _______________ (1) The term was extended upon receipt of waivers of enforcement rights and remedies under the loan agreements, as described below, with the expected settlement in 2025. December 31, 2023 (in thousands) Contractual Contractual Net Carrying Value 2023 Unsecured SPA Notes August 2029 10% - 15% $ 542 Notes Payable — China December 2023 18.0% 5,103 Notes Payable on Demand — China Due on Demand —% 3,789 FFGP Note Various 5.27% 326 $ 9,760 Related party notes payable, current $ 9,760 Related party notes payable, long-term $ — "]
["Schedule of Notes Payable","The Company has entered into notes payable agreements with third parties. The tables below summarize these agreements as of December 31, 2024, and 2023, providing details on contractual maturity dates, contractual interest rates, unpaid principal balances, fair value adjustments, original issue discounts, including proceeds allocated to warrants, and net carrying values. December 31, 2024 (in thousands) Contractual Contractual Unpaid Principal Fair Value Original Issue Discount and Proceeds Allocated to Warrants Net Secured SPA Notes Various 10 % - 15% $ 3,118 $ 2,651 $ (312) $ 5,457 2023 Unsecured SPA Notes Various dates in 2029 10 % - 15% 4,380 2,844 (508) 6,716 Junior Secured SPA Notes September 2029 10% 28,840 13,163 (15,944) 26,059 2024 Unsecured SPA Notes December 2029 10% 10,015 8,741 (11,724) 7,032 Notes payable – China other Due on Demand —% 4,173 — — 4,173 Auto loans October 2026 7% 51 — — 51 $ 50,577 $ 27,399 $ (28,488) $ 49,488 Notes payable, current portion $ 4,224 Notes payable, long-term portion $ 45,264 December 31, 2023 (in thousands) Contractual Contractual Unpaid Principal Fair Value Original Issue Discount and Proceeds Allocated to Warrants Net Secured SPA Notes Various 10 % - 15% $ 100,052 $ (15,501) $ (10,319) $ 74,232 2023 Unsecured SPA Notes Various dates in 2029 10 % - 15% 13,219 1,262 (2,543) 11,938 (1) Notes payable – China other Due on Demand —% 4,898 — — 4,898 Auto loans October 2026 7% 82 — — 82 $ 118,251 $ (14,239) $ (12,862) $ 91,150 Notes payable, current portion $ 91,150 Notes payable, long-term portion $ — _____________________ (1) The 2023 Unsecured SPA Notes line item values above were updated to exclude related party balance of $542 thousand for comparability of the presentation with the current year. (See Note 8, Related Party Transactions. ) The future scheduled principal maturities of Related party notes payable as of December 31, 2024, are as follows: (in thousands) Due on demand $ 492 2025 4,954 2026 2,003 2027 751 Thereafter — $ 8,200 "]

{"sheet":"Other Financing Liabilities (Ta","index":36,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Other Financing Liabilities (Tables)","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Organization, Consolidation and Presentation of Financial Statements [Abstract]"," "]
["Schedule of Maturities of Finance Lease Liabilities","The future scheduled principal maturities of financing obligations as of December 31, 2024 are as follows (in thousands): Years Ending December 31, 2025 $ 761 2026 951 2027 1,189 2028 60,455 $ 63,356 The following table summarizes future lease payments: (in thousands) Years Ending December 31, Operating Leases 2025 $ 2,243 2026 12 2027 2 Total 2,257 Less: Imputed Interest 115 Present value of net lease payments $ 2,142 Lease liability, current portion $ 2,128 Lease liability, net of current portion 14 Total lease liability $ 2,142 "]

{"sheet":"Leases (Tables)","index":37,"n_rows":6,"n_cols":2,"rows_kept":6,"merged":[[0,0,1,0]]}
["Leases (Tables)","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Leases [Abstract]"," "]
["Schedule of Total Lease Costs","Lease cost includes both the fixed and variable expenses recorded for leases. The components of lease cost for the were as follows: Years Ended December 31, (in thousands) 2024 2023 Finance lease cost Amortization of ROU assets $ — $ 273 Interest on lease liabilities — 275 Total finance lease cost — 548 Operating lease cost 4,389 5,915 Variable lease cost 398 257 Total lease cost $ 4,787 $ 6,720 Supplemental information and non-cash activities related to operating and finance leases are as follows: Years Ended December 31, (in thousands) 2024 2023 Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases $ 3,230 $ 5,709 Operating cash flows from finance leases — 275 Financing cash flows from finance leases — 1,016 $ 3,230 $ 7,000 Lease assets obtained in exchange for operating lease liabilities $ 30 $ — Years Ended December 31, 2024 2023 Weighted average remaining lease term (in years) Operating leases 0.70 5.70 Finance leases 0.00 5.00 Weighted average discount rate Operating leases 16.4 % 15.6 % Finance leases — % 9.2 %"]
["Schedule of Maturities of Operating Lease Liabilities","The following table summarizes future lease payments: (in thousands) Years Ending December 31, Operating Leases 2025 $ 2,243 2026 12 2027 2 Total 2,257 Less: Imputed Interest 115 Present value of net lease payments $ 2,142 Lease liability, current portion $ 2,128 Lease liability, net of current portion 14 Total lease liability $ 2,142 "]
["Schedule of Maturities of Finance Lease Liabilities","The future scheduled principal maturities of financing obligations as of December 31, 2024 are as follows (in thousands): Years Ending December 31, 2025 $ 761 2026 951 2027 1,189 2028 60,455 $ 63,356 The following table summarizes future lease payments: (in thousands) Years Ending December 31, Operating Leases 2025 $ 2,243 2026 12 2027 2 Total 2,257 Less: Imputed Interest 115 Present value of net lease payments $ 2,142 Lease liability, current portion $ 2,128 Lease liability, net of current portion 14 Total lease liability $ 2,142 "]

{"sheet":"Stockholders_ Equity (Tables)","index":38,"n_rows":6,"n_cols":2,"rows_kept":6,"merged":[[0,0,1,0]]}
["Stockholders’ Equity (Tables)","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Equity [Abstract]"," "]
["Schedule of Authorized, Issued and Outstanding Stock","The number of authorized, issued and outstanding stock, were as follows: December 31, 2024 Authorized Issued Shares Preferred Stock 10,000,000 1 Class A Common Stock 99,815,625 65,919,127 Class B Common Stock 4,429,688 6,667 114,245,313 65,925,795 December 31, 2023 Authorized Issued Shares Preferred Stock 10,000,000 — Class A Common Stock 1,232,292 1,060,833 Class B Common Stock 54,688 6,667 11,286,980 1,067,500 "]
["Schedule of Stockholders' Equity Note, Warrants or Rights","The number of outstanding warrants to purchase the Company’s Class A Common Stock as of December 31, 2024 were as follows: Number of Warrants Exercise Price Expiration Date Ares Warrants 5,776,657 $1.16 August 5, 2027 SPA Warrants 15,238 $1.16 Various through November 1, 2031 Junior SPA Warrants 5,931,638 $1.16 Various through September 30, 2029 2024 Unsecured SPA Warrants 10,788,746 $1.39 December 31, 2029 Public Warrants 2,453 $110,400.00 July 21, 2026 Private Warrants 12 $110,400.00 July 21, 2026 22,514,744 The number of outstanding warrants to purchase the Company’s Class A Common Stock as of December 31, 2023 were as follows: Number of Warrants Exercise Price Expiration Date Ares warrants 228,482 $ 29.33 August 5, 2027 SPA Warrants 13,906 $ 29.33 Various through November 28, 2030 Public Warrants 2,453 $ 110,400.00 July 21, 2026 Private Warrants 12 $ 110,400.00 July 21, 2026 244,853 "]
["Schedule of Weighted-Average Assumptions used in the Black-Scholes Option Pricing Model","The following table provides the assumptions used in the Black-Scholes option pricing model for equity-classified SPA Portfolio Note warrants granted during the year ended December 31, 2024: 2024 Risk-free interest rate: 3.83% - 4.35% Expected term (in years): 7 Expected volatility: 110% - 115% Dividend yield: 0% 2023 Risk-free interest rate: 3.53 % Expected term (in years): 8.71 Expected volatility: 89.62 % Dividend yield: 0 %"]

{"sheet":"Stock-Based Compensation (Table","index":39,"n_rows":7,"n_cols":2,"rows_kept":7,"merged":[[0,0,1,0]]}
["Stock-Based Compensation (Tables)","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Share-Based Payment Arrangement [Abstract]"," "]
["Schedule of the Company’s Stock Option Activity","A summary of the Company’s stock option activity under the 2021Plan is as follows: (dollars in thousands except weighted average exercise price) Number of Weighted Weighted Aggregate Outstanding as of December 31, 2022 693 $ 26,496.00 8.97 $ — Granted 313 $ 10,368.00 Exercised (6) $ 8,544.00 Expired/forfeited (202) $ 28,020.00 Outstanding as of December 31, 2023 798 $ 19,885.20 8.74 $ 5,351 Expired/forfeited (390) $ 20,794.36 Outstanding as of December 31, 2024 408 $ 21,156.47 7.59 $ 8,317 Exercisable as of December 31, 2024 286 $ 21,480.84 7.58 $ 5,940 A summary of the Company’s stock option activity under the EI Plan is as follows: (dollars in thousands except weighted average exercise price) Number of Weighted Weighted Aggregate Outstanding as of December 31, 2022 2,440 $ 27,168.00 6.92 $ 22 Expired/forfeited (409) $ 31,130.40 Outstanding as of December 31, 2023 2,031 $ 26,408.80 5.92 $ 31,743 Expired/forfeited (82) $ 28,973.01 Outstanding as of December 31, 2024 1,949 $ 26,237.95 4.84 $ 50,054 Exercisable as of December 31, 2024 1,931 $ 26,077.74 4.83 $ 49,283 A summary of the Company’s stock option activity under the STI Plan is as follows: (dollars in thousands except weighted average exercise price) Number of Weighted Weighted Aggregate Outstanding as of December 31, 2022 586 $ 60,864.00 6.94 $ — Expired/forfeited (22) $ 78,722.80 Outstanding as of December 31, 2023 564 $ 60,169.20 6.64 $ 16,318 Expired/forfeited (77) $ 95,528.84 Outstanding as of December 31, 2024 487 $ 52,893.32 5.50 $ 25,481 Exercisable as of December 31, 2024 374 $ 41,906.97 5.23 $ 15,448 "]
["Schedule of Weighted-Average Assumptions used in the Black-Scholes Option Pricing Model","The following table provides the assumptions used in the Black-Scholes option pricing model for equity-classified SPA Portfolio Note warrants granted during the year ended December 31, 2024: 2024 Risk-free interest rate: 3.83% - 4.35% Expected term (in years): 7 Expected volatility: 110% - 115% Dividend yield: 0% 2023 Risk-free interest rate: 3.53 % Expected term (in years): 8.71 Expected volatility: 89.62 % Dividend yield: 0 %"]
["Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity","A summary of the Company’s RSU activity under the 2021 Plan is as follows: (dollars in thousands except weighted average fair value) Shares Weighted Average Fair Value Outstanding as of December 31, 2022 (1) 1,862 $ 10,464.00 Granted 2,551 $ 2,702.00 Released (650) $ 10,329.60 Forfeited (878) $ 9,817.60 Outstanding as of December 31, 2023 2,885 $ 3,784.80 Granted 1,797,111 $ 3.72 Released (1,322,382) $ 1.31 Forfeited (37,207) $ 2.32 Outstanding as of December 31, 2024 440,407 $ 3.61 (1) The Company’s subsidiaries in China have employees who are citizens of the PRC. Pursuant to the regulation Circular 78 and Circular 7 issued by the Central State Administration of Foreign Exchange of PRC (“SAFE”), we cannot release vested RSUs to it’s PRC citizen employees before they have completed the required SAFE registration with a dedicated account set up for each of them to repatriate proceeds back to China under the SAFE. As a result, 151 RSUs of the Company’s PRC citizens employees vested in 2022 were included in the outstanding RSUs at December 31, 2022 as unreleased RSUs because those employees did not complete the SAFE registration process."]
["Schedule of Stock-Based Compensation Expense Included in Each Respective Expense Category","The following table presents stock-based compensation expense for all of the Company’s 2021 Plan, EI Plan, STI Plan and Common Units of FF Global included in each respective expense category in the Consolidated Statements of Operations and Comprehensive Loss is as follows: Years Ended December 31, (in thousands) 2024 2023 Research and development $ 2,670 $ 6,812 Sales and marketing 915 807 General and administrative 4,797 1,548 $ 8,382 $ 9,167 "]

{"sheet":"Fair Value of Financial Instr_2","index":40,"n_rows":5,"n_cols":2,"rows_kept":5,"merged":[[0,0,1,0]]}
["Fair Value of Financial Instruments (Tables)","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Fair Value Disclosures [Abstract]"," "]
["Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis","The following tables present financial assets and liabilities remeasured on a recurring basis by level within the fair value hierarchy: December 31, 2024 (in thousands) Level 1 Level 2 Level 3 Liabilities: Warrant liabilities 1 $ — $ — $ 28,864 Derivative call options $ — $ — $ 29,709 Notes payable 1 $ — $ — $ 46,628 1 Includes both related party and non-related party balances for the Company’s notes payable and warrant liabilities. December 31, 2023 (in thousands) Level 1 Level 2 Level 3 Liabilities: Warrant liabilities 1 $ — $ — $ 306 Notes payable 1 — — 86,712 1 Includes both related party and non-related party balances for the Company’s notes payable and warrant liabilities."]
["Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation","The following table summarizes the activity of Level 3 fair value measurements: (in thousands) Warrant Liabilities 1 Derivative Call Option Notes Payable 1 Balance as of December 31, 2023 $ 306 $ — $ 86,712 Additions 34,441 14,267 58,789 Debt extinguishments — — 2,699 Change in fair value measurements (5,723) 15,442 (34,460) Reclassification of liability classified warrants to equity (160) — — Conversions of notes to Class A Common Stock — — (67,112) Balance as of December 31, 2024 $ 28,864 $ 29,709 $ 46,628 1 Includes both related party and non-related party balances for the Company’s notes payable and warrant liabilities."]

{"sheet":"Income Taxes (Tables)","index":41,"n_rows":9,"n_cols":2,"rows_kept":9,"merged":[[0,0,1,0]]}
["Income Taxes (Tables)","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Income Tax Disclosure [Abstract]"," "]
["Schedule of Provision For Income Taxes","The provision for income tax consisted of the following: (in thousands) 2024 2023 Current: Federal $ — $ — State (4) 2 Foreign (263) 107 (267) 109 Deferred: Federal (21,218) (48,499) State (10,013) (22,277) Foreign (504) 6,577 (31,735) (64,199) Valuation allowance 31,735 64,199 — — $ (267) $ 109 "]
["Schedule of Components of Losses Before Income Taxes, by Taxing Jurisdiction","The components of losses before income taxes, by taxing jurisdiction, were as follows for the years ended December 31,: (in thousands) 2024 2023 U.S. $ (324,929) $ (411,790) Foreign (31,185) (19,845) $ (356,114) $ (431,635)"]
["Schedule of Federal Income Tax Rate","The provision for income taxes for the years ended December 31, 2024, and 2023 differs from the amount computed by applying the statutory federal corporate income tax rate of 21% to losses before income taxes. The following adjustments account for these differences for the years ended December 31, 2024, and 2023: 2024 2023 Federal income tax expense 21.0 % 21.0 % State income taxes (net of federal benefit) 2.3 % 4.1 % Other permanent differences (1.4) % (0.7) % Fair value debt adjustments (10.3) % (5.8) % Disallowed interest (1.8) % (1.2) % Foreign tax rate difference 0.1 % 0.2 % Prior year true-up on deferred taxes (0.2) % (0.1) % Return-to-provision adjustment (1.3) % — % Uncertain tax benefit 0.8 % (1.0) % Expiration of tax attributes (0.3) % (1.8) % Valuation allowance (9.0) % (14.7) % 0.1 % 0.0 % These adjustments result in an effective tax rate of 0.1% in 2024 compared to 0.0% in 2023. The main changes in permanent differences related to fair value adjustments on convertible related party notes payable and notes payable and disallowed interest expense. The main changes in foreign tax rate difference and valuation allowance related to lower foreign losses incurred in 2024."]
["Schedule of Deferred Tax Assets And Deferred Tax Liabilities","The tax effects of temporary differences for the years ended December 31, 2024, and 2023 that give rise to significant portions of the deferred tax assets and deferred tax liabilities are provided below: (in thousands) 2024 2023 Deferred Tax Assets: Net operating losses (“NOL”) $ 411,244 $ 353,839 Research and development credits 4,239 4,239 Accrued liabilities 25,581 16,646 Capital loss — 3,420 Amortization 8,803 9,921 Capitalized R&D expense 53,125 74,835 Stock-based compensation 450 418 Transaction costs 35 45 Other 379 594 Gross deferred tax assets 503,856 463,957 Valuation allowance (457,738) (426,003) Deferred tax assets, net of valuation allowance 46,118 37,954 Deferred Tax Liabilities: Depreciation (20,174) (14,113) State taxes (25,944) (23,841) Gross deferred tax liabilities (46,118) (37,954) Net deferred tax assets (liabilities) $ — $ — "]
["Summary of Valuation Allowance","The following table summarizes the valuation allowance: (in thousands) 2024 2023 Beginning balance $ 426,003 $ 361,804 Increase related to current year tax positions 31,735 64,199 Ending balance $ 457,738 $ 426,003 "]
["Schedule of Unrecognized Tax Benefits","The aggregate change in the balance of unrecognized tax benefits for the years ended December 31, 2024, and 2023 is as follows: (in thousands) 2024 2023 Beginning balance $ 12,972 $ 8,807 Increase related to current year tax positions 389 4,165 Decrease related to prior year positions (3,274) — Ending balance $ 10,087 $ 12,972 "]

{"sheet":"Net Loss per Share (Tables)","index":42,"n_rows":5,"n_cols":2,"rows_kept":5,"merged":[[0,0,1,0]]}
["Net Loss per Share (Tables)","12 Months Ended"]
[null,"Dec. 31, 2024"]
["Earnings Per Share [Abstract]"," "]
["Schedule of Earnings Per Share, Basic and Diluted","The following data shows the amounts used in computing net loss per share and the effect on net loss and the weighted-average number of shares for the years ended December 31, 2024, and 2023: (in thousands, except share and per share amounts) 2024 2023 Net loss $ (355,847) $ (431,744) Less: Deemed Dividend (7,576) — Net loss available to common stockholders $ (363,423) $ (431,744) Weighted average shares used in computing net loss per share of Class A and B Common Stock: Basic 18,529,525 240,869 Diluted 18,529,525 240,869 Net loss per share of Class A and B Common Stock attributable to common stockholders: Basic $ (19.61) $ (1,792.44) Diluted $ (19.61) $ (1,792.44)"]
["Schedule of Antidilutive Shares Excluded From Calculation of Diluted Net Loss Per Share","The table below presents the potentially dilutive shares that were excluded from the computation of diluted net loss per share of Common Stock attributable to Common Stock stockholders due to their antidilutive effect as of December 31,: 2024 2023 Shares issuable upon conversion of SPA Portfolio Notes 41,054,586 1,069,202 Shares issuable upon conversion of Unsecured Convertible Notes 749,866 — Shares issuable upon exercise of equity classified SPA Portfolio Note warrants 15,238 13,906 Shares issuable upon exercise of liability classified SPA Portfolio Note warrants 16,720,384 — Other warrants 5,776,657 228,482 Stock-based compensation awards – Options 2,591 798 Stock-based compensation awards – RSUs 161,225 2,885 Public warrants 2,453 2,453 Private warrants 12 12 64,483,012 1,317,738 "]

{"sheet":"Nature of Business and Organi_4","index":43,"n_rows":52,"n_cols":16,"rows_kept":52,"merged":[[0,0,1,0],[0,8,0,9]]}
["Nature of Business and Organization, Basis of Presentation, and Summary of Significant Accounting Policies - Narrative (Details) $ / shares in Units, ¥ in Thousands",{"$nulls":7},"12 Months Ended"]
[null,"Aug. 04, 2024 $ / shares shares","Aug. 01, 2024","Feb. 29, 2024","Feb. 23, 2024 $ / shares shares","Feb. 05, 2024 shares","Aug. 22, 2023 shares","Aug. 16, 2023","Dec. 31, 2024 USD ($) segment shares","Dec. 31, 2023 USD ($)","Dec. 31, 2024 CNY (¥) shares","Aug. 31, 2024 shares","Jul. 31, 2024 shares","Feb. 04, 2024 shares","Aug. 25, 2023 shares","Feb. 28, 2023 shares"]
["Organization, Consolidation and Presentation of Financial Statements [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Number of operating segments | segment"," "," "," "," "," "," "," ",{"v":1,"d":"1 "}," "," "," "," "," "," "," "]
["Insurance limits"," "," "," "," "," "," "," ",{"v":250000,"d":"$ 250,000"}," ",{"v":500,"d":"¥ 500"}," "," "," "," "," "]
["Stockholder's equity, stock split, conversion ratio",0.025," "," ",0.333," ",0.0125," "," "," "," "," "," "," "," "," "]
["Common stock, shares authorized (in shares) | shares",{"v":104245313,"d":"104,245,313 "}," "," ",{"v":11582813,"d":"11,582,813 "},{"v":34748438,"d":"34,748,438 "},{"v":3860938,"d":"3,860,938 "}," ",{"v":104245313,"d":"104,245,313 "}," ",{"v":104245313,"d":"104,245,313 "},{"v":104245313,"d":"104,245,313 "},{"v":104245313,"d":"104,245,313 "},{"v":3860938,"d":"3,860,938 "},{"v":1286980,"d":"1,286,980 "},{"v":433855,"d":"433,855 "}]
["Common stock, shares authorized before effect of reverse stock split (in shares) | shares"," "," "," ",{"v":34748438,"d":"34,748,438 "}," ",{"v":308875000,"d":"308,875,000 "}," "," "," "," "," "," "," "," "," "]
["Common stock, par value (in dollars per share) | $ / shares",{"v":0.0001,"d":"$ 0.0001"}," "," ",{"v":0.0001,"d":"$ 0.0001"}," "," "," "," "," "," "," "," "," "," "," "]
["Number of reportable segments | segment"," "," "," "," "," "," "," ",{"v":1,"d":"1 "}," "," "," "," "," "," "," "]
["Other"," "," "," "," "," "," "," ",{"v":963000,"d":"$ 963,000"},{"v":1075000,"d":"$ 1,075,000"}," "," "," "," "," "," "]
["Accounts payable"," "," "," "," "," "," "," ",{"v":56754000,"d":"56,754,000 "},{"v":62391000,"d":"62,391,000 "}," "," "," "," "," "," "]
["Impairment charges"," "," "," "," "," "," "," ",{"v":0,"d":"$ 0"},{"v":0,"d":"0 "}," "," "," "," "," "," "]
["Term of contract (in months)"," "," "," "," "," "," "," ","36 months"," ","36 months"," "," "," "," "," "]
["Sales-type lease, term of contract"," "," "," "," "," "," "," ","36 months"," ","36 months"," "," "," "," "," "]
["Customer deposits"," "," "," "," "," "," "," ",{"v":3027000,"d":"$ 3,027,000"},{"v":3246000,"d":"3,246,000 "}," "," "," "," "," "," "]
["Deferred revenue"," "," "," "," "," "," "," ",{"v":0,"d":"0 "},{"v":0,"d":"0 "}," "," "," "," "," "," "]
["Stock-based compensation expense"," "," "," "," "," "," "," ",{"v":8382000,"d":"8,382,000 "},{"v":9167000,"d":"9,167,000 "}," "," "," "," "," "," "]
["Revenue From Contract With Customer, Excluding Assessed Tax"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Organization, Consolidation and Presentation of Financial Statements [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Co-creation fees"," "," "," "," "," "," "," ",{"v":300000,"d":"300,000 "},{"v":400000,"d":"400,000 "}," "," "," "," "," "," "]
["Marketing Expense"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Organization, Consolidation and Presentation of Financial Statements [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Co-creation fees"," "," "," "," "," "," "," ",{"v":600000,"d":"600,000 "},{"v":400000,"d":"400,000 "}," "," "," "," "," "," "]
["Nonrelated Party"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Organization, Consolidation and Presentation of Financial Statements [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Gain (loss) extinguishments of debt"," "," "," "," "," "," "," ",{"v":-161725000,"d":"(161,725,000)"},{"v":-217019000,"d":"(217,019,000)"}," "," "," "," "," "," "]
["Accounts payable"," "," "," "," "," "," "," ",{"v":45677000,"d":"45,677,000 "},{"v":55109000,"d":"55,109,000 "}," "," "," "," "," "," "]
["Related Party"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Organization, Consolidation and Presentation of Financial Statements [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Gain (loss) extinguishments of debt"," "," "," "," "," "," "," ",{"v":-14295000,"d":"(14,295,000)"},{"v":-20045000,"d":"(20,045,000)"}," "," "," "," "," "," "]
["Accounts payable"," "," "," "," "," "," "," ",{"v":11077000,"d":"11,077,000 "},{"v":7282000,"d":"7,282,000 "}," "," "," "," "," "," "]
["Revision of Prior Period, Reclassification, Adjustment"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Organization, Consolidation and Presentation of Financial Statements [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Gain (loss) extinguishments of debt"," "," "," "," "," "," "," ",{"v":-237100000,"d":"(237,100,000)"}," "," "," "," "," "," "," "]
["Other"," "," "," "," "," "," "," ",{"v":400000,"d":"400,000 "},{"v":1100000,"d":"1,100,000 "}," "," "," "," "," "," "]
["Revision of Prior Period, Reclassification, Adjustment | Nonrelated Party"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Organization, Consolidation and Presentation of Financial Statements [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Gain (loss) extinguishments of debt"," "," "," "," "," "," "," "," ",{"v":-217000000,"d":"(217,000,000)"}," "," "," "," "," "," "]
["Accounts payable"," "," "," "," "," "," "," ",{"v":7300000,"d":"$ 7,300,000"}," "," "," "," "," "," "," "]
["Revision of Prior Period, Reclassification, Adjustment | Related Party"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Organization, Consolidation and Presentation of Financial Statements [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Gain (loss) extinguishments of debt"," "," "," "," "," "," "," "," ",{"v":-20000000,"d":"(20,000,000)"}," "," "," "," "," "," "]
["Revision of Prior Period, Adjustment"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Organization, Consolidation and Presentation of Financial Statements [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Stock-based compensation expense"," "," "," "," "," "," "," "," ",{"v":1800000,"d":"1,800,000 "}," "," "," "," "," "," "]
["Previously Reported"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Organization, Consolidation and Presentation of Financial Statements [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Other"," "," "," "," "," "," "," "," ",{"v":700000,"d":"$ 700,000"}," "," "," "," "," "," "]
["Common Stock"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Organization, Consolidation and Presentation of Financial Statements [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Stockholder's equity, stock split, conversion ratio"," ",0.025,0.333," ",0.333,0.0125,0.125," "," "," "," "," "," "," "," "]

{"sheet":"Nature of Business and Organi_5","index":44,"n_rows":28,"n_cols":2,"rows_kept":28}
["Nature of Business and Organization, Basis of Presentation, and Summary of Significant Accounting Policies - Property and Equipment (Details)","Dec. 31, 2024"]
["Buildings"," "]
["Property, Plant and Equipment [Line Items]"," "]
["Useful Life \u2028(in years)","39 years"]
["Building improvements"," "]
["Property, Plant and Equipment [Line Items]"," "]
["Useful Life \u2028(in years)","15 years"]
["Computer hardware"," "]
["Property, Plant and Equipment [Line Items]"," "]
["Useful Life \u2028(in years)","5 years"]
["Tooling, machinery, and equipment | Minimum"," "]
["Property, Plant and Equipment [Line Items]"," "]
["Useful Life \u2028(in years)","5 years"]
["Tooling, machinery, and equipment | Maximum"," "]
["Property, Plant and Equipment [Line Items]"," "]
["Useful Life \u2028(in years)","10 years"]
["Vehicles"," "]
["Property, Plant and Equipment [Line Items]"," "]
["Useful Life \u2028(in years)","5 years"]
["Lease vehicles"," "]
["Property, Plant and Equipment [Line Items]"," "]
["Useful Life \u2028(in years)","7 years"]
["Computer software"," "]
["Property, Plant and Equipment [Line Items]"," "]
["Useful Life \u2028(in years)","3 years"]
["Leasehold improvements | Minimum"," "]
["Property, Plant and Equipment [Line Items]"," "]
["Useful Life \u2028(in years)","15 years"]

{"sheet":"Nature of Business and Organi_6","index":45,"n_rows":10,"n_cols":3,"rows_kept":10,"merged":[[0,0,1,0],[0,1,0,2]]}
["Nature of Business and Organization, Basis of Presentation, and Summary of Significant Accounting Policies - Disaggregation of Revenue (Details) - USD ($) $ in Thousands","12 Months Ended"]
[null,"Dec. 31, 2024","Dec. 31, 2023"]
["Organization, Consolidation and Presentation of Financial Statements [Line Items]"," "," "]
["Revenue",{"v":539,"d":"$ 539"},{"v":784,"d":"$ 784"}]
["Automotive sales"," "," "]
["Organization, Consolidation and Presentation of Financial Statements [Line Items]"," "," "]
["Revenue",{"v":495,"d":"495 "},{"v":771,"d":"771 "}]
["Automotive leasing"," "," "]
["Organization, Consolidation and Presentation of Financial Statements [Line Items]"," "," "]
["Revenue",{"v":44,"d":"$ 44"},{"v":13,"d":"$ 13"}]

{"sheet":"Nature of Business and Organi_7","index":46,"n_rows":7,"n_cols":3,"rows_kept":7,"merged":[[0,0,1,0],[0,1,0,2]]}
["Nature of Business and Organization, Basis of Presentation, and Summary of Significant Accounting Policies - Warranties (Details) - USD ($) $ in Thousands","12 Months Ended"]
[null,"Dec. 31, 2024","Dec. 31, 2023"]
["Movement in Standard Product Warranty Accrual [Roll Forward]"," "," "]
["Accrued warranty- beginning of period",{"v":684,"d":"$ 684"},{"v":0,"d":"$ 0"}]
["Provision for warranty",{"v":34,"d":"34 "},{"v":731,"d":"731 "}]
["Warranty costs incurred",{"v":-173,"d":"(173)"},{"v":-47,"d":"(47)"}]
["Accrued warranty- end of period",{"v":545,"d":"$ 545"},{"v":684,"d":"$ 684"}]

{"sheet":"Liquidity and Capital Resourc_2","index":47,"n_rows":27,"n_cols":5,"rows_kept":27}
["Liquidity and Capital Resources and Going Concern (Details) - USD ($) $ in Thousands","Dec. 31, 2024","Dec. 31, 2023","Sep. 26, 2023","Nov. 11, 2022"]
["Debt Instrument [Line Items]"," "," "," "," "]
["Accumulated deficit",{"v":-4314346,"d":"$ (4,314,346)"},{"v":-3958499,"d":"$ (3,958,499)"}," "," "]
["Cash",{"v":7144,"d":"7,144 "},{"v":1898,"d":"$ 1,898"}," "," "]
["Working capital",{"v":-120900,"d":"(120,900)"}," "," "," "]
["Standby Equity Purchase Agreement"," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "]
["Option to increase commitment amount"," "," "," ",{"v":350000,"d":"$ 350,000"}]
["Class A Common Stock | Standby Equity Purchase Agreement"," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "]
["Commitment amount",{"v":342500,"d":"342,500 "}," "," ",{"v":200000,"d":"$ 200,000"}]
["Additional commitment amount",{"v":192500,"d":"192,500 "}," "," "," "]
["Class A Common Stock | Sales Agreement | Sales Agents"," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "]
["Commitment amount"," "," ",{"v":90000,"d":"$ 90,000"}," "]
["SPA Notes | Committed Debt"," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "]
["Aggregate principal amount",{"v":614500,"d":"614,500 "}," "," "," "]
["Funded",{"v":405300,"d":"405,300 "}," "," "," "]
["To be funded",{"v":209200,"d":"209,200 "}," "," "," "]
["Outstanding",{"v":46400,"d":"46,400 "}," "," "," "]
["SPA Notes | Optional Debt"," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "]
["Aggregate principal amount",{"v":426000,"d":"426,000 "}," "," "," "]
["Funded",{"v":50900,"d":"50,900 "}," "," "," "]
["To be funded",{"v":375100,"d":"375,100 "}," "," "," "]
["Outstanding",{"v":3100,"d":"$ 3,100"}," "," "," "]

{"sheet":"Inventory, net - Schedule of In","index":48,"n_rows":6,"n_cols":3,"rows_kept":6}
["Inventory, net - Schedule of Inventory (Details) - USD ($) $ in Thousands","Dec. 31, 2024","Dec. 31, 2023"]
["Inventory Disclosure [Abstract]"," "," "]
["Raw materials (net of reserves)",{"v":27440,"d":"$ 27,440"},{"v":33345,"d":"$ 33,345"}]
["Work in progress",{"v":46,"d":"46 "},{"v":572,"d":"572 "}]
["Finished goods",{"v":0,"d":"0 "},{"v":312,"d":"312 "}]
["Inventory, net",{"v":27486,"d":"$ 27,486"},{"v":34229,"d":"$ 34,229"}]

{"sheet":"Inventory, net - Narrative (Det","index":49,"n_rows":3,"n_cols":3,"rows_kept":3}
["Inventory, net - Narrative (Details) - USD ($) $ in Millions","Dec. 31, 2024","Dec. 31, 2023"]
["Inventory Disclosure [Abstract]"," "," "]
["Inventory reserve",{"v":3.3,"d":"$ 3.3"},{"v":2.8,"d":"$ 2.8"}]

{"sheet":"Deposits and Other Current As_3","index":50,"n_rows":9,"n_cols":3,"rows_kept":9}
["Deposits and Other Current Assets - Deposits and Other Current Assets (Details) - USD ($) $ in Thousands","Dec. 31, 2024","Dec. 31, 2023"]
["Deposits"," "," "]
["Deposits for research and development, prototype and production parts, and other",{"v":29318,"d":"$ 29,318"},{"v":28609,"d":"$ 28,609"}]
["Deposits for goods and services yet to be received (“Future Work”)",{"v":1776,"d":"1,776 "},{"v":2773,"d":"2,773 "}]
["Deposits",{"v":31094,"d":"31,094 "},{"v":31382,"d":"31,382 "}]
["Other current assets"," "," "]
["Prepaid expenses",{"v":4832,"d":"4,832 "},{"v":13309,"d":"13,309 "}]
["Other current assets",{"v":1295,"d":"1,295 "},{"v":8412,"d":"8,412 "}]
["Other current assets",{"v":6127,"d":"$ 6,127"},{"v":21721,"d":"$ 21,721"}]

{"sheet":"Property, Plant, and Equipmen_3","index":51,"n_rows":26,"n_cols":3,"rows_kept":26}
["Property, Plant, and Equipment, Net (Details) - USD ($) $ in Thousands","Dec. 31, 2024","Dec. 31, 2023"]
["Property, Plant and Equipment [Line Items]"," "," "]
["Property and equipment, gross",{"v":468421,"d":"$ 468,421"},{"v":467352,"d":"$ 467,352"}]
["Less: Accumulated depreciation",{"v":-119834,"d":"(119,834)"},{"v":-49540,"d":"(49,540)"}]
["Property, plant and equipment, net",{"v":348587,"d":"348,587 "},{"v":417812,"d":"417,812 "}]
["Land, buildings and leasehold improvements"," "," "]
["Property, Plant and Equipment [Line Items]"," "," "]
["Property and equipment, gross",{"v":111443,"d":"111,443 "},{"v":103522,"d":"103,522 "}]
["Computer hardware"," "," "]
["Property, Plant and Equipment [Line Items]"," "," "]
["Property and equipment, gross",{"v":2397,"d":"2,397 "},{"v":2195,"d":"2,195 "}]
["Tooling, machinery, and equipment"," "," "]
["Property, Plant and Equipment [Line Items]"," "," "]
["Property and equipment, gross",{"v":319313,"d":"319,313 "},{"v":318301,"d":"318,301 "}]
["Vehicles"," "," "]
["Property, Plant and Equipment [Line Items]"," "," "]
["Property and equipment, gross",{"v":245,"d":"245 "},{"v":669,"d":"669 "}]
["Lease vehicles"," "," "]
["Property, Plant and Equipment [Line Items]"," "," "]
["Property and equipment, gross",{"v":3121,"d":"3,121 "},{"v":1873,"d":"1,873 "}]
["Computer software"," "," "]
["Property, Plant and Equipment [Line Items]"," "," "]
["Property and equipment, gross",{"v":4339,"d":"4,339 "},{"v":4301,"d":"4,301 "}]
["Construction in process"," "," "]
["Property, Plant and Equipment [Line Items]"," "," "]
["Property and equipment, gross",{"v":27563,"d":"$ 27,563"},{"v":36491,"d":"$ 36,491"}]

{"sheet":"Property, Plant, and Equipmen_4","index":52,"n_rows":13,"n_cols":3,"rows_kept":13,"merged":[[0,0,1,0],[0,1,0,2]]}
["Property, Plant, and Equipment, Net - Narrative (Details) - USD ($) $ in Thousands","12 Months Ended"]
[null,"Dec. 31, 2024","Dec. 31, 2023"]
["Property, Plant and Equipment [Line Items]"," "," "]
["Gain (loss) on disposition of property plant equipment",{"v":-1667,"d":"$ (1,667)"},{"v":-4453,"d":"$ (4,453)"}]
["Accumulated depreciation, depletion and amortization, sale or disposal of property, plant and equipment",{"v":1000,"d":"1,000 "},{"v":4500,"d":"4,500 "}]
["Depreciation",{"v":71400,"d":"71,400 "},{"v":42500,"d":"42,500 "}]
["Asset retirement obligation",{"v":800,"d":"800 "},{"v":700,"d":"700 "}]
["Construction in process"," "," "]
["Property, Plant and Equipment [Line Items]"," "," "]
["Property and equipment disposed",{"v":5300,"d":"5,300 "},{"v":9600,"d":"9,600 "}]
["Construction in process | Operating Expense"," "," "]
["Property, Plant and Equipment [Line Items]"," "," "]
["Property and equipment disposed",{"v":5300,"d":"$ 5,300"},{"v":3700,"d":"$ 3,700"}]

{"sheet":"Accrued Expenses and Other Cu_3","index":53,"n_rows":7,"n_cols":3,"rows_kept":7}
["Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Liabilities (Details) - USD ($) $ in Thousands","Dec. 31, 2024","Dec. 31, 2023"]
["Accounts Payable and Accrued Liabilities, Current [Abstract]"," "," "]
["Accrued payroll and benefits",{"v":27713,"d":"$ 27,713"},{"v":28037,"d":"$ 28,037"}]
["Accrued legal contingencies",{"v":9091,"d":"9,091 "},{"v":21590,"d":"21,590 "}]
["Customer deposits",{"v":3027,"d":"3,027 "},{"v":3246,"d":"3,246 "}]
["Other current liabilities",{"v":16923,"d":"16,923 "},{"v":9518,"d":"9,518 "}]
["Accrued expenses and other current liabilities",{"v":56754,"d":"$ 56,754"},{"v":62391,"d":"$ 62,391"}]

{"sheet":"Notes Payable - Schedule of Not","index":54,"n_rows":66,"n_cols":3,"rows_kept":66,"merged":[[0,0,1,0]]}
["Notes Payable - Schedule of Notes Payable (Details) - USD ($) $ in Thousands","12 Months Ended"]
[null,"Dec. 31, 2023","Dec. 31, 2024"]
["Debt Outstanding [Abstract]"," "," "]
["Payments with related party (less than)",{"v":542,"d":"$ 542"}," "]
["Nonrelated Party"," "," "]
["Debt Outstanding [Abstract]"," "," "]
["Notes payable",{"v":91150,"d":"91,150 "},{"v":4224,"d":"$ 4,224"}]
["Notes payable, long-term portion",{"v":0,"d":"0 "},{"v":45264,"d":"45,264 "}]
["Notes Payable"," "," "]
["Debt Outstanding [Abstract]"," "," "]
["Unpaid Principal Balance",{"v":118251,"d":"118,251 "},{"v":50577,"d":"50,577 "}]
["Fair Value Measurement Adjustments",{"v":-14239,"d":"(14,239)"},{"v":27399,"d":"27,399 "}]
["Original Issue Discount and Proceeds Allocated to Warrants",{"v":-12862,"d":"(12,862)"},{"v":-28488,"d":"(28,488)"}]
["Net Carrying Value",{"v":91150,"d":"91,150 "},{"v":49488,"d":"49,488 "}]
["Secured SPA Notes | Notes Payable"," "," "]
["Debt Outstanding [Abstract]"," "," "]
["Unpaid Principal Balance",{"v":100052,"d":"100,052 "},{"v":3118,"d":"3,118 "}]
["Fair Value Measurement Adjustments",{"v":-15501,"d":"(15,501)"},{"v":2651,"d":"2,651 "}]
["Original Issue Discount and Proceeds Allocated to Warrants",{"v":-10319,"d":"(10,319)"},{"v":-312,"d":"(312)"}]
["Net Carrying Value",{"v":74232,"d":"74,232 "},{"v":5457,"d":"5,457 "}]
["2023 Unsecured SPA Notes | Notes Payable"," "," "]
["Debt Outstanding [Abstract]"," "," "]
["Unpaid Principal Balance",{"v":13219,"d":"13,219 "},{"v":4380,"d":"4,380 "}]
["Fair Value Measurement Adjustments",{"v":1262,"d":"1,262 "},{"v":2844,"d":"2,844 "}]
["Original Issue Discount and Proceeds Allocated to Warrants",{"v":-2543,"d":"(2,543)"},{"v":-508,"d":"(508)"}]
["Net Carrying Value",{"v":11938,"d":"$ 11,938"},{"v":6716,"d":"$ 6,716"}]
["Junior Secured SPA Notes | Notes Payable"," "," "]
["Debt Outstanding [Abstract]"," "," "]
["Contractual Interest Rates"," ",{"v":0.1,"d":"10%"}]
["Unpaid Principal Balance"," ",{"v":28840,"d":"$ 28,840"}]
["Fair Value Measurement Adjustments"," ",{"v":13163,"d":"13,163 "}]
["Original Issue Discount and Proceeds Allocated to Warrants"," ",{"v":-15944,"d":"(15,944)"}]
["Net Carrying Value"," ",{"v":26059,"d":"$ 26,059"}]
["2024 Unsecured SPA Notes | Notes Payable"," "," "]
["Debt Outstanding [Abstract]"," "," "]
["Contractual Interest Rates"," ",{"v":0.1,"d":"10%"}]
["Unpaid Principal Balance"," ",{"v":10015,"d":"$ 10,015"}]
["Fair Value Measurement Adjustments"," ",{"v":8741,"d":"8,741 "}]
["Original Issue Discount and Proceeds Allocated to Warrants"," ",{"v":-11724,"d":"(11,724)"}]
["Net Carrying Value"," ",{"v":7032,"d":"$ 7,032"}]
["Notes payable – China other | Notes Payable"," "," "]
["Debt Outstanding [Abstract]"," "," "]
["Contractual Interest Rates",{"v":0,"d":"0%"},{"v":0,"d":"0%"}]
["Unpaid Principal Balance",{"v":4898,"d":"$ 4,898"},{"v":4173,"d":"$ 4,173"}]
["Fair Value Measurement Adjustments",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Original Issue Discount and Proceeds Allocated to Warrants",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Net Carrying Value",{"v":4898,"d":"$ 4,898"},{"v":4173,"d":"$ 4,173"}]
["Auto loans | Notes Payable"," "," "]
["Debt Outstanding [Abstract]"," "," "]
["Contractual Interest Rates",{"v":0.07,"d":"7%"},{"v":0.07,"d":"7%"}]
["Unpaid Principal Balance",{"v":82,"d":"$ 82"},{"v":51,"d":"$ 51"}]
["Fair Value Measurement Adjustments",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Original Issue Discount and Proceeds Allocated to Warrants",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Net Carrying Value",{"v":82,"d":"$ 82"},{"v":51,"d":"$ 51"}]
["Minimum | Secured SPA Notes | Notes Payable"," "," "]
["Debt Outstanding [Abstract]"," "," "]
["Contractual Interest Rates",{"v":0.1,"d":"10%"},{"v":0.1,"d":"10%"}]
["Minimum | 2023 Unsecured SPA Notes | Notes Payable"," "," "]
["Debt Outstanding [Abstract]"," "," "]
["Contractual Interest Rates",{"v":0.1,"d":"10%"},{"v":0.1,"d":"10%"}]
["Maximum | Secured SPA Notes | Notes Payable"," "," "]
["Debt Outstanding [Abstract]"," "," "]
["Contractual Interest Rates",{"v":0.15,"d":"15%"},{"v":0.15,"d":"15%"}]
["Maximum | 2023 Unsecured SPA Notes | Notes Payable"," "," "]
["Debt Outstanding [Abstract]"," "," "]
["Contractual Interest Rates",{"v":0.15,"d":"15%"},{"v":0.15,"d":"15%"}]

{"sheet":"Notes Payable - Schedule of N_2","index":55,"n_rows":90,"n_cols":3,"rows_kept":90,"merged":[[0,0,1,0],[0,1,0,2]]}
["Notes Payable - Schedule of Note Payable Rollforward (Details) - Notes Payable - USD ($)","12 Months Ended"]
[null,"Dec. 31, 2024","Dec. 31, 2023"]
["Notes Payable [Roll Forward]"," "," "]
["Beginning balance",{"v":91150000,"d":"$ 91,150,000"},{"v":31105000,"d":"$ 31,105,000"}]
["New issuances",{"v":57291000,"d":"57,291,000 "},{"v":194648000,"d":"194,648,000 "}]
["Repayments of debt",{"v":-31000,"d":"(31,000)"},{"v":-1167000,"d":"(1,167,000)"}]
["Conversion of debt to equity",{"v":-66678000,"d":"(66,678,000)"},{"v":-123387000,"d":"(123,387,000)"}]
["Gain (loss) extinguishments of debt",{"v":2699000,"d":"2,699,000 "},{"v":13078000,"d":"13,078,000 "}]
["Fair value adjustments of debt",{"v":-34218000,"d":"(34,218,000)"},{"v":23028000,"d":"23,028,000 "}]
["Reclassification of debt between debt categories",{"v":0,"d":"0 "}," "]
["Other adjustments",{"v":-725000,"d":"(725,000)"},{"v":-99000,"d":"(99,000)"}]
["Ending balance",{"v":49488000,"d":"49,488,000 "},{"v":91150000,"d":"91,150,000 "}]
["Secured SPA Notes"," "," "]
["Notes Payable [Roll Forward]"," "," "]
["Beginning balance",{"v":74232000,"d":"74,232,000 "},{"v":26008000,"d":"26,008,000 "}]
["New issuances",{"v":10701000,"d":"10,701,000 "},{"v":173730000,"d":"173,730,000 "}]
["Repayments of debt",{"v":0,"d":"0 "},{"v":-1167000,"d":"(1,167,000)"}]
["Conversion of debt to equity",{"v":-50691000,"d":"(50,691,000)"},{"v":-114252000,"d":"(114,252,000)"}]
["Gain (loss) extinguishments of debt",{"v":5158000,"d":"5,158,000 "},{"v":13078000,"d":"13,078,000 "}]
["Fair value adjustments of debt",{"v":-33943000,"d":"(33,943,000)"},{"v":23165000,"d":"23,165,000 "}]
["Reclassification of debt between debt categories",{"v":0,"d":"0 "}," "]
["Other adjustments",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Ending balance",{"v":5457000,"d":"5,457,000 "},{"v":74232000,"d":"74,232,000 "}]
["2023 Unsecured SPA Notes"," "," "]
["Notes Payable [Roll Forward]"," "," "]
["Beginning balance",{"v":11938000,"d":"11,938,000 "},{"v":0,"d":"0 "}]
["New issuances",{"v":0,"d":"0 "},{"v":20936000,"d":"20,936,000 "}]
["Repayments of debt",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Conversion of debt to equity",{"v":-14931000,"d":"(14,931,000)"},{"v":-9135000,"d":"(9,135,000)"}]
["Gain (loss) extinguishments of debt",{"v":-2394000,"d":"(2,394,000)"},{"v":0,"d":"0 "}]
["Fair value adjustments of debt",{"v":-10268000,"d":"(10,268,000)"},{"v":-137000,"d":"(137,000)"}]
["Reclassification of debt between debt categories",{"v":22371000,"d":"22,371,000 "}," "]
["Other adjustments",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Ending balance",{"v":6716000,"d":"6,716,000 "},{"v":11938000,"d":"11,938,000 "}]
["Unsecured Convertible Note"," "," "]
["Notes Payable [Roll Forward]"," "," "]
["Beginning balance",{"v":0,"d":"0 "}," "]
["New issuances",{"v":34885000,"d":"34,885,000 "}," "]
["Repayments of debt",{"v":0,"d":"0 "}," "]
["Conversion of debt to equity",{"v":0,"d":"0 "}," "]
["Gain (loss) extinguishments of debt",{"v":-65000,"d":"(65,000)"}," "]
["Fair value adjustments of debt",{"v":328000,"d":"328,000 "}," "]
["Reclassification of debt between debt categories",{"v":-35148000,"d":"(35,148,000)"}," "]
["Other adjustments",{"v":0,"d":"0 "}," "]
["Ending balance",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Junior Secured SPA Notes"," "," "]
["Notes Payable [Roll Forward]"," "," "]
["Beginning balance",{"v":0,"d":"0 "}," "]
["New issuances",{"v":9950000,"d":"9,950,000 "}," "]
["Repayments of debt",{"v":0,"d":"0 "}," "]
["Conversion of debt to equity",{"v":-1056000,"d":"(1,056,000)"}," "]
["Gain (loss) extinguishments of debt",{"v":0,"d":"0 "}," "]
["Fair value adjustments of debt",{"v":9665000,"d":"9,665,000 "}," "]
["Reclassification of debt between debt categories",{"v":7500000,"d":"7,500,000 "}," "]
["Other adjustments",{"v":0,"d":"0 "}," "]
["Ending balance",{"v":26059000,"d":"26,059,000 "},{"v":0,"d":"0 "}]
["2024 Unsecured SPA Notes"," "," "]
["Notes Payable [Roll Forward]"," "," "]
["Beginning balance",{"v":0,"d":"0 "}," "]
["New issuances",{"v":1755000,"d":"1,755,000 "}," "]
["Repayments of debt",{"v":0,"d":"0 "}," "]
["Conversion of debt to equity",{"v":0,"d":"0 "}," "]
["Gain (loss) extinguishments of debt",{"v":0,"d":"0 "}," "]
["Fair value adjustments of debt",{"v":0,"d":"0 "}," "]
["Reclassification of debt between debt categories",{"v":5277000,"d":"5,277,000 "}," "]
["Other adjustments",{"v":0,"d":"0 "}," "]
["Ending balance",{"v":7032000,"d":"7,032,000 "},{"v":0,"d":"0 "}]
["Notes payable – China other"," "," "]
["Notes Payable [Roll Forward]"," "," "]
["Beginning balance",{"v":4898000,"d":"4,898,000 "},{"v":4997000,"d":"4,997,000 "}]
["New issuances"," ",{"v":0,"d":"0 "}]
["Repayments of debt",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Conversion of debt to equity",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Gain (loss) extinguishments of debt",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Fair value adjustments of debt",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Reclassification of debt between debt categories",{"v":0,"d":"0 "}," "]
["Other adjustments",{"v":-725000,"d":"(725,000)"},{"v":-99000,"d":"(99,000)"}]
["Ending balance",{"v":4173000,"d":"4,173,000 "},{"v":4898000,"d":"4,898,000 "}]
["Auto loans"," "," "]
["Notes Payable [Roll Forward]"," "," "]
["Beginning balance",{"v":82000,"d":"82,000 "},{"v":100000,"d":"100,000 "}]
["New issuances",{"v":0,"d":"0 "}," "]
["New issuances, adjustment"," ",{"v":-18000,"d":"(18,000)"}]
["Repayments of debt",{"v":-31000,"d":"(31,000)"},{"v":0,"d":"0 "}]
["Conversion of debt to equity",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Gain (loss) extinguishments of debt",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Fair value adjustments of debt",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Reclassification of debt between debt categories",{"v":0,"d":"0 "}," "]
["Other adjustments",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Ending balance",{"v":51000,"d":"$ 51,000"},{"v":82000,"d":"$ 82,000"}]

{"sheet":"Notes Payable - Schedule of Mat","index":56,"n_rows":10,"n_cols":3,"rows_kept":10}
["Notes Payable - Schedule of Maturities of Long-term Debt (Details) - Notes Payable - USD ($) $ in Thousands","Dec. 31, 2024","Dec. 31, 2023"]
["Debt Instrument [Line Items]"," "," "]
["Due on demand",{"v":4173,"d":"$ 4,173"}," "]
["2025",{"v":0,"d":"0 "}," "]
["2026",{"v":51,"d":"51 "}," "]
["2027",{"v":0,"d":"0 "}," "]
["2028",{"v":0,"d":"0 "}," "]
["2029",{"v":39546,"d":"39,546 "}," "]
["Thereafter",{"v":6807,"d":"6,807 "}," "]
["Total",{"v":50577,"d":"$ 50,577"},{"v":118251,"d":"$ 118,251"}]

{"sheet":"Notes Payable - Secured SPA Not","index":57,"n_rows":110,"n_cols":11,"rows_kept":110,"merged":[[0,0,1,0],[0,3,0,4]]}
["Notes Payable - Secured SPA Notes Narrative (Details) - USD ($)",null,"6 Months Ended","12 Months Ended"]
[null,"Aug. 02, 2024","Jun. 30, 2024","Dec. 31, 2024","Dec. 31, 2023","Dec. 21, 2024","Sep. 05, 2024","May 09, 2023","May 08, 2023","Mar. 23, 2023","Feb. 03, 2023"]
["Debt Instrument [Line Items]"," "," "," "," "," "," "," "," "," "," "]
["Payments of notes payable issuance costs"," "," ",{"v":2087000,"d":"$ 2,087,000"},{"v":2503000,"d":"$ 2,503,000"}," "," "," "," "," "," "]
["Notes Payable"," "," "," "," "," "," "," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "," "," "," "," "," "," "]
["Gain (loss) extinguishments of debt"," "," ",{"v":2699000,"d":"2,699,000 "},{"v":13078000,"d":"13,078,000 "}," "," "," "," "," "," "]
["Gain (loss) on fair value adjustment of debts"," "," ",{"v":34218000,"d":"$ 34,218,000"},{"v":-23028000,"d":"(23,028,000)"}," "," "," "," "," "," "]
["Secured SPA Notes"," "," "," "," "," "," "," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "," "," "," "," "," "," "]
["Conversion price (in dollars per share)"," "," "," "," "," "," ",{"v":8568,"d":"$ 8,568"},{"v":10080,"d":"$ 10,080"}," "," "]
["Debt instrument, floor price (in dollars per share)"," "," "," "," "," "," ",{"v":960,"d":"$ 960"},{"v":2016,"d":"$ 2,016"}," "," "]
["Secured SPA Notes | Notes Payable"," "," "," "," "," "," "," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "," "," "," "," "," "," "]
["Debt instrument, fixed conversion price percentage"," "," ",{"v":0.9,"d":"90%"}," "," "," "," "," "," "," "]
["Conversion price (in dollars per share)"," ",{"v":29.33,"d":"$ 29.33"},{"v":1.16,"d":"$ 1.16"}," "," "," "," "," "," "," "]
["Debt instrument, term (in years)"," "," ","6 years"," "," "," "," "," "," "," "]
["Aggregate principal amount"," "," ",{"v":108800000,"d":"$ 108,800,000"}," "," "," "," "," ",{"v":25000000,"d":"$ 25,000,000"}," "]
["Notes payable"," "," ",{"v":5500000,"d":"5,500,000 "},{"v":74200000,"d":"74,200,000 "}," "," "," "," "," "," "]
["Proceeds from debt, net of issuance costs"," "," ",{"v":10700000,"d":"10,700,000 "},{"v":187200000,"d":"187,200,000 "}," "," "," "," "," "," "]
["Payments of notes payable issuance costs"," "," ",{"v":200000,"d":"$ 200,000"},{"v":1900000,"d":"$ 1,900,000"}," "," "," "," "," "," "]
["Shares issued from conversion (in shares)"," "," ",{"v":41727089,"d":"41,727,089 "},{"v":419646,"d":"419,646 "}," "," "," "," "," "," "]
["Gain (loss) extinguishments of debt"," "," ",{"v":5158000,"d":"$ 5,158,000"},{"v":13078000,"d":"$ 13,078,000"}," "," "," "," "," "," "]
["Gain (loss) on fair value adjustment of debts"," "," ",{"v":33943000,"d":"33,943,000 "},{"v":-23165000,"d":"(23,165,000)"}," "," "," "," "," "," "]
["Debt conversion, converted amount"," "," "," ",{"v":188100000,"d":"188,100,000 "}," "," "," "," "," "," "]
["Secured SPA Notes | Notes Payable | Class A Common Stock"," "," "," "," "," "," "," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "," "," "," "," "," "," "]
["Redemption price, percentage"," ",{"v":1.05,"d":"105%"}," "," "," "," "," "," "," "," "]
["Gain (loss) extinguishments of debt"," "," ",{"v":-126100000,"d":"$ (126,100,000)"},{"v":-193500000,"d":"(193,500,000)"}," "," "," "," "," "," "]
["Secured SPA Notes | Notes Payable | Metaverse Horizon Limited and V W Investment Holding Limited"," "," "," "," "," "," "," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "," "," "," "," "," "," "]
["Percent of purchaser's conversion shares"," "," ",{"v":0.33,"d":"33%"}," "," "," "," "," "," "," "]
["Secured SPA Notes | Notes Payable | Tranche C"," "," "," "," "," "," "," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "," "," "," "," "," "," "]
["Conversion price (in dollars per share)"," "," "," "," "," "," "," "," "," ",{"v":10080,"d":"$ 10,080"}]
["Aggregate principal amount"," "," "," "," "," "," "," "," "," ",{"v":135000000,"d":"$ 135,000,000"}]
["Replacement Note | Notes Payable"," "," "," "," "," "," "," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "," "," "," "," "," "," "]
["Aggregate principal amount"," "," "," "," "," "," "," "," "," ",{"v":31000000,"d":"$ 31,000,000"}]
["Streeterville SPA | Notes Payable | Streeterville Capital, LLC | Class A Common Stock"," "," "," "," "," "," "," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "," "," "," "," "," "," "]
["Conversion price (in dollars per share)"," "," "," "," "," "," "," "," "," ",{"v":8568,"d":"$ 8,568"}]
["Tranche C Notes | Notes Payable"," "," "," "," "," "," "," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "," "," "," "," "," "," "]
["Aggregate principal amount"," "," "," "," "," "," "," "," ",{"v":40000000,"d":"$ 40,000,000"}," "]
["Original issue discount percent"," "," "," "," "," "," "," "," ",{"v":0.14,"d":"14%"}," "]
["Tranche B Notes | Notes Payable"," "," "," "," "," "," "," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "," "," "," "," "," "," "]
["Aggregate principal amount"," "," "," "," "," "," "," "," ",{"v":5000000,"d":"$ 5,000,000"}," "]
["Original issue discount percent"," "," "," "," "," "," "," "," ",{"v":0.16,"d":"16%"}," "]
["SPA Notes | Notes Payable"," "," "," "," "," "," "," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "," "," "," "," "," "," "]
["Conversion price (in dollars per share)",{"v":29.33,"d":"$ 29.33"}," "," "," "," "," "," "," "," "," "]
["SPA Notes | Notes Payable | Class A Common Stock"," "," "," "," "," "," "," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "," "," "," "," "," "," "]
["Redemption price, percentage",{"v":0.9,"d":"90%"}," "," "," "," "," "," "," "," "," "]
["Junior Secured SPA Notes | Notes Payable"," "," "," "," "," "," "," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "," "," "," "," "," "," "]
["Notes payable bearing interest rate"," "," "," "," "," ",{"v":0.1,"d":"10%"}," "," "," "," "]
["Conversion price (in dollars per share)"," "," "," "," ",{"v":1.16,"d":"$ 1.16"},{"v":5.24,"d":"$ 5.24"}," "," "," "," "]
["Debt instrument, term (in years)"," "," ","1 year"," "," "," "," "," "," "," "]
["Debt instrument, floor price (in dollars per share)"," "," "," "," "," ",{"v":1.05,"d":"$ 1.05"}," "," "," "," "]
["Proceeds from debt, net of issuance costs"," "," ",{"v":22500000,"d":"$ 22,500,000"}," "," "," "," "," "," "," "]
["Payments of notes payable issuance costs"," "," ",{"v":1300000,"d":"1,300,000 "}," "," "," "," "," "," "," "]
["Gain (loss) extinguishments of debt"," "," ",{"v":0,"d":"0 "}," "," "," "," "," "," "," "]
["Gain (loss) on fair value adjustment of debts"," "," ",{"v":-9665000,"d":"$ (9,665,000)"}," "," "," "," "," "," "," "]
["Junior Secured SPA Notes | Notes Payable | Class A Common Stock"," "," "," "," "," "," "," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "," "," "," "," "," "," "]
["Shares issued from conversion (in shares)"," "," ",{"v":1046651,"d":"1,046,651 "}," "," "," "," "," "," "," "]
["Gain (loss) extinguishments of debt"," "," ",{"v":1400000,"d":"$ 1,400,000"}," "," "," "," "," "," "," "]
["Debt conversion, converted amount"," "," ",{"v":1100000,"d":"$ 1,100,000"}," "," "," "," "," "," "," "]
["2024 Unsecured SPA Notes | Notes Payable"," "," "," "," "," "," "," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "," "," "," "," "," "," "]
["Notes payable bearing interest rate"," "," ",{"v":0.1,"d":"10%"}," "," "," "," "," "," "," "]
["Conversion price (in dollars per share)"," "," ",{"v":1.16,"d":"$ 1.16"}," ",{"v":1.16,"d":"$ 1.16"}," "," "," "," "," "]
["Debt instrument, term (in years)"," "," ","1 year"," "," "," "," "," "," "," "]
["Aggregate principal amount"," "," ",{"v":7500000,"d":"$ 7,500,000"}," "," "," "," "," "," "," "]
["Debt instrument, floor price (in dollars per share)"," "," ",{"v":1.05,"d":"$ 1.05"}," "," "," "," "," "," "," "]
["Proceeds from debt, net of issuance costs"," "," ",{"v":2500000,"d":"$ 2,500,000"}," "," "," "," "," "," "," "]
["Payments of notes payable issuance costs"," "," ",{"v":0,"d":"0 "}," "," "," "," "," "," "," "]
["Gain (loss) extinguishments of debt"," "," ",{"v":0,"d":"0 "}," "," "," "," "," "," "," "]
["Gain (loss) on fair value adjustment of debts"," "," ",{"v":0,"d":"$ 0"}," "," "," "," "," "," "," "]
["2023 Unsecured SPA Notes | Notes Payable"," "," "," "," "," "," "," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "," "," "," "," "," "," "]
["Conversion price (in dollars per share)"," "," ",{"v":1.16,"d":"$ 1.16"}," "," "," "," "," "," "," "]
["Debt instrument, term (in years)"," "," ","6 years"," "," "," "," "," "," "," "]
["Aggregate principal amount"," "," ",{"v":22100000,"d":"$ 22,100,000"}," "," "," "," "," "," "," "]
["Notes payable"," "," ",{"v":6700000,"d":"6,700,000 "},{"v":11900000,"d":"11,900,000 "}," "," "," "," "," "," "]
["Proceeds from debt, net of issuance costs"," "," ",{"v":0,"d":"$ 0"},{"v":23300000,"d":"23,300,000 "}," "," "," "," "," "," "]
["Payments of notes payable issuance costs"," "," "," ",{"v":200000,"d":"$ 200,000"}," "," "," "," "," "," "]
["Shares issued from conversion (in shares)"," "," ",{"v":19368059,"d":"19,368,059 "},{"v":85830,"d":"85,830 "}," "," "," "," "," "," "]
["Gain (loss) extinguishments of debt"," "," ",{"v":-2394000,"d":"$ (2,394,000)"},{"v":0,"d":"$ 0"}," "," "," "," "," "," "]
["Gain (loss) on fair value adjustment of debts"," "," ",{"v":10268000,"d":"10,268,000 "},{"v":137000,"d":"137,000 "}," "," "," "," "," "," "]
["Debt conversion, converted amount"," "," ",{"v":31000000,"d":"$ 31,000,000"},{"v":12500000,"d":"12,500,000 "}," "," "," "," "," "," "]
["2023 Unsecured SPA Notes | Notes Payable | Class A Common Stock"," "," "," "," "," "," "," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "," "," "," "," "," "," "]
["Debt instrument, fixed conversion price percentage"," "," ",{"v":0.9,"d":"90%"}," "," "," "," "," "," "," "]
["Gain (loss) extinguishments of debt"," "," ",{"v":-31500000,"d":"$ (31,500,000)"},{"v":-9200000,"d":"$ (9,200,000)"}," "," "," "," "," "," "]
["Minimum | Secured SPA Notes | Notes Payable"," "," "," "," "," "," "," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "," "," "," "," "," "," "]
["Notes payable bearing interest rate"," "," ",{"v":0.1,"d":"10%"},{"v":0.1,"d":"10%"}," "," "," "," "," "," "]
["Minimum | 2023 Unsecured SPA Notes | Notes Payable"," "," "," "," "," "," "," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "," "," "," "," "," "," "]
["Notes payable bearing interest rate"," "," ",{"v":0.1,"d":"10%"},{"v":0.1,"d":"10%"}," "," "," "," "," "," "]
["Maximum | Secured SPA Notes | Notes Payable"," "," "," "," "," "," "," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "," "," "," "," "," "," "]
["Notes payable bearing interest rate"," "," ",{"v":0.15,"d":"15%"},{"v":0.15,"d":"15%"}," "," "," "," "," "," "]
["Maximum | 2023 Unsecured SPA Notes | Notes Payable"," "," "," "," "," "," "," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "," "," "," "," "," "," "]
["Notes payable bearing interest rate"," "," ",{"v":0.15,"d":"15%"},{"v":0.15,"d":"15%"}," "," "," "," "," "," "]

{"sheet":"Notes Payable - 2023 Unsecured ","index":58,"n_rows":55,"n_cols":5,"rows_kept":55,"merged":[[0,0,1,0],[0,1,0,2]]}
["Notes Payable - 2023 Unsecured SPA Notes Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands","12 Months Ended"]
[null,"Dec. 31, 2024","Dec. 31, 2023","Dec. 21, 2024","Sep. 05, 2024"]
["Debt Instrument [Line Items]"," "," "," "," "]
["Payments of notes payable issuance costs",{"v":2087,"d":"$ 2,087"},{"v":2503,"d":"$ 2,503"}," "," "]
["Notes Payable"," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "]
["Reclassification of debt between debt categories",{"v":0,"d":"0 "}," "," "," "]
["Gain (loss) extinguishments of debt",{"v":2699,"d":"$ 2,699"},{"v":13078,"d":"13,078 "}," "," "]
["2023 Unsecured SPA Notes | Notes Payable"," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "]
["Conversion price (in dollars per share)",{"v":1.16,"d":"$ 1.16"}," "," "," "]
["Debt instrument, term (in years)","6 years"," "," "," "]
["Notes payable",{"v":6700,"d":"$ 6,700"},{"v":11900,"d":"11,900 "}," "," "]
["Proceeds from debt, net of issuance costs",{"v":0,"d":"0 "},{"v":23300,"d":"23,300 "}," "," "]
["Aggregate principal amount",{"v":22100,"d":"22,100 "}," "," "," "]
["Reclassification of debt between debt categories",{"v":22371,"d":"22,371 "}," "," "," "]
["Debt conversion, converted amount",{"v":31000,"d":"$ 31,000"},{"v":12500,"d":"$ 12,500"}," "," "]
["Shares issued from conversion (in shares)",{"v":19368059,"d":"19,368,059 "},{"v":85830,"d":"85,830 "}," "," "]
["Gain (loss) extinguishments of debt",{"v":-2394,"d":"$ (2,394)"},{"v":0,"d":"$ 0"}," "," "]
["Payments of notes payable issuance costs"," ",{"v":200,"d":"200 "}," "," "]
["Gain (loss) on fair value adjustment of debts, favorable, net"," ",{"v":100,"d":"100 "}," "," "]
["2023 Unsecured SPA Notes | Notes Payable | Class A Common Stock"," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "]
["Debt instrument, fixed conversion price percentage",{"v":0.9,"d":"90%"}," "," "," "]
["Gain (loss) extinguishments of debt",{"v":-31500,"d":"$ (31,500)"},{"v":-9200,"d":"$ (9,200)"}," "," "]
["Unsecured SPA Notes | Notes Payable"," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "]
["Percent of purchaser's conversion shares",{"v":0.33,"d":"33%"}," "," "," "]
["Junior Secured SPA Notes | Notes Payable"," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "]
["Contractual Interest Rates"," "," "," ",{"v":0.1,"d":"10%"}]
["Conversion price (in dollars per share)"," "," ",{"v":1.16,"d":"$ 1.16"},{"v":5.24,"d":"$ 5.24"}]
["Debt instrument, term (in years)","1 year"," "," "," "]
["Proceeds from debt, net of issuance costs",{"v":22500,"d":"$ 22,500"}," "," "," "]
["Reclassification of debt between debt categories",{"v":7500,"d":"7,500 "}," "," "," "]
["Gain (loss) extinguishments of debt",{"v":0,"d":"0 "}," "," "," "]
["Payments of notes payable issuance costs",{"v":1300,"d":"1,300 "}," "," "," "]
["Junior Secured SPA Notes | Notes Payable | Class A Common Stock"," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "]
["Debt conversion, converted amount",{"v":1100,"d":"$ 1,100"}," "," "," "]
["Shares issued from conversion (in shares)",{"v":1046651,"d":"1,046,651 "}," "," "," "]
["Gain (loss) extinguishments of debt",{"v":1400,"d":"$ 1,400"}," "," "," "]
["Unsecured Convertible Note | Notes Payable"," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "]
["Contractual Interest Rates",{"v":0.0427,"d":"4.27%"}," "," "," "]
["Debt instrument, term (in years)","3 months"," "," "," "]
["Aggregate principal amount",{"v":19900,"d":"$ 19,900"}," "," "," "]
["Reclassification of debt between debt categories",{"v":-35148,"d":"(35,148)"}," "," "," "]
["Gain (loss) extinguishments of debt",{"v":-65,"d":"$ (65)"}," "," "," "]
["Minimum | 2023 Unsecured SPA Notes | Notes Payable"," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "]
["Contractual Interest Rates",{"v":0.1,"d":"10%"},{"v":0.1,"d":"10%"}," "," "]
["Maximum | 2023 Unsecured SPA Notes | Notes Payable"," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "]
["Contractual Interest Rates",{"v":0.15,"d":"15%"},{"v":0.15,"d":"15%"}," "," "]

{"sheet":"Notes Payable - Unsecured Conve","index":59,"n_rows":11,"n_cols":4,"rows_kept":11,"merged":[[0,0,1,0],[0,1,0,2]]}
["Notes Payable - Unsecured Convertible Notes Narrative (Details) - Notes Payable - USD ($)","12 Months Ended"]
[null,"Dec. 31, 2024","Dec. 31, 2023","Dec. 31, 2022"]
["Debt Instrument [Line Items]"," "," "," "]
["Notes and loans payable",{"v":49488000,"d":"$ 49,488,000"},{"v":91150000,"d":"$ 91,150,000"},{"v":31105000,"d":"$ 31,105,000"}]
["New issuances",{"v":57291000,"d":"$ 57,291,000"},{"v":194648000,"d":"194,648,000 "}," "]
["Unsecured Convertible Note"," "," "," "]
["Debt Instrument [Line Items]"," "," "," "]
["Debt instrument, term (in years)","3 months"," "," "]
["Notes payable bearing interest rate",{"v":0.0427,"d":"4.27%"}," "," "]
["Notes and loans payable",{"v":0,"d":"$ 0"},{"v":0,"d":"$ 0"}," "]
["New issuances",{"v":34885000,"d":"$ 34,885,000"}," "," "]

{"sheet":"Notes Payable - Junior Secured ","index":60,"n_rows":32,"n_cols":5,"rows_kept":32,"merged":[[0,0,1,0],[0,1,0,2]]}
["Notes Payable - Junior Secured SPA Notes Narrative (Details) $ / shares in Units, $ in Thousands","12 Months Ended"]
[null,"Dec. 31, 2024 USD ($) trading_day shares","Dec. 31, 2023 USD ($)","Dec. 21, 2024 $ / shares","Sep. 05, 2024 $ / shares shares"]
["Debt Instrument [Line Items]"," "," "," "," "]
["Payments of notes payable issuance costs",{"v":2087,"d":"$ 2,087"},{"v":2503,"d":"$ 2,503"}," "," "]
["Junior SPA Warrants"," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "]
["Percent of purchaser's conversion shares"," "," "," ",{"v":1,"d":"100%"}]
["Debt instrument, term (in years)","5 years"," "," "," "]
["Junior SPA Warrants | Class A Common Stock"," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "]
["Warrants rights (in shares) | shares"," "," "," ",{"v":202768,"d":"202,768 "}]
["Notes Payable"," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "]
["Reclassification of debt between debt categories",{"v":0,"d":"$ 0"}," "," "," "]
["Gain (loss) extinguishments of debt",{"v":2699,"d":"$ 2,699"},{"v":13078,"d":"$ 13,078"}," "," "]
["Junior Secured SPA Notes | Notes Payable"," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "]
["Notes payable bearing interest rate"," "," "," ",{"v":0.1,"d":"10%"}]
["Debt instrument, floor price (in dollars per share) | $ / shares"," "," "," ",{"v":1.05,"d":"$ 1.05"}]
["Debt instrument, convertible, threshold consecutive trading days | trading_day",{"v":5,"d":"5 "}," "," "," "]
["Debt instrument, fixed price | $ / shares"," "," "," ",1.16]
["Debt instrument, term (in years)","1 year"," "," "," "]
["Conversion price (in dollars per share) | $ / shares"," "," ",{"v":1.16,"d":"$ 1.16"},{"v":5.24,"d":"$ 5.24"}]
["Proceeds from debt, net of issuance costs",{"v":22500,"d":"$ 22,500"}," "," "," "]
["Payments of notes payable issuance costs",{"v":1300,"d":"1,300 "}," "," "," "]
["Reclassification of debt between debt categories",{"v":7500,"d":"7,500 "}," "," "," "]
["Gain (loss) extinguishments of debt",{"v":0,"d":"0 "}," "," "," "]
["Junior Secured SPA Notes | Notes Payable | Class A Common Stock"," "," "," "," "]
["Debt Instrument [Line Items]"," "," "," "," "]
["Debt conversion, converted amount",{"v":1100,"d":"$ 1,100"}," "," "," "]
["Shares issued from conversion (in shares) | shares",{"v":1046651,"d":"1,046,651 "}," "," "," "]
["Gain (loss) extinguishments of debt",{"v":1400,"d":"$ 1,400"}," "," "," "]

{"sheet":"Notes Payable - 2024 Unsecured ","index":61,"n_rows":21,"n_cols":4,"rows_kept":21,"merged":[[0,0,1,0],[0,1,0,2]]}
["Notes Payable - 2024 Unsecured SPA Notes Narrative (Details) $ / shares in Units, $ in Thousands","12 Months Ended"]
[null,"Dec. 31, 2024 USD ($) day $ / shares","Dec. 31, 2023 USD ($)","Dec. 21, 2024 $ / shares"]
["Debt Instrument [Line Items]"," "," "," "]
["Payments of notes payable issuance costs",{"v":2087,"d":"$ 2,087"},{"v":2503,"d":"$ 2,503"}," "]
["2024 Unsecured SPA Warrants"," "," "," "]
["Debt Instrument [Line Items]"," "," "," "]
["Percent of purchaser's conversion shares",{"v":1,"d":"100%"}," "," "]
["Debt instrument, term (in years)","5 years"," "," "]
["2024 Unsecured SPA Notes"," "," "," "]
["Debt Instrument [Line Items]"," "," "," "]
["Debt instrument, convertible, threshold consecutive trading days | day",{"v":1,"d":"1 "}," "," "]
["2024 Unsecured SPA Notes | Notes Payable"," "," "," "]
["Debt Instrument [Line Items]"," "," "," "]
["Notes payable bearing interest rate",{"v":0.1,"d":"10%"}," "," "]
["Conversion price (in dollars per share) | $ / shares",{"v":1.16,"d":"$ 1.16"}," ",{"v":1.16,"d":"$ 1.16"}]
["Debt instrument, floor price (in dollars per share) | $ / shares",{"v":1.05,"d":"$ 1.05"}," "," "]
["Debt instrument, convertible, threshold consecutive trading days | day",{"v":5,"d":"5 "}," "," "]
["Debt instrument, term (in years)","1 year"," "," "]
["Proceeds from debt, net of issuance costs",{"v":2500,"d":"$ 2,500"}," "," "]
["Payments of notes payable issuance costs",{"v":0,"d":"0 "}," "," "]
["Aggregate principal amount",{"v":7500,"d":"$ 7,500"}," "," "]

{"sheet":"Notes Payable - Notes Payable, ","index":62,"n_rows":4,"n_cols":3,"rows_kept":4}
["Notes Payable - Notes Payable, China Other Narrative (Details)","Dec. 31, 2024","Dec. 31, 2023"]
["Notes payable – China other | Notes Payable"," "," "]
["Debt Instrument [Line Items]"," "," "]
["Notes payable bearing interest rate",{"v":0,"d":"0%"},{"v":0,"d":"0%"}]

{"sheet":"Notes Payable - Auto Loans Narr","index":63,"n_rows":8,"n_cols":3,"rows_kept":8,"merged":[[0,0,1,0],[0,1,0,2]]}
["Notes Payable - Auto Loans Narrative (Details) - Notes Payable - USD ($)","12 Months Ended"]
[null,"Dec. 31, 2024","Dec. 31, 2023"]
["Debt Instrument [Line Items]"," "," "]
["Repayments of debt",{"v":31000,"d":"$ 31,000"},{"v":1167000,"d":"$ 1,167,000"}]
["Auto loans"," "," "]
["Debt Instrument [Line Items]"," "," "]
["Notes payable bearing interest rate",{"v":0.07,"d":"7%"},{"v":0.07,"d":"7%"}]
["Repayments of debt",{"v":31000,"d":"$ 31,000"},{"v":0,"d":"$ 0"}]

{"sheet":"Related Party Transactions - Sc","index":64,"n_rows":44,"n_cols":6,"rows_kept":44}
["Related Party Transactions - Schedule of Related Party Notes Payable (Details) - Related Party - USD ($) $ in Thousands","Dec. 31, 2024","Feb. 29, 2024","Jan. 31, 2024","Dec. 31, 2023","Nov. 30, 2023"]
["Related Party Transaction [Line Items]"," "," "," "," "," "]
["Net Carrying Value",{"v":8064,"d":"$ 8,064"}," "," ",{"v":9760,"d":"$ 9,760"}," "]
["Related party notes payable, current",{"v":5310,"d":"5,310 "}," "," ",{"v":9760,"d":"9,760 "}," "]
["Related party notes payable, long-term",{"v":2754,"d":"$ 2,754"}," "," ",{"v":0,"d":"0 "}," "]
["Unsecured Convertible Note"," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "]
["Contractual Interest Rates",{"v":0.0427,"d":"4.27%"}," "," "," "," "]
["Net Carrying Value",{"v":1364,"d":"$ 1,364"}," "," "," "," "]
["2023 Unsecured SPA Notes"," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "]
["Net Carrying Value"," "," "," ",{"v":542,"d":"$ 542"}," "]
["2023 Unsecured SPA Notes | Minimum"," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "]
["Contractual Interest Rates"," "," "," ",{"v":0.1,"d":"10%"}," "]
["2023 Unsecured SPA Notes | Maximum"," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "]
["Contractual Interest Rates"," "," "," ",{"v":0.15,"d":"15%"}," "]
["Notes Payable — China"," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "]
["Contractual Interest Rates",{"v":0.18,"d":"18%"}," "," ",{"v":0.18,"d":"18%"}," "]
["Net Carrying Value",{"v":4382,"d":"$ 4,382"}," "," ",{"v":5103,"d":"$ 5,103"}," "]
["Notes Payable on Demand — China"," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "]
["Contractual Interest Rates",{"v":0,"d":"0%"}," "," ",{"v":0,"d":"0%"}," "]
["Net Carrying Value",{"v":417,"d":"$ 417"}," "," ",{"v":3789,"d":"$ 3,789"}," "]
["FFGP Note"," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "]
["Contractual Interest Rates",{"v":0.0427,"d":"4.27%"}," "," ",{"v":0.0527,"d":"5.27%"}," "]
["Net Carrying Value",{"v":1576,"d":"$ 1,576"}," ",{"v":1600,"d":"$ 1,600"},{"v":326,"d":"$ 326"},{"v":1600,"d":"$ 1,600"}]
["FFGP Note | Minimum"," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "]
["Contractual Interest Rates",{"v":0.0427,"d":"4.27%"}," "," "," "," "]
["FFGP Note | Maximum"," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "]
["Contractual Interest Rates",{"v":0.0527,"d":"5.27%"}," "," "," "," "]
["Convertible FFGP Note"," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "]
["Contractual Interest Rates",{"v":0.0427,"d":"4.27%"}," "," "," "," "]
["Net Carrying Value",{"v":250,"d":"$ 250"},{"v":300,"d":"$ 300"}," "," "," "]
["Other Notes"," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "]
["Contractual Interest Rates",{"v":0.12,"d":"12%"}," "," "," "," "]
["Net Carrying Value",{"v":75,"d":"$ 75"}," "," "," "," "]

{"sheet":"Related Party Transactions - _2","index":65,"n_rows":11,"n_cols":3,"rows_kept":11}
["Related Party Transactions - Schedule of Principal Maturities of Related Party Notes Payable (Details) - Related Party - USD ($) $ in Thousands","Dec. 31, 2024","Dec. 31, 2023"]
["Related Party Transaction [Line Items]"," "," "]
["Total",{"v":8064,"d":"$ 8,064"},{"v":9760,"d":"$ 9,760"}]
["Notes Payable, Related Party"," "," "]
["Related Party Transaction [Line Items]"," "," "]
["Due on demand",{"v":492,"d":"492 "}," "]
["2025",{"v":4954,"d":"4,954 "}," "]
["2026",{"v":2003,"d":"2,003 "}," "]
["2027",{"v":751,"d":"751 "}," "]
["Thereafter",{"v":0,"d":"0 "}," "]
["Total",{"v":8200,"d":"$ 8,200"}," "]

{"sheet":"Related Party Transactions - Na","index":66,"n_rows":112,"n_cols":17,"rows_kept":112,"merged":[[0,0,1,0],[0,3,0,4],[0,5,0,7]]}
["Related Party Transactions - Narrative (Details) $ / shares in Units, $ in Thousands",null,null,"1 Months Ended",null,"12 Months Ended",null,null,"51 Months Ended"]
[null,"Mar. 06, 2023 USD ($)","Feb. 09, 2023 USD ($)","Dec. 31, 2024 USD ($)","Oct. 31, 2024 USD ($) shares","Dec. 31, 2024 USD ($) shares","Dec. 31, 2023 USD ($) shares","Dec. 31, 2022 $ / shares shares","Mar. 31, 2022 lease","Sep. 30, 2024 USD ($)","Mar. 06, 2024 USD ($)","Feb. 29, 2024 USD ($)","Jan. 31, 2024 USD ($)","Nov. 30, 2023 USD ($)","Feb. 28, 2023 USD ($)","Jan. 31, 2023 USD ($)","Jul. 30, 2022 USD ($)"]
["Related Party Transaction [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Additional paid-in capital"," "," ",{"v":4421563,"d":"$ 4,421,563"}," ",{"v":4421563,"d":"$ 4,421,563"},{"v":4180873,"d":"$ 4,180,873"}," "," "," "," "," "," "," "," "," "," "]
["Debt instrument, penalties and interest accrued"," "," ",{"v":23100,"d":"23,100 "}," ",{"v":23100,"d":"23,100 "},{"v":700,"d":"700 "}," "," "," "," "," "," "," "," "," "," "]
["Payments with related party (less than)"," "," "," "," "," ",{"v":542,"d":"542 "}," "," "," "," "," "," "," "," "," "," "]
["Accounts payable"," "," ",{"v":56754,"d":"56,754 "}," ",{"v":56754,"d":"56,754 "},{"v":62391,"d":"62,391 "}," "," "," "," "," "," "," "," "," "," "]
["Accounts payable"," "," ",{"v":71414,"d":"71,414 "}," ",{"v":71414,"d":"71,414 "},{"v":93170,"d":"93,170 "}," "," "," "," "," "," "," "," "," "," "]
["Related Party"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Gain (loss) extinguishments of debt"," "," "," "," ",{"v":-14295,"d":"(14,295)"},{"v":-20045,"d":"(20,045)"}," "," "," "," "," "," "," "," "," "," "]
["Unpaid Principal Balance"," "," ",{"v":8064,"d":"8,064 "}," ",{"v":8064,"d":"8,064 "},{"v":9760,"d":"9,760 "}," "," "," "," "," "," "," "," "," "," "]
["Change in fair value of notes payable, warrant liabilities, and derivative call options"," "," "," "," ",{"v":253,"d":"253 "},{"v":7101,"d":"7,101 "}," "," "," "," "," "," "," "," "," "," "]
["Accounts payable"," "," ",{"v":11077,"d":"11,077 "}," ",{"v":11077,"d":"11,077 "},{"v":7282,"d":"7,282 "}," "," "," "," "," "," "," "," "," "," "]
["Accounts payable"," "," ",{"v":300,"d":"300 "}," ",{"v":300,"d":"300 "},{"v":200,"d":"200 "}," "," "," "," "," "," "," "," "," "," "]
["2023 Unsecured SPA Notes | Related Party"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Unpaid Principal Balance"," "," ",{"v":0,"d":"0 "}," ",{"v":0,"d":"0 "},{"v":500,"d":"500 "}," "," "," "," "," "," "," "," "," "," "]
["2023 Unsecured SPA Notes | Related Party"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Unpaid Principal Balance"," "," "," "," "," ",{"v":542,"d":"$ 542"}," "," "," "," "," "," "," "," "," "," "]
["2023 Unsecured SPA Notes | Related Party | Minimum"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Contractual Interest Rates"," "," "," "," "," ",{"v":0.1,"d":"10%"}," "," "," "," "," "," "," "," "," "," "]
["2023 Unsecured SPA Notes | Related Party | Maximum"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Contractual Interest Rates"," "," "," "," "," ",{"v":0.15,"d":"15%"}," "," "," "," "," "," "," "," "," "," "]
["Notes Payable — China | Related Party"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Gain (loss) extinguishments of debt"," "," "," "," ",{"v":-14100,"d":"(14,100)"}," "," "," "," "," "," "," "," "," "," "," "]
["Unpaid Principal Balance"," "," ",{"v":4382,"d":"$ 4,382"}," ",{"v":4382,"d":"$ 4,382"},{"v":5103,"d":"$ 5,103"}," "," "," "," "," "," "," "," "," "," "]
["Contractual Interest Rates"," "," ",{"v":0.18,"d":"18%"}," ",{"v":0.18,"d":"18%"},{"v":0.18,"d":"18%"}," "," "," "," "," "," "," "," "," "," "]
["Repayments of debt"," "," ",{"v":-100,"d":"$ (100)"}," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Additional paid-in capital"," "," ",{"v":700,"d":"700 "}," ",{"v":700,"d":"$ 700"}," "," "," "," "," "," "," "," "," "," "," "]
["Notes Payable on Demand — China | Related Party"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Unpaid Principal Balance"," "," ",{"v":417,"d":"$ 417"}," ",{"v":417,"d":"$ 417"},{"v":3789,"d":"$ 3,789"}," "," "," "," "," "," "," "," "," "," "]
["Contractual Interest Rates"," "," ",{"v":0,"d":"0%"}," ",{"v":0,"d":"0%"},{"v":0,"d":"0%"}," "," "," "," "," "," "," "," "," "," "]
["Accrued liabilities and other liabilities"," "," ",{"v":3400,"d":"$ 3,400"}," ",{"v":3400,"d":"$ 3,400"}," "," "," "," "," "," "," "," "," "," "," "]
["FFGP Note | Related Party"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Unpaid Principal Balance"," "," ",{"v":1576,"d":"$ 1,576"}," ",{"v":1576,"d":"$ 1,576"},{"v":326,"d":"$ 326"}," "," "," "," "," ",{"v":1600,"d":"$ 1,600"},{"v":1600,"d":"$ 1,600"}," "," "," "]
["Debt instrument, term (in years)"," "," "," "," ","3 months"," "," "," "," "," "," "," "," "," "," "," "]
["Contractual Interest Rates"," "," ",{"v":0.0427,"d":"4.27%"}," ",{"v":0.0427,"d":"4.27%"},{"v":0.0527,"d":"5.27%"}," "," "," "," "," "," "," "," "," "," "]
["FFGP Note | Related Party | Minimum"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Contractual Interest Rates"," "," ",{"v":0.0427,"d":"4.27%"}," ",{"v":0.0427,"d":"4.27%"}," "," "," "," "," "," "," "," "," "," "," "]
["FFGP Note | Related Party | Maximum"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Contractual Interest Rates"," "," ",{"v":0.0527,"d":"5.27%"}," ",{"v":0.0527,"d":"5.27%"}," "," "," "," "," "," "," "," "," "," "," "]
["Convertible FFGP Note | Related Party"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Unpaid Principal Balance"," "," ",{"v":250,"d":"$ 250"}," ",{"v":250,"d":"$ 250"}," "," "," "," "," ",{"v":300,"d":"$ 300"}," "," "," "," "," "]
["Contractual Interest Rates"," "," ",{"v":0.0427,"d":"4.27%"}," ",{"v":0.0427,"d":"4.27%"}," "," "," "," "," "," "," "," "," "," "," "]
["Rancho Palos Verdes Real Property Leases | Affiliated Entity"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Number of leases | lease"," "," "," "," "," "," "," ",{"v":2,"d":"2 "}," "," "," "," "," "," "," "," "]
["Accounts payable"," "," ",{"v":300,"d":"$ 300"}," ",{"v":300,"d":"$ 300"},{"v":100,"d":"$ 100"}," "," "," "," "," "," "," "," "," "," "]
["X-Butler | Related Party"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Payments with related party (less than)"," "," "," "," ",{"v":100,"d":"100 "},{"v":100,"d":"100 "}," "," "," "," "," "," "," "," "," "," "]
["Ocean View Drive Inc. | Related Party"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Payments for seizure of funds related to ongoing litigation"," ",{"v":200,"d":"$ 200"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["FF Top Executive Reimbursements | Related Party"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Payments with related party (less than)"," "," "," "," ",{"v":1000,"d":"1,000 "},{"v":1800,"d":"1,800 "}," "," "," "," "," "," "," "," "," "," "]
["Accounts payable"," "," ",{"v":2000,"d":"2,000 "}," ",{"v":2000,"d":"2,000 "},{"v":600,"d":"600 "}," "," "," "," "," "," "," "," "," "," "]
["Notes payable"," "," "," "," "," "," "," "," "," "," "," "," "," "," ",{"v":700,"d":"$ 700"},{"v":300,"d":"$ 300"}]
["Legal expense reimbursement requested"," "," "," "," "," "," "," "," "," "," "," "," "," ",{"v":6500,"d":"$ 6,500"}," "," "]
["Consulting Service Agreement With FF Global Partners | Related Party"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Monthly fee",{"v":200,"d":"$ 200"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Initial term (in months)","12 months"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Threshold amount"," "," "," "," "," "," "," "," "," ",{"v":100,"d":"$ 100"}," "," "," "," "," "," "]
["Common Units Of FF Global Partners LLC | Affiliated Entity | FF Global Partners LLC"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Granted to executives and employees of the company (in shares) | shares"," "," "," "," "," "," ",{"v":600000,"d":"600,000 "}," "," "," "," "," "," "," "," "," "]
["Purchase price per share (in dollars per share) | $ / shares"," "," "," "," "," "," ",{"v":20,"d":"$ 20"}," "," "," "," "," "," "," "," "," "]
["Installments term (in years)"," "," "," "," "," "," ","10 years"," "," "," "," "," "," "," "," "," "]
["Leshi Information Technology Co., Ltd. (“LeTV”) | Related Party"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Accounts payable"," "," ",{"v":7700,"d":"7,700 "}," ",{"v":7700,"d":"7,700 "},{"v":7500,"d":"7,500 "}," "," "," "," "," "," "," "," "," "," "]
["Grow Fandor | Related Party"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Aggregate principal amount"," "," "," "," "," "," "," "," ",{"v":75,"d":"$ 75"}," "," "," "," "," "," "," "]
["Donation received (in shares) | shares"," "," "," ",{"v":15000000,"d":"15,000,000 "}," "," "," "," "," "," "," "," "," "," "," "," "]
["Net profit percentage"," "," "," ",{"v":0.5,"d":"50%"}," "," "," "," "," "," "," "," "," "," "," "," "]
["Net sales revenue, percentage"," "," "," ",{"v":0.05,"d":"5%"}," "," "," "," "," "," "," "," "," "," "," "," "]
["Annual base license fee"," "," "," ",{"v":250,"d":"$ 250"}," "," "," "," "," "," "," "," "," "," "," "," "]
["Grow Fandor | Related Party | Faraday Future"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Subsidiary, ownership percentage, parent"," "," "," ",{"v":0.1,"d":"10%"}," "," "," "," "," "," "," "," "," "," "," "," "]
["Notes Payable"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Gain (loss) extinguishments of debt"," "," "," "," ",{"v":2699,"d":"2,699 "},{"v":13078,"d":"13,078 "}," "," "," "," "," "," "," "," "," "," "]
["Unpaid Principal Balance"," "," ",{"v":50577,"d":"50,577 "}," ",{"v":50577,"d":"50,577 "},{"v":118251,"d":"118,251 "}," "," "," "," "," "," "," "," "," "," "]
["Repayments of debt"," "," "," "," ",{"v":-31,"d":"(31)"},{"v":-1167,"d":"(1,167)"}," "," "," "," "," "," "," "," "," "," "]
["Metaverse Horizon Limited and V W Investment Holding Limited | Unsecured SPA Notes and Warrants | Notes Payable"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Debt conversion, converted amount"," "," "," "," ",{"v":700,"d":"$ 700"},{"v":22300,"d":"$ 22,300"}," "," "," "," "," "," "," "," "," "," "]
["Conversion of notes payable and accrued interest into Class A Common Stock (in shares) | shares"," "," "," "," ",{"v":33107,"d":"33,107 "},{"v":125267,"d":"125,267 "}," "," "," "," "," "," "," "," "," "," "]
["Gain (loss) extinguishments of debt"," "," "," "," ",{"v":-200,"d":"$ (200)"},{"v":-20000,"d":"$ (20,000)"}," "," "," "," "," "," "," "," "," "," "]
["Loss on fair value of adjustments"," "," ",{"v":100,"d":"$ 100"}," ",{"v":100,"d":"$ 100"},{"v":5900,"d":"$ 5,900"}," "," "," "," "," "," "," "," "," "," "]
["Senyun And Metaverse Horizon Limited | Related Party Notes – Unsecured Convertible Note | Related Party"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Debt instrument, term (in years)"," "," "," "," ","3 months"," "," "," "," "," "," "," "," "," "," "," "]
["Contractual Interest Rates"," "," ",{"v":0.0427,"d":"4.27%"}," ",{"v":0.0427,"d":"4.27%"}," "," "," "," "," "," "," "," "," "," "," "]
["Metaverse Horizon Limited | Related Party Notes – Unsecured Convertible Note | Related Party"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Related Party Transaction [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Unpaid Principal Balance"," "," "," "," "," "," "," "," "," "," "," ",{"v":1500,"d":"$ 1,500"}," "," "," "," "]
["Change in fair value of notes payable, warrant liabilities, and derivative call options"," "," "," "," ",{"v":100,"d":"$ 100"}," "," "," "," "," "," "," "," "," "," "," "]

{"sheet":"Other Financing Liabilities - N","index":67,"n_rows":43,"n_cols":8,"rows_kept":43,"merged":[[0,0,1,0],[0,4,0,5]]}
["Other Financing Liabilities - Narrative (Details)",null,null,"1 Months Ended","12 Months Ended"]
[null,"Aug. 27, 2024 USD ($)","Oct. 19, 2023 USD ($)","Jan. 31, 2025 USD ($)","Dec. 31, 2024 USD ($)","Dec. 31, 2023 USD ($)","Jul. 11, 2024 USD ($) payment","Mar. 14, 2024 USD ($)"]
["Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]"," "," "," "," "," "," "," "]
["Proceeds from other financial obligations"," ",{"v":13100000,"d":"$ 13,100,000"}," ",{"v":11812000,"d":"$ 11,812,000"},{"v":24897000,"d":"$ 24,897,000"}," "," "]
["Loss from failed sale leaseback arrangement"," "," "," ",{"v":0,"d":"0 "},{"v":-5173000,"d":"(5,173,000)"}," "," "]
["Liability, lease repayment plan"," "," "," "," "," "," ",{"v":1700000,"d":"$ 1,700,000"}]
["Security deposit"," "," "," "," "," "," ",{"v":1500000,"d":"1,500,000 "}]
["Security deposit, past due amount"," "," "," "," "," "," ",{"v":600000,"d":"$ 600,000"}]
["Proceeds from tenant allowance",{"v":12000000,"d":"$ 12,000,000"}," "," "," "," "," "," "]
["Reimbursing tenant improvement allowance",{"v":10000000,"d":"10,000,000 "}," "," "," "," "," "," "]
["Other improvement costs, tenant improvement allowance",{"v":2000000,"d":"$ 2,000,000"}," "," "," "," "," "," "]
["Other improvement costs, tenant improvement allowance, percentage",{"v":0.6667,"d":"66.67%"}," "," "," "," "," "," "]
["Leasehold improvements, gross"," "," "," ",{"v":6900000,"d":"6,900,000 "}," "," "," "]
["Interest expense"," "," "," ",{"v":3000000,"d":"3,000,000 "},{"v":500000,"d":"500,000 "}," "," "]
["Sale and leaseback transaction, liability, noncurrent"," "," "," ",{"v":35200000,"d":"35,200,000 "},{"v":25500000,"d":"25,500,000 "}," "," "]
["Other financing liabilities, current portion"," "," "," ",{"v":761000,"d":"761,000 "},{"v":0,"d":"0 "}," "," "]
["Other financing liabilities, long term portion"," "," "," ",{"v":38698000,"d":"38,698,000 "},{"v":25483000,"d":"25,483,000 "}," "," "]
["Notes Payable"," "," "," "," "," "," "," "]
["Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]"," "," "," "," "," "," "," "]
["Long-term debt"," "," "," ",{"v":49488000,"d":"49,488,000 "},{"v":91150000,"d":"91,150,000 "}," "," "]
["Repayments of debt"," "," "," ",{"v":31000,"d":"31,000 "},{"v":1167000,"d":"$ 1,167,000"}," "," "]
["Collateralized loan"," "," "," "," "," "," "," "]
["Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]"," "," "," "," "," "," "," "]
["Long-term debt"," "," "," ",{"v":4300000,"d":"4,300,000 "}," "," "," "]
["Other financing liabilities, current portion"," "," "," ",{"v":800000,"d":"800,000 "}," "," "," "]
["Other financing liabilities, long term portion"," "," "," ",{"v":3500000,"d":"$ 3,500,000"}," "," "," "]
["Collateralized loan | Notes Payable"," "," "," "," "," "," "," "]
["Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]"," "," "," "," "," "," "," "]
["Contractual Interest Rates"," "," "," ",{"v":0.23,"d":"23%"}," "," "," "]
["Number of monthly payments | payment"," "," "," "," "," ",{"v":51,"d":"51 "}," "]
["Debt instrument, periodic payment"," "," "," ",{"v":100000,"d":"$ 100,000"}," "," "," "]
["Debt instrument, periodic payment terms, balloon payment to be paid"," "," "," "," "," ",{"v":500000,"d":"$ 500,000"}," "]
["Repayments of debt"," "," "," ",{"v":300000,"d":"300,000 "}," "," "," "]
["Subsequent Event"," "," "," "," "," "," "," "]
["Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]"," "," "," "," "," "," "," "]
["Payment for security deposit"," "," ",{"v":600000,"d":"$ 600,000"}," "," "," "," "]
["Ocean West Capital Partners (“Landlord”) | Hanford Manufacturing Facility"," "," "," "," "," "," "," "]
["Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]"," "," "," "," "," "," "," "]
["Sale Leaseback Transaction, Tenant Improvement Allowance Receivable"," ",{"v":12000000,"d":"$ 12,000,000"}," "," "," "," "," "]
["Lease term (in years)"," ","5 years"," "," "," "," "," "]
["Monthly lease rate"," ",{"v":355197,"d":"$ 355,197"}," "," "," "," "," "]
["Lease term extension option (in years)"," ","5 years"," "," "," "," "," "]
["Loss from failed sale leaseback arrangement"," "," "," ",{"v":0,"d":"$ 0"}," "," "," "]

{"sheet":"Other Financing Liabilities - F","index":68,"n_rows":7,"n_cols":2,"rows_kept":7}
["Other Financing Liabilities - Future Scheduled Payments of Financing Obligations (Details) $ in Thousands","Dec. 31, 2024 USD ($)"]
["Organization, Consolidation and Presentation of Financial Statements [Abstract]"," "]
["2025",{"v":761,"d":"$ 761"}]
["2026",{"v":951,"d":"951 "}]
["2027",{"v":1189,"d":"1,189 "}]
["2028",{"v":60455,"d":"60,455 "}]
["Future minimum lease payments, sale leaseback transactions, minimum liability requirements",{"v":63356,"d":"$ 63,356"}]

{"sheet":"Leases - Narrative (Details)","index":69,"n_rows":9,"n_cols":3,"rows_kept":9,"merged":[[0,0,1,0],[0,1,0,2]]}
["Leases - Narrative (Details) - USD ($) $ in Thousands","12 Months Ended"]
[null,"Dec. 31, 2024","Dec. 31, 2023"]
["Leases [Abstract]"," "," "]
["Lessee, finance lease, renewal term (in years)","5 years"," "]
["Lessee, operating lease, renewal term (in years)","5 years"," "]
["Operating lease, right-of-use asset, write-down",{"v":8800,"d":"$ 8,800"}," "]
["Lease, liability",{"v":7000,"d":"7,000 "}," "]
["Business exit costs",{"v":100,"d":"100 "}," "]
["Loss on lease impairment",{"v":1847,"d":"$ 1,847"},{"v":0,"d":"$ 0"}]

{"sheet":"Leases - Total Lease Costs (Det","index":70,"n_rows":9,"n_cols":3,"rows_kept":9,"merged":[[0,0,1,0],[0,1,0,2]]}
["Leases - Total Lease Costs (Details) - USD ($) $ in Thousands","12 Months Ended"]
[null,"Dec. 31, 2024","Dec. 31, 2023"]
["Lessee, Finance Lease, Description [Abstract]"," "," "]
["Amortization of ROU assets",{"v":0,"d":"$ 0"},{"v":273,"d":"$ 273"}]
["Interest on lease liabilities",{"v":0,"d":"0 "},{"v":275,"d":"275 "}]
["Total finance lease cost",{"v":0,"d":"0 "},{"v":548,"d":"548 "}]
["Operating lease cost",{"v":4389,"d":"4,389 "},{"v":5915,"d":"5,915 "}]
["Variable lease cost",{"v":398,"d":"398 "},{"v":257,"d":"257 "}]
["Total lease cost",{"v":4787,"d":"$ 4,787"},{"v":6720,"d":"$ 6,720"}]

{"sheet":"Leases - Future Lease Payments ","index":71,"n_rows":11,"n_cols":3,"rows_kept":11}
["Leases - Future Lease Payments (Details) - USD ($) $ in Thousands","Dec. 31, 2024","Dec. 31, 2023"]
["Operating Leases"," "," "]
["2025",{"v":2243,"d":"$ 2,243"}," "]
["2026",{"v":12,"d":"12 "}," "]
["2027",{"v":2,"d":"2 "}," "]
["Total",{"v":2257,"d":"2,257 "}," "]
["Less: Imputed Interest",{"v":115,"d":"115 "}," "]
["Present value of net lease payments",{"v":2142,"d":"2,142 "}," "]
["Lease liability, current portion",{"v":2128,"d":"2,128 "},{"v":3621,"d":"$ 3,621"}]
["Lease liability, net of current portion",{"v":14,"d":"14 "},{"v":14306,"d":"$ 14,306"}]
["Total lease liability",{"v":2142,"d":"$ 2,142"}," "]

{"sheet":"Leases - Supplemental Informati","index":72,"n_rows":15,"n_cols":3,"rows_kept":15,"merged":[[0,0,1,0],[0,1,0,2]]}
["Leases - Supplemental Information And Non-Cash Activities Related To Operating Leases (Details) - USD ($) $ in Thousands","12 Months Ended"]
[null,"Dec. 31, 2024","Dec. 31, 2023"]
["Cash paid for amounts included in the measurement of lease liabilities"," "," "]
["Operating cash flows from operating leases",{"v":3230,"d":"$ 3,230"},{"v":5709,"d":"$ 5,709"}]
["Operating cash flows from finance leases",{"v":0,"d":"0 "},{"v":275,"d":"275 "}]
["Financing cash flows from finance leases",{"v":0,"d":"0 "},{"v":1016,"d":"1,016 "}]
["Cash Paid For Amounts Included In The Measurement Of Lease Liabilities",{"v":3230,"d":"3,230 "},{"v":7000,"d":"7,000 "}]
["Lease Liabilities Arising From New Right-Of-Use Assets"," "," "]
["Lease assets obtained in exchange for operating lease liabilities",{"v":30,"d":"$ 30"},{"v":0,"d":"$ 0"}]
["Weighted average remaining lease term (in years)"," "," "]
["Operating leases","8 months 12 days","5 years 8 months 12 days"]
["Finance leases","0 years","5 years"]
["Weighted average discount rate"," "," "]
["Operating leases",{"v":0.164,"d":"16.40%"},{"v":0.156,"d":"15.60%"}]
["Finance leases",{"v":0,"d":"0%"},{"v":0.092,"d":"9.20%"}]

{"sheet":"Commitments and Contingencies (","index":73,"n_rows":85,"n_cols":27,"rows_kept":85,"merged":[[0,0,1,0],[0,14,0,18],[0,19,0,20]]}
["Commitments and Contingencies (Details) shares in Thousands, $ in Thousands",{"$nulls":13},"1 Months Ended",{"$nulls":4},"12 Months Ended"]
[null,"Mar. 06, 2025 USD ($)","Aug. 09, 2024 USD ($) shares","Aug. 01, 2024 USD ($)","Apr. 10, 2024 USD ($)","Mar. 29, 2024 USD ($)","Mar. 26, 2024 USD ($)","Mar. 11, 2024 USD ($)","Jan. 26, 2024 USD ($)","Dec. 08, 2023 USD ($)","Jul. 07, 2023 USD ($)","Jun. 13, 2023 USD ($)","May 02, 2023 USD ($)","Apr. 14, 2022","Dec. 31, 2024 USD ($)","Jun. 30, 2024 USD ($)","May 31, 2024 USD ($)","Feb. 29, 2024 USD ($)","Oct. 31, 2023 USD ($)","Dec. 31, 2024 USD ($)","Dec. 31, 2023 USD ($)","Jul. 31, 2024 USD ($)","Feb. 14, 2024 USD ($)","Oct. 19, 2023 USD ($)","Apr. 26, 2023 USD ($)","Jan. 31, 2023 USD ($)","Nov. 15, 2021 reservation"]
["Loss Contingencies [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Accrued legal contingencies"," "," "," "," "," "," "," "," "," "," "," "," "," ",{"v":9091,"d":"$ 9,091"}," "," "," "," ",{"v":9091,"d":"$ 9,091"},{"v":21590,"d":"$ 21,590"}," "," "," "," "," "," "]
["Legal claims were settled in cash"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," ",{"v":7500,"d":"$ 7,500"}," "," "," "," "," "," "," "," "]
["Loss contingency, initial deposit"," "," "," "," "," "," "," "," "," "," "," "," "," ",{"v":1900,"d":"1,900 "}," "," "," "," ",{"v":1900,"d":"1,900 "}," "," "," "," "," "," "," "]
["Loss continency, tooling equipment"," "," "," "," "," "," "," "," "," "," "," "," "," ",{"v":12900,"d":"12,900 "}," "," "," "," ",{"v":12900,"d":"12,900 "}," "," "," "," "," "," "," "]
["Loss Contingency, loss in period"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," ",{"v":2700,"d":"2,700 "}," "," "," "," "," "," "," "]
["Estimate of possible loss"," "," "," "," "," "," "," "," "," "," "," "," "," ",{"v":500,"d":"500 "}," "," "," "," ",{"v":500,"d":"500 "}," "," "," "," "," "," "," "]
["Issuance of common stock"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," ",{"v":34492,"d":"$ 34,492"}," "," "," "," "," "," "]
["Number of reservations received for vehicles | reservation"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," ",{"v":14000,"d":"14,000 "}]
["Number of unpaid indications of interest | reservation"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," ",{"v":14000,"d":"14,000 "}]
["Probation period"," "," "," "," "," "," "," "," "," "," "," "," ","6 months"," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Chief Executive Officer"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Loss Contingencies [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Annual base salary reduction"," "," "," "," "," "," "," "," "," "," "," "," ",{"v":0.25,"d":"25%"}," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Chief Product And User Ecosystem Officer"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Loss Contingencies [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Annual base salary reduction"," "," "," "," "," "," "," "," "," "," "," "," ",{"v":0.25,"d":"25%"}," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Raymond Handling Solutions, Inc. (“Raymond”) | Pending Litigation"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Loss Contingencies [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Estimate of possible loss"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," ",{"v":1100,"d":"$ 1,100"}," "]
["Palantir Technologies Inc."," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Loss Contingencies [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Damages sought"," "," "," "," "," "," "," "," "," ",{"v":41500,"d":"$ 41,500"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Loss contingency, unpaid invoices"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," ",{"v":12300,"d":"$ 12,300"}," "," "]
["Damages awarded"," "," "," "," "," "," ",{"v":5000,"d":"$ 5,000"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Damages awarded, liquidation damages clause"," "," "," "," "," "," ",{"v":300,"d":"$ 300"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Loss contingency, remaining damages to be awarded, value"," ",{"v":4800,"d":"$ 4,800"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Issuance of common stock (in shares) | shares"," ",{"v":11100,"d":"11,100 "}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Palantir Technologies Inc. | Stock Issuance, Tranche One"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Loss Contingencies [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Issuance of common stock"," ",{"v":2400,"d":"$ 2,400"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Palantir Technologies Inc. | Stock Issuance, Tranche Two"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Loss Contingencies [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Issuance of common stock"," ",{"v":2400,"d":"$ 2,400"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Envisage Group Developments Inc. USA (“Envisage”)"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Loss Contingencies [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Damages sought"," "," "," "," "," "," "," "," "," "," "," ",{"v":1100,"d":"$ 1,100"}," "," ",{"v":1100,"d":"$ 1,100"}," "," "," "," "," "," "," "," "," "," "," "]
["Damages awarded"," "," "," "," "," "," "," "," "," "," "," "," "," "," ",{"v":1400,"d":"$ 1,400"}," "," "," "," "," "," "," "," "," "," "," "]
["L & W LLC (“Autokiniton”)"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Loss Contingencies [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Estimate of possible loss"," "," "," "," "," "," "," "," "," "," ",{"v":8100,"d":"$ 8,100"}," "," "," "," "," "," "," "," "," ",{"v":8100,"d":"$ 8,100"}," "," "," "," "," "]
["Damages awarded"," "," "," "," "," "," "," "," "," "," ",{"v":4600,"d":"$ 4,600"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Litigation settlement, amount awarded to other party"," "," "," "," "," "," "," "," "," "," "," "," "," ",{"v":3700,"d":"$ 3,700"}," "," "," "," "," "," "," "," "," "," "," "," "]
["Rexford Industrial - 18455 Figueroa, LCC (\"Rexford\")"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Loss Contingencies [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Unpaid rent"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," ",{"v":900,"d":"$ 900"}," "," "," "," "]
["Draexlmaier Automotive Technologies of America LLC"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Loss Contingencies [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Damages sought"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," ",{"v":5000,"d":"$ 5,000"},{"v":3200,"d":"$ 3,200"}," "," "," "," "," "," "," "," "," "]
["Tesca USA vs. Faraday&Future Inc. | Subsequent Event"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Loss Contingencies [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Payments for property, plant and equipment, preproduction design and development costs",{"v":36000,"d":"$ 36,000"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Damages sought",{"v":36000,"d":"$ 36,000"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Cooper Standard GmbH vs. Faraday&Future Inc. | Pending Litigation"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Loss Contingencies [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Damages sought"," "," "," "," ",{"v":1500,"d":"$ 1,500"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Jose Guerrero and Victoria Xie vs. Faraday&Future Inc. | Pending Litigation"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Loss Contingencies [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Damages sought"," "," "," "," ",{"v":1000,"d":"$ 1,000"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Yun Han vs. Faraday&Future Inc. | Pending Litigation"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Loss Contingencies [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Damages sought"," "," ",{"v":1200,"d":"$ 1,200"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Bankruptcy Matter, Deposit Write-off"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Loss Contingencies [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Loss Contingency, loss in period"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," ",{"v":1400,"d":"1,400 "}," "," "," "," "," "," "," "]
["Bankruptcy Matter, Additional Payments"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Loss Contingencies [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Loss Contingency, loss in period"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," ",{"v":1300,"d":"$ 1,300"}," "," "," "," "," "," "," "]
["Unpaid Rent, October - December 2023 | 10701 Idaho Owner, LLC (“Landlord”)"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Loss Contingencies [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Rental defaults"," "," "," "," "," "," "," "," ",{"v":600,"d":"$ 600"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Damages sought, late fee (in percent)"," "," "," "," "," "," "," "," ",{"v":0.05,"d":"5%"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Damages sought, annual interest (in percent)"," "," "," "," "," "," "," "," ",{"v":0.18,"d":"18%"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Unpaid Rent | 10701 Idaho Owner, LLC (“Landlord”)"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Loss Contingencies [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Damages sought"," "," "," "," "," ",{"v":1000,"d":"$ 1,000"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Rental defaults"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," ",{"v":1100,"d":"$ 1,100"}," "," "," "]
["Rental defaults, partial payment"," "," "," "," "," "," "," ",{"v":100,"d":"$ 100"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Rental defaults, late fees and charges"," "," "," "," "," "," "," ",{"v":200,"d":"$ 200"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Rental defaults payable"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," ",{"v":1200,"d":"1,200 "}," "," "," "]
["Amount of letter of credit required to be replenished or provided"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," ",{"v":600,"d":"$ 600"}," "," "," "]
["Damages sought, maximum payment term (in days)"," "," "," "," "," ","5 days"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Damages paid"," "," "," ",{"v":200,"d":"$ 200"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]

{"sheet":"Stockholders_ Equity - Schedule","index":74,"n_rows":24,"n_cols":14,"rows_kept":24}
["Stockholders’ Equity - Schedule of Common Stock (Details) - shares","Mar. 10, 2025","Dec. 31, 2024","Aug. 31, 2024","Aug. 04, 2024","Jul. 31, 2024","Feb. 23, 2024","Feb. 05, 2024","Feb. 04, 2024","Dec. 31, 2023","Aug. 25, 2023","Aug. 22, 2023","Feb. 28, 2023","Feb. 27, 2023"]
["Authorized \u2028Shares"," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Preferred stock, shares authorized (in shares)"," ",{"v":10000000,"d":"10,000,000 "}," "," ",{"v":114245313,"d":"114,245,313 "},{"v":12582813,"d":"12,582,813 "}," "," ",{"v":10000000,"d":"10,000,000 "}," "," "," "," "]
["Common stock, shares authorized (in shares)"," ",{"v":104245313,"d":"104,245,313 "},{"v":104245313,"d":"104,245,313 "},{"v":104245313,"d":"104,245,313 "},{"v":104245313,"d":"104,245,313 "},{"v":11582813,"d":"11,582,813 "},{"v":34748438,"d":"34,748,438 "},{"v":3860938,"d":"3,860,938 "}," ",{"v":1286980,"d":"1,286,980 "},{"v":3860938,"d":"3,860,938 "},{"v":433855,"d":"433,855 "}," "]
["Authorized Shares (in shares)"," ",{"v":114245313,"d":"114,245,313 "}," "," "," "," "," "," ",{"v":11286980,"d":"11,286,980 "}," "," "," "," "]
["Issued Shares"," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Preferred stock, shares issued (in shares)"," ",{"v":1,"d":"1 "}," "," "," "," "," "," ",{"v":0,"d":"0 "}," "," "," "," "]
["Shares issued (in shares)"," ",{"v":65925795,"d":"65,925,795 "}," "," "," "," "," "," ",{"v":1067500,"d":"1,067,500 "}," "," "," "," "]
["Class A Common Stock"," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Authorized \u2028Shares"," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Common stock, shares authorized (in shares)"," ",{"v":99815625,"d":"99,815,625 "}," "," "," "," "," "," ",{"v":1232292,"d":"1,232,292 "},{"v":1232292,"d":"1,232,292 "}," ",{"v":176042,"d":"176,042 "},{"v":84896,"d":"84,896 "}]
["Issued Shares"," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Common stock, shares issued (in shares)"," ",{"v":65919127,"d":"65,919,127 "}," "," "," "," "," "," ",{"v":1060833,"d":"1,060,833 "}," "," "," "," "]
["Class B Common Stock"," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Authorized \u2028Shares"," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Common stock, shares authorized (in shares)"," ",{"v":4429688,"d":"4,429,688 "}," "," "," "," "," "," ",{"v":54688,"d":"54,688 "},{"v":54688,"d":"54,688 "}," "," "," "]
["Issued Shares"," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Common stock, shares issued (in shares)"," ",{"v":6667,"d":"6,667 "}," "," "," "," "," "," ",{"v":6667,"d":"6,667 "}," "," "," "," "]
["Common Stock And Preferred Stock"," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Authorized \u2028Shares"," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Authorized Shares (in shares)"," ",{"v":114245313,"d":"114,245,313 "}," "," "," "," "," "," "," "," "," "," "," "]
["Common Stock And Preferred Stock | Subsequent Event"," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Authorized \u2028Shares"," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Authorized Shares (in shares)",{"v":139245313,"d":"139,245,313 "}," "," "," "," "," "," "," "," "," "," "," "," "]

{"sheet":"Stockholders_ Equity - Amendmen","index":75,"n_rows":35,"n_cols":19,"rows_kept":35}
["Stockholders’ Equity - Amendments to the Company’s Certificate of Incorporation (Details)","Aug. 04, 2024 shares","Aug. 01, 2024","Jul. 31, 2024 $ / shares shares","Feb. 29, 2024","Feb. 23, 2024 shares","Feb. 05, 2024 shares","Aug. 22, 2023 shares","Aug. 16, 2023","Mar. 21, 2025 $ / shares","Mar. 10, 2025 shares","Dec. 31, 2024 shares","Dec. 21, 2024 $ / shares","Aug. 31, 2024 shares","Feb. 04, 2024 shares","Dec. 31, 2023 shares","Aug. 25, 2023 shares","Feb. 28, 2023 shares","Feb. 27, 2023 shares"]
["Class of Stock [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Preferred stock, shares authorized (in shares)"," "," ",{"v":114245313,"d":"114,245,313 "}," ",{"v":12582813,"d":"12,582,813 "}," "," "," "," "," ",{"v":10000000,"d":"10,000,000 "}," "," "," ",{"v":10000000,"d":"10,000,000 "}," "," "," "]
["Common stock, shares authorized (in shares)",{"v":104245313,"d":"104,245,313 "}," ",{"v":104245313,"d":"104,245,313 "}," ",{"v":11582813,"d":"11,582,813 "},{"v":34748438,"d":"34,748,438 "},{"v":3860938,"d":"3,860,938 "}," "," "," ",{"v":104245313,"d":"104,245,313 "}," ",{"v":104245313,"d":"104,245,313 "},{"v":3860938,"d":"3,860,938 "}," ",{"v":1286980,"d":"1,286,980 "},{"v":433855,"d":"433,855 "}," "]
["Stock, shares authorized (in shares)"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," ",{"v":342709,"d":"342,709 "}]
["Exercise Price | $ / shares"," "," ",{"v":110400,"d":"$ 110,400"}," "," "," "," "," "," "," "," ",{"v":1.16,"d":"$ 1.16"}," "," "," "," "," "," "]
["Authorized shares (in shares)"," "," "," "," "," "," "," "," "," "," ",{"v":114245313,"d":"114,245,313 "}," "," "," ",{"v":11286980,"d":"11,286,980 "}," "," "," "]
["Stockholder's equity, stock split, conversion ratio",0.025," "," "," ",0.333," ",0.0125," "," "," "," "," "," "," "," "," "," "," "]
["Subsequent Event"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Class of Stock [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Exercise Price | $ / shares"," "," "," "," "," "," "," "," ",{"v":1.548,"d":"$ 1.548"}," "," "," "," "," "," "," "," "," "]
["Class A Common Stock"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Class of Stock [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Common stock, shares authorized (in shares)"," "," "," "," "," "," "," "," "," "," ",{"v":99815625,"d":"99,815,625 "}," "," "," ",{"v":1232292,"d":"1,232,292 "},{"v":1232292,"d":"1,232,292 "},{"v":176042,"d":"176,042 "},{"v":84896,"d":"84,896 "}]
["Class B Common Stock"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Class of Stock [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Common stock, shares authorized (in shares)"," "," "," "," "," "," "," "," "," "," ",{"v":4429688,"d":"4,429,688 "}," "," "," ",{"v":54688,"d":"54,688 "},{"v":54688,"d":"54,688 "}," "," "]
["Common Stock"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Class of Stock [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Stockholder's equity, stock split, conversion ratio"," ",0.025," ",0.333," ",0.333,0.0125,0.125," "," "," "," "," "," "," "," "," "," "]
["Common Stock | Subsequent Event"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Class of Stock [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Common stock, shares authorized (in shares)"," "," "," "," "," "," "," "," "," ",{"v":129245313,"d":"129,245,313 "}," "," "," "," "," "," "," "," "]
["Common Stock | Maximum"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Class of Stock [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Stockholder's equity, stock split, conversion ratio"," "," ",0.025," "," "," "," ",0.0111111," "," "," "," "," "," "," "," "," "," "]
["Common Stock | Minimum"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Class of Stock [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Stockholder's equity, stock split, conversion ratio"," "," ",0.5," "," "," "," ",0.5," "," "," "," "," "," "," "," "," "," "]
["Common Stock And Preferred Stock"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Class of Stock [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Authorized shares (in shares)"," "," "," "," "," "," "," "," "," "," ",{"v":114245313,"d":"114,245,313 "}," "," "," "," "," "," "," "]
["Common Stock And Preferred Stock | Subsequent Event"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Class of Stock [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Authorized shares (in shares)"," "," "," "," "," "," "," "," "," ",{"v":139245313,"d":"139,245,313 "}," "," "," "," "," "," "," "," "]

{"sheet":"Stockholders_ Equity - Series A","index":76,"n_rows":19,"n_cols":8,"rows_kept":19}
["Stockholders’ Equity - Series A Preferred Stock (Details)","Aug. 04, 2024","Jun. 21, 2024 vote $ / shares","Feb. 23, 2024","Aug. 22, 2023","Jan. 28, 2025 $ / shares","Dec. 31, 2024 $ / shares","Dec. 31, 2023 $ / shares"]
["Class of Stock [Line Items]"," "," "," "," "," "," "," "]
["Preferred stock, par value (in dollars per share)"," "," "," "," "," ",{"v":0.0001,"d":"$ 0.0001"},{"v":0.0001,"d":"$ 0.0001"}]
["Stockholder's equity, stock split, conversion ratio",0.025," ",0.333,0.0125," "," "," "]
["Series A Preferred Stock"," "," "," "," "," "," "," "]
["Class of Stock [Line Items]"," "," "," "," "," "," "," "]
["Preferred stock, par value (in dollars per share)"," ",{"v":0.0001,"d":"$ 0.0001"}," "," "," "," "," "]
["Purchase price per share (in dollars per share)"," ",{"v":100,"d":"$ 100"}," "," "," "," "," "]
["Series A Preferred Stock | Subsequent Event"," "," "," "," "," "," "," "]
["Class of Stock [Line Items]"," "," "," "," "," "," "," "]
["Purchase price per share (in dollars per share)"," "," "," "," ",{"v":100,"d":"$ 100"}," "," "]
["First Series A Preferred"," "," "," "," "," "," "," "]
["Class of Stock [Line Items]"," "," "," "," "," "," "," "]
["Preferred stock, voting rights per share | vote"," ",{"v":16000000000,"d":"16,000,000,000 "}," "," "," "," "," "]
["Stockholder's equity, stock split, conversion ratio"," ",0.333," "," "," "," "," "]
["Second Series A Preferred"," "," "," "," "," "," "," "]
["Class of Stock [Line Items]"," "," "," "," "," "," "," "]
["Preferred stock, voting rights per share | vote"," ",{"v":3000000,"d":"3,000,000 "}," "," "," "," "," "]
["Stockholder's equity, stock split, conversion ratio"," ",0.333," "," "," "," "," "]

{"sheet":"Stockholders' Equity - Common S","index":77,"n_rows":3,"n_cols":2,"rows_kept":3}
["Stockholders' Equity - Common Stock (Details)","Dec. 31, 2024 vote"]
["Equity [Abstract]"," "]
["Common stock, number of votes per share",{"v":10,"d":"10 "}]

{"sheet":"Stockholders_ Equity - Schedu_2","index":78,"n_rows":37,"n_cols":9,"rows_kept":37}
["Stockholders’ Equity - Schedule of Warrants (Details) - $ / shares","Dec. 31, 2024","Dec. 21, 2024","Dec. 20, 2024","Sep. 05, 2024","Sep. 04, 2024","Jul. 31, 2024","Dec. 31, 2023","Jul. 21, 2021"]
["Class of Stock [Line Items]"," "," "," "," "," "," "," "," "]
["Exercise Price"," ",{"v":1.16,"d":"$ 1.16"}," "," "," ",{"v":110400,"d":"$ 110,400"}," "," "]
["Class A Common Stock"," "," "," "," "," "," "," "," "]
["Class of Stock [Line Items]"," "," "," "," "," "," "," "," "]
["Warrants (in shares)",{"v":22514744,"d":"22,514,744 "}," "," "," "," "," ",{"v":244853,"d":"244,853 "}," "]
["Ares Warrants | Class A Common Stock"," "," "," "," "," "," "," "," "]
["Class of Stock [Line Items]"," "," "," "," "," "," "," "," "]
["Warrants (in shares)",{"v":5776657,"d":"5,776,657 "}," "," "," "," "," "," "," "]
["Exercise Price",{"v":1.16,"d":"$ 1.16"}," ",{"v":5.24,"d":"$ 5.24"}," ",{"v":29.33,"d":"$ 29.33"}," "," "," "]
["SPA Warrants | Class A Common Stock"," "," "," "," "," "," "," "," "]
["Class of Stock [Line Items]"," "," "," "," "," "," "," "," "]
["Warrants (in shares)",{"v":15238,"d":"15,238 "}," "," "," "," "," ",{"v":13906,"d":"13,906 "}," "]
["Exercise Price",{"v":1.16,"d":"$ 1.16"},{"v":1.16,"d":"$ 1.16"}," ",{"v":5.24,"d":"$ 5.24"}," "," ",{"v":29.33,"d":"$ 29.33"}," "]
["Junior SPA Warrants | Class A Common Stock"," "," "," "," "," "," "," "," "]
["Class of Stock [Line Items]"," "," "," "," "," "," "," "," "]
["Warrants (in shares)",{"v":5931638,"d":"5,931,638 "}," "," "," "," "," "," "," "]
["Exercise Price",{"v":1.16,"d":"$ 1.16"}," "," "," "," "," "," "," "]
["2024 Unsecured SPA Warrants | Class A Common Stock"," "," "," "," "," "," "," "," "]
["Class of Stock [Line Items]"," "," "," "," "," "," "," "," "]
["Warrants (in shares)",{"v":10788746,"d":"10,788,746 "}," "," "," "," "," "," "," "]
["Exercise Price",{"v":1.39,"d":"$ 1.39"}," "," "," "," "," "," "," "]
["Ares warrants | Class A Common Stock"," "," "," "," "," "," "," "," "]
["Class of Stock [Line Items]"," "," "," "," "," "," "," "," "]
["Warrants (in shares)"," "," "," "," "," "," ",{"v":228482,"d":"228,482 "}," "]
["Exercise Price"," "," "," "," "," "," ",{"v":29.33,"d":"$ 29.33"}," "]
["Public Warrants | Class A Common Stock"," "," "," "," "," "," "," "," "]
["Class of Stock [Line Items]"," "," "," "," "," "," "," "," "]
["Warrants (in shares)",{"v":2453,"d":"2,453 "}," "," "," "," "," ",{"v":2453,"d":"2,453 "},{"v":2394,"d":"2,394 "}]
["Exercise Price",{"v":110400,"d":"$ 110,400"}," "," "," "," "," ",{"v":110400,"d":"$ 110,400"}," "]
["Private Warrants"," "," "," "," "," "," "," "," "]
["Class of Stock [Line Items]"," "," "," "," "," "," "," "," "]
["Warrants (in shares)"," "," "," "," "," "," "," ",{"v":62,"d":"62 "}]
["Private Warrants | Class A Common Stock"," "," "," "," "," "," "," "," "]
["Class of Stock [Line Items]"," "," "," "," "," "," "," "," "]
["Warrants (in shares)",{"v":12,"d":"12 "}," "," "," "," "," ",{"v":12,"d":"12 "}," "]
["Exercise Price",{"v":110400,"d":"$ 110,400"}," "," "," "," "," ",{"v":110400,"d":"$ 110,400"}," "]

{"sheet":"Stockholders_ Equity - Weighted","index":79,"n_rows":15,"n_cols":3,"rows_kept":15,"merged":[[0,0,1,0],[0,1,0,2]]}
["Stockholders’ Equity - Weighted-Average Assumptions Used in the Black-Scholes Option Pricing Model (Details) - Share-based Payment Arrangement, Option - Stock Incentive Plan","12 Months Ended"]
[null,"Dec. 31, 2024","Dec. 31, 2023"]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "]
["Risk-free interest rate (in percent)"," ",{"v":0.0353,"d":"3.53%"}]
["Expected term (in years)","7 years","8 years 8 months 15 days"]
["Expected volatility (in percent)"," ",{"v":0.8962,"d":"89.62%"}]
["Dividend yield (in percent)",{"v":0,"d":"0%"},{"v":0,"d":"0%"}]
["Minimum"," "," "]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "]
["Risk-free interest rate (in percent)",{"v":0.0383,"d":"3.83%"}," "]
["Expected volatility (in percent)",{"v":1.1,"d":"110%"}," "]
["Maximum"," "," "]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "]
["Risk-free interest rate (in percent)",{"v":0.0435,"d":"4.35%"}," "]
["Expected volatility (in percent)",{"v":1.15,"d":"115%"}," "]

{"sheet":"Stockholders_ Equity - Warrants","index":80,"n_rows":19,"n_cols":8,"rows_kept":19,"merged":[[0,0,1,0],[0,1,0,2]]}
["Stockholders’ Equity - Warrants (Details) - USD ($) $ / shares in Units, $ in Thousands","12 Months Ended"]
[null,"Dec. 31, 2024","Dec. 31, 2023","Dec. 21, 2024","Dec. 20, 2024","Sep. 05, 2024","Sep. 04, 2024","Jul. 31, 2024"]
["Class of Warrant or Right [Line Items]"," "," "," "," "," "," "," "]
["Class of warrant or right, exercised during the period",{"v":0,"d":"0 "}," "," "," "," "," "," "]
["Exercise price (in dollars per share)"," "," ",{"v":1.16,"d":"$ 1.16"}," "," "," ",{"v":110400,"d":"$ 110,400"}]
["Deemed dividends",{"v":-7576,"d":"$ (7,576)"},{"v":0,"d":"$ 0"}," "," "," "," "," "]
["Exercise of warrants (in shares)"," ",{"v":6292,"d":"6,292 "}," "," "," "," "," "]
["Proceeds from exercise of warrants",{"v":0,"d":"$ 0"},{"v":4074,"d":"$ 4,074"}," "," "," "," "," "]
["Warrants surrendered (in shares)"," ",{"v":966,"d":"966 "}," "," "," "," "," "]
["Class A Common Stock | Common Stock"," "," "," "," "," "," "," "]
["Class of Warrant or Right [Line Items]"," "," "," "," "," "," "," "]
["Exercise of warrants (in shares)"," ",{"v":5326,"d":"5,326 "}," "," "," "," "," "]
["Proceeds from exercise of warrants"," ",{"v":4100,"d":"$ 4,100"}," "," "," "," "," "]
["SPA Warrants | Class A Common Stock"," "," "," "," "," "," "," "]
["Class of Warrant or Right [Line Items]"," "," "," "," "," "," "," "]
["Exercise price (in dollars per share)",{"v":1.16,"d":"$ 1.16"},{"v":29.33,"d":"$ 29.33"},{"v":1.16,"d":"$ 1.16"}," ",{"v":5.24,"d":"$ 5.24"}," "," "]
["Ares Warrants | Class A Common Stock"," "," "," "," "," "," "," "]
["Class of Warrant or Right [Line Items]"," "," "," "," "," "," "," "]
["Exercise price (in dollars per share)",{"v":1.16,"d":"$ 1.16"}," "," ",{"v":5.24,"d":"$ 5.24"}," ",{"v":29.33,"d":"$ 29.33"}," "]

{"sheet":"Stockholders_ Equity - Insuffic","index":81,"n_rows":7,"n_cols":2,"rows_kept":7}
["Stockholders’ Equity - Insufficient Authorized Shares (Details) $ in Millions","Aug. 25, 2023 USD ($)"]
["Liability for Insufficient Authorized Shares Related to Stock Options and RSUs | Class A Common Stock"," "]
["Class of Stock [Line Items]"," "]
["Reclassification of earnout shares from equity to liability (in shares)",{"v":2,"d":"$ 2"}]
["Additional \u2028Paid-in \u2028Capital"," "]
["Class of Stock [Line Items]"," "]
["Amount reclassified for earnout liability",{"v":-1.4,"d":"$ (1.4)"}]

{"sheet":"Stockholders_ Equity - Salary D","index":82,"n_rows":17,"n_cols":4,"rows_kept":17,"merged":[[0,0,1,0]]}
["Stockholders’ Equity - Salary Deduction and Stock Purchase Agreement (Details) - USD ($) $ / shares in Units, $ in Thousands",null,null,"12 Months Ended"]
[null,"Sep. 04, 2024","Sep. 21, 2023","Dec. 31, 2024"]
["Class of Stock [Line Items]"," "," "," "]
["Salary deduction and stock purchase agreement, anniversary period","3 months"," "," "]
["Purchase of class A common stock under salary deduction and stock purchase agreements (in shares)"," "," ",{"v":49659,"d":"49,659 "}]
["Salary deduction and stock purchased agreement, per share weighted average price of shares purchased"," "," ",{"v":2.06,"d":"$ 2.06"}]
["Mr. Aydt"," "," "," "]
["Class of Stock [Line Items]"," "," "," "]
["Salary reduction per paycheck (in percent)",{"v":0.64,"d":"64%"}," "," "]
["Salary deduction and stock purchase agreement, initial pro-rated based salary",{"v":550,"d":"$ 550"}," "," "]
["Mr. Jia"," "," "," "]
["Class of Stock [Line Items]"," "," "," "]
["Salary reduction per paycheck (in percent)",{"v":0.56,"d":"56%"}," "," "]
["Salary deduction and stock purchase agreement, initial pro-rated based salary",{"v":612,"d":"$ 612"}," "," "]
["Certain Executive Officers"," "," "," "]
["Class of Stock [Line Items]"," "," "," "]
["Salary reduction per paycheck (in percent)"," ",{"v":0.5,"d":"50%"}," "]

{"sheet":"Stock-Based Compensation - Narr","index":83,"n_rows":33,"n_cols":7,"rows_kept":33,"merged":[[0,0,1,0],[0,2,0,3]]}
["Stock-Based Compensation - Narrative (Details) - USD ($) $ in Millions",null,"12 Months Ended"]
[null,"Jul. 31, 2024","Dec. 31, 2024","Dec. 31, 2023","Jul. 31, 2021","May 02, 2019","Feb. 01, 2018"]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "," "," "," "," "]
["Share-based payment awards classified as liabilities, gain (loss)"," "," ",{"v":4.1,"d":"$ 4.1"}," "," "," "]
["Stock Incentive Plan"," "," "," "," "," "," "]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "," "," "," "," "]
["Stock available for future issuance (in shares)"," ",{"v":530131,"d":"530,131 "},{"v":2527,"d":"2,527 "},{"v":5164,"d":"5,164 "}," "," "]
["Percent threshold of common stock issued and outstanding for annual increase of shares available for issue"," "," "," ",{"v":0.05,"d":"5%"}," "," "]
["Share-based compensation arrangement by share-based payment award, number of additional shares authorized",{"v":2206324,"d":"2,206,324 "}," "," "," "," "," "]
["Options vested in period, fair value"," ",{"v":2,"d":"$ 2"},{"v":2.5,"d":"$ 2.5"}," "," "," "]
["Stock-based compensation expense for unvested awards"," ",0.8," "," "," "," "]
["Stock Incentive Plan | Share-based Payment Arrangement, Option"," "," "," "," "," "," "]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "," "," "," "," "]
["Stock-based compensation expense for unvested stock options"," ",{"v":0.1,"d":"$ 0.1"}," "," "," "," "]
["Expected weighted average period (in years)"," ","2 years 3 months 3 days"," "," "," "," "]
["Stock Incentive Plan | Restricted Stock Units (RSUs)"," "," "," "," "," "," "]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "," "," "," "," "]
["Expected weighted average period (in years)"," ","1 year 8 months 15 days"," "," "," "," "]
["Vested in period, fair value"," ",{"v":8.4,"d":"$ 8.4"},4.4," "," "," "]
["Equity Incentive Plan"," "," "," "," "," "," "]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "," "," "," "," "]
["Options vested in period, fair value"," ",{"v":2.3,"d":"$ 2.3"},9.3," "," "," "]
["Authorized to grant (in shares)"," "," "," "," "," ",{"v":4416,"d":"4,416 "}]
["Equity Incentive Plan | Share-based Payment Arrangement, Option"," "," "," "," "," "," "]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "," "," "," "," "]
["Expected weighted average period (in years)"," ","1 year 8 months 8 days"," "," "," "," "]
["Share-based payment arrangement, nonvested award, cost not yet recognized, amount (less than)"," ",{"v":0.1,"d":"$ 0.1"}," "," "," "," "]
["STI Plan"," "," "," "," "," "," "]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "," "," "," "," "]
["Expected weighted average period (in years)"," ","1 year 9 months 10 days"," "," "," "," "]
["Options vested in period, fair value"," ",{"v":7.8,"d":"$ 7.8"},{"v":1.7,"d":"$ 1.7"}," "," "," "]
["Share-based payment arrangement, nonvested award, cost not yet recognized, amount (less than)"," ",{"v":0.1,"d":"$ 0.1"}," "," "," "," "]
["Authorized to grant (in shares)"," "," "," "," ",{"v":1472,"d":"1,472 "}," "]

{"sheet":"Stock-Based Compensation - Summ","index":84,"n_rows":57,"n_cols":4,"rows_kept":57,"merged":[[0,0,1,0],[0,1,0,3]]}
["Stock-Based Compensation - Summary of the Company’s Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands","12 Months Ended"]
[null,"Dec. 31, 2024","Dec. 31, 2023","Dec. 31, 2022"]
["Stock Incentive Plan"," "," "," "]
["Number of \u2028Options"," "," "," "]
["Beginning balance (in shares)",{"v":798,"d":"798 "},{"v":693,"d":"693 "}," "]
["Granted (in shares)",{"v":0,"d":"0 "},{"v":313,"d":"313 "}," "]
["Exercised (in shares)"," ",{"v":-6,"d":"(6)"}," "]
["Expired/forfeited (in shares)",{"v":-390,"d":"(390)"},{"v":-202,"d":"(202)"}," "]
["Ending balance (in shares)",{"v":408,"d":"408 "},{"v":798,"d":"798 "},{"v":693,"d":"693 "}]
["Exercisable (in shares)",{"v":286,"d":"286 "}," "," "]
["Weighted \u2028Average \u2028Exercise \u2028Price"," "," "," "]
["Beginning balance (in dollars per share)",{"v":19885.2,"d":"$ 19,885.2"},{"v":26496,"d":"$ 26,496"}," "]
["Granted (in dollars per share)"," ",{"v":10368,"d":"10,368 "}," "]
["Exercised (in dollars per share)"," ",{"v":8544,"d":"8,544 "}," "]
["Expired/forfeited (in dollars per share)",{"v":20794.36,"d":"20,794.36"},{"v":28020,"d":"28,020 "}," "]
["Ending balance (in dollars per share)",{"v":21156.47,"d":"21,156.47"},{"v":19885.2,"d":"$ 19,885.2"},{"v":26496,"d":"$ 26,496"}]
["Exercisable (in dollars per share)",{"v":21480.84,"d":"$ 21,480.84"}," "," "]
["Weighted \u2028Average \u2028Remaining \u2028Contractual Life (Years)"," "," "," "]
["Outstanding (in years)","7 years 7 months 2 days","8 years 8 months 26 days","8 years 11 months 19 days"]
["Exercisable (in years)","7 years 6 months 29 days"," "," "]
["Aggregate \u2028Intrinsic \u2028Value"," "," "," "]
["Aggregate intrinsic value, outstanding",{"v":8317,"d":"$ 8,317"},{"v":5351,"d":"$ 5,351"},{"v":0,"d":"$ 0"}]
["Aggregate intrinsic value, exercisable",{"v":5940,"d":"$ 5,940"}," "," "]
["Equity Incentive Plan"," "," "," "]
["Number of \u2028Options"," "," "," "]
["Beginning balance (in shares)",{"v":2031,"d":"2,031 "},{"v":2440,"d":"2,440 "}," "]
["Expired/forfeited (in shares)",{"v":-82,"d":"(82)"},{"v":-409,"d":"(409)"}," "]
["Ending balance (in shares)",{"v":1949,"d":"1,949 "},{"v":2031,"d":"2,031 "},{"v":2440,"d":"2,440 "}]
["Exercisable (in shares)",{"v":1931,"d":"1,931 "}," "," "]
["Weighted \u2028Average \u2028Exercise \u2028Price"," "," "," "]
["Beginning balance (in dollars per share)",{"v":26408.8,"d":"$ 26,408.8"},{"v":27168,"d":"$ 27,168"}," "]
["Expired/forfeited (in dollars per share)",{"v":28973.01,"d":"28,973.01"},{"v":31130.4,"d":"31,130.4"}," "]
["Ending balance (in dollars per share)",{"v":26237.95,"d":"26,237.95"},{"v":26408.8,"d":"$ 26,408.8"},{"v":27168,"d":"$ 27,168"}]
["Exercisable (in dollars per share)",{"v":26077.74,"d":"$ 26,077.74"}," "," "]
["Weighted \u2028Average \u2028Remaining \u2028Contractual Life (Years)"," "," "," "]
["Outstanding (in years)","4 years 10 months 2 days","5 years 11 months 1 day","6 years 11 months 1 day"]
["Exercisable (in years)","4 years 9 months 29 days"," "," "]
["Aggregate \u2028Intrinsic \u2028Value"," "," "," "]
["Aggregate intrinsic value, outstanding",{"v":50054,"d":"$ 50,054"},{"v":31743,"d":"$ 31,743"},{"v":22,"d":"$ 22"}]
["Aggregate intrinsic value, exercisable",{"v":49283,"d":"$ 49,283"}," "," "]
["STI Plan"," "," "," "]
["Number of \u2028Options"," "," "," "]
["Beginning balance (in shares)",{"v":564,"d":"564 "},{"v":586,"d":"586 "}," "]
["Expired/forfeited (in shares)",{"v":-77,"d":"(77)"},{"v":-22,"d":"(22)"}," "]
["Ending balance (in shares)",{"v":487,"d":"487 "},{"v":564,"d":"564 "},{"v":586,"d":"586 "}]
["Exercisable (in shares)",{"v":374,"d":"374 "}," "," "]
["Weighted \u2028Average \u2028Exercise \u2028Price"," "," "," "]
["Beginning balance (in dollars per share)",{"v":60169.2,"d":"$ 60,169.2"},{"v":60864,"d":"$ 60,864"}," "]
["Expired/forfeited (in dollars per share)",{"v":95528.84,"d":"95,528.84"},{"v":78722.8,"d":"78,722.8"}," "]
["Ending balance (in dollars per share)",{"v":52893.32,"d":"52,893.32"},{"v":60169.2,"d":"$ 60,169.2"},{"v":60864,"d":"$ 60,864"}]
["Exercisable (in dollars per share)",{"v":41906.97,"d":"$ 41,906.97"}," "," "]
["Weighted \u2028Average \u2028Remaining \u2028Contractual Life (Years)"," "," "," "]
["Outstanding (in years)","5 years 6 months","6 years 7 months 20 days","6 years 11 months 8 days"]
["Exercisable (in years)","5 years 2 months 23 days"," "," "]
["Aggregate \u2028Intrinsic \u2028Value"," "," "," "]
["Aggregate intrinsic value, outstanding",{"v":25481,"d":"$ 25,481"},{"v":16318,"d":"$ 16,318"},{"v":0,"d":"$ 0"}]
["Aggregate intrinsic value, exercisable",{"v":15448,"d":"$ 15,448"}," "," "]

{"sheet":"Stock-Based Compensation - Weig","index":85,"n_rows":7,"n_cols":3,"rows_kept":7,"merged":[[0,0,1,0],[0,1,0,2]]}
["Stock-Based Compensation - Weighted-Average Assumptions Used in the Black-Scholes Option Pricing Model (Details) - Share-based Payment Arrangement, Option - Stock Incentive Plan","12 Months Ended"]
[null,"Dec. 31, 2024","Dec. 31, 2023"]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "]
["Risk-free interest rate (in percent)"," ",{"v":0.0353,"d":"3.53%"}]
["Expected term (in years)","7 years","8 years 8 months 15 days"]
["Expected volatility (in percent)"," ",{"v":0.8962,"d":"89.62%"}]
["Dividend yield (in percent)",{"v":0,"d":"0%"},{"v":0,"d":"0%"}]

{"sheet":"Stock-Based Compensation - Sche","index":86,"n_rows":15,"n_cols":4,"rows_kept":15,"merged":[[0,0,1,0],[0,1,0,3]]}
["Stock-Based Compensation - Schedule of Restricted Stock Units (Details) - Stock Incentive Plan - Restricted Stock Units (RSUs) - $ / shares","12 Months Ended"]
[null,"Dec. 31, 2024","Dec. 31, 2023","Dec. 31, 2022"]
["Shares"," "," "," "]
["Beginning balance (in shares)",{"v":2885,"d":"2,885 "},{"v":1862,"d":"1,862 "}," "]
["Granted (in shares)",{"v":1797111,"d":"1,797,111 "},{"v":2551,"d":"2,551 "}," "]
["Released (in shares)",{"v":-1322382,"d":"(1,322,382)"},{"v":-650,"d":"(650)"}," "]
["Forfeited (in shares)",{"v":-37207,"d":"(37,207)"},{"v":-878,"d":"(878)"}," "]
["Ending balance (in shares)",{"v":440407,"d":"440,407 "},{"v":2885,"d":"2,885 "},{"v":1862,"d":"1,862 "}]
["Weighted Average Fair Value"," "," "," "]
["Beginning balance (in dollars per share)",{"v":3784.8,"d":"$ 3,784.8"},{"v":10464,"d":"$ 10,464"}," "]
["Granted (in dollars per share)",3.72,{"v":2702,"d":"2,702 "}," "]
["Released (in dollars per share)",1.31,{"v":10329.6,"d":"10,329.6"}," "]
["Forfeited (in dollars per share)",2.32,{"v":9817.6,"d":"9,817.6"}," "]
["Ending balance (in dollars per share)",{"v":3.61,"d":"$ 3.61"},{"v":3784.8,"d":"$ 3,784.8"},{"v":10464,"d":"$ 10,464"}]
["Vested (in shares)"," "," ",{"v":151,"d":"151 "}]

{"sheet":"Stock-Based Compensation - Stoc","index":87,"n_rows":13,"n_cols":3,"rows_kept":13,"merged":[[0,0,1,0],[0,1,0,2]]}
["Stock-Based Compensation - Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands","12 Months Ended"]
[null,"Dec. 31, 2024","Dec. 31, 2023"]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "]
["Stock-based compensation expense",{"v":8382,"d":"$ 8,382"},{"v":9167,"d":"$ 9,167"}]
["Research and development"," "," "]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "]
["Stock-based compensation expense",{"v":2670,"d":"2,670 "},{"v":6812,"d":"6,812 "}]
["Sales and marketing"," "," "]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "]
["Stock-based compensation expense",{"v":915,"d":"915 "},{"v":807,"d":"807 "}]
["General and administrative"," "," "]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "]
["Stock-based compensation expense",{"v":4797,"d":"$ 4,797"},{"v":1548,"d":"$ 1,548"}]

{"sheet":"Fair Value of Financial Instr_3","index":88,"n_rows":15,"n_cols":4,"rows_kept":15}
["Fair Value of Financial Instruments - Narrative (Details) - USD ($) $ in Millions","Jul. 21, 2021","Dec. 31, 2024","Dec. 31, 2023"]
["Private Warrants"," "," "," "]
["Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"," "," "," "]
["Warrants (in shares)",{"v":62,"d":"62 "}," "," "]
["Warrants issued (in shares)",{"v":9,"d":"9 "}," "," "]
["Fair value of warrants"," ",{"v":0,"d":"$ 0"},{"v":0.1,"d":"$ 0.1"}]
["Class A Common Stock"," "," "," "]
["Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"," "," "," "]
["Warrants (in shares)"," ",{"v":22514744,"d":"22,514,744 "},{"v":244853,"d":"244,853 "}]
["Class A Common Stock | Public Warrants"," "," "," "]
["Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"," "," "," "]
["Warrants (in shares)",{"v":2394,"d":"2,394 "},{"v":2453,"d":"2,453 "},{"v":2453,"d":"2,453 "}]
["Class A Common Stock | Private Warrants"," "," "," "]
["Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"," "," "," "]
["Warrants (in shares)"," ",{"v":12,"d":"12 "},{"v":12,"d":"12 "}]

{"sheet":"Fair Value of Financial Instr_4","index":89,"n_rows":16,"n_cols":3,"rows_kept":16}
["Fair Value of Financial Instruments - Schedule of Financial Instruments Measured at Fair Value (Details) - Fair Value, Recurring - USD ($) $ in Thousands","Dec. 31, 2024","Dec. 31, 2023"]
["Level 1"," "," "]
["Liabilities:"," "," "]
["Warrant liabilities",{"v":0,"d":"$ 0"},{"v":0,"d":"$ 0"}]
["Derivative call options",{"v":0,"d":"0 "}," "]
["Notes payable",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Level 2"," "," "]
["Liabilities:"," "," "]
["Warrant liabilities",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Derivative call options",{"v":0,"d":"0 "}," "]
["Notes payable",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Level 3"," "," "]
["Liabilities:"," "," "]
["Warrant liabilities",{"v":28864,"d":"28,864 "},{"v":306,"d":"306 "}]
["Derivative call options",{"v":29709,"d":"29,709 "}," "]
["Notes payable",{"v":46628,"d":"$ 46,628"},{"v":86712,"d":"$ 86,712"}]

{"sheet":"Fair Value of Financial Instr_5","index":90,"n_rows":39,"n_cols":2,"rows_kept":39,"merged":[[0,0,1,0]]}
["Fair Value of Financial Instruments - Schedule of Changes in Liability for Unobservable Inputs (Details) $ in Thousands","12 Months Ended"]
[null,"Dec. 31, 2024 USD ($)"]
["Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"," "]
["Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income Flag","Change in fair value of notes payable, warrant liabilities, and derivative call options"]
["Warrant Liabilities"," "]
["Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"," "]
["Beginning balance",{"v":306,"d":"$ 306"}]
["Additions",{"v":34441,"d":"34,441 "}]
["Debt extinguishments",{"v":0,"d":"0 "}]
["Change in fair value measurements",{"v":-5723,"d":"(5,723)"}]
["Ending balance",{"v":28864,"d":"28,864 "}]
["Warrant Liabilities | Class A Common Stock"," "]
["Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"," "]
["Conversions of notes to Class A Common Stock",{"v":0,"d":"0 "}]
["Warrant Liabilities | Class A Common Stock | February 28, 2023"," "]
["Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"," "]
["Reclassification of liability classified warrants to equity",{"v":-160,"d":"(160)"}]
["Derivative Call Option"," "]
["Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"," "]
["Beginning balance",{"v":0,"d":"0 "}]
["Additions",{"v":14267,"d":"14,267 "}]
["Debt extinguishments",{"v":0,"d":"0 "}]
["Change in fair value measurements",{"v":15442,"d":"15,442 "}]
["Reclassification of liability classified warrants to equity",{"v":0,"d":"0 "}]
["Conversions of notes to Class A Common Stock",{"v":0,"d":"0 "}]
["Ending balance",{"v":29709,"d":"29,709 "}]
["Notes Payable"," "]
["Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"," "]
["Beginning balance",{"v":86712,"d":"86,712 "}]
["Additions",{"v":58789,"d":"58,789 "}]
["Debt extinguishments",{"v":2699,"d":"2,699 "}]
["Change in fair value measurements",{"v":-34460,"d":"(34,460)"}]
["Ending balance",{"v":46628,"d":"46,628 "}]
["Notes Payable | Class A Common Stock"," "]
["Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"," "]
["Conversions of notes to Class A Common Stock",{"v":-67112,"d":"(67,112)"}]
["Notes Payable | Class A Common Stock | February 28, 2023"," "]
["Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"," "]
["Reclassification of liability classified warrants to equity",{"v":0,"d":"$ 0"}]

{"sheet":"Income Taxes - Schedule of Prov","index":91,"n_rows":15,"n_cols":3,"rows_kept":15,"merged":[[0,0,1,0],[0,1,0,2]]}
["Income Taxes - Schedule of Provision for Income Taxes (Details) - USD ($) $ in Thousands","12 Months Ended"]
[null,"Dec. 31, 2024","Dec. 31, 2023"]
["Current:"," "," "]
["Federal",{"v":0,"d":"$ 0"},{"v":0,"d":"$ 0"}]
["State",{"v":-4,"d":"(4)"},{"v":2,"d":"2 "}]
["Foreign",{"v":-263,"d":"(263)"},{"v":107,"d":"107 "}]
["Current income tax expense (benefit), total",{"v":-267,"d":"(267)"},{"v":109,"d":"109 "}]
["Deferred:"," "," "]
["Federal",{"v":-21218,"d":"(21,218)"},{"v":-48499,"d":"(48,499)"}]
["State",{"v":-10013,"d":"(10,013)"},{"v":-22277,"d":"(22,277)"}]
["Foreign",{"v":-504,"d":"(504)"},{"v":6577,"d":"6,577 "}]
["Deferred income tax expense (benefit), total",{"v":-31735,"d":"(31,735)"},{"v":-64199,"d":"(64,199)"}]
["Valuation allowance",{"v":31735,"d":"31,735 "},{"v":64199,"d":"64,199 "}]
["Deferred income tax expense (benefit), net of valuation allowance",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Income tax expense (benefit), total",{"v":-267,"d":"$ (267)"},{"v":109,"d":"$ 109"}]

{"sheet":"Income Taxes - Schedule of Comp","index":92,"n_rows":6,"n_cols":3,"rows_kept":6,"merged":[[0,0,1,0],[0,1,0,2]]}
["Income Taxes - Schedule of Components of Losses Before Income Taxes by Taxing Jurisdiction (Details) - USD ($) $ in Thousands","12 Months Ended"]
[null,"Dec. 31, 2024","Dec. 31, 2023"]
["Income Tax Disclosure [Abstract]"," "," "]
["U.S.",{"v":-324929,"d":"$ (324,929)"},{"v":-411790,"d":"$ (411,790)"}]
["Foreign",{"v":-31185,"d":"(31,185)"},{"v":-19845,"d":"(19,845)"}]
["Loss before income taxes",{"v":-356114,"d":"$ (356,114)"},{"v":-431635,"d":"$ (431,635)"}]

{"sheet":"Income Taxes - Schedule of Effe","index":93,"n_rows":15,"n_cols":3,"rows_kept":15,"merged":[[0,0,1,0],[0,1,0,2]]}
["Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)","12 Months Ended"]
[null,"Dec. 31, 2024","Dec. 31, 2023"]
["Income Tax Disclosure [Abstract]"," "," "]
["Federal income tax expense",{"v":0.21,"d":"21%"},{"v":0.21,"d":"21%"}]
["State income taxes (net of federal benefit)",{"v":0.023,"d":"2.30%"},{"v":0.041,"d":"4.10%"}]
["Other permanent differences","(1.40%)","(0.70%)"]
["Fair value debt adjustments","(10.30%)","(5.80%)"]
["Disallowed interest","(1.80%)","(1.20%)"]
["Foreign tax rate difference",{"v":0.001,"d":"0.10%"},{"v":0.002,"d":"0.20%"}]
["Prior year true-up on deferred taxes","(0.20%)","(0.10%)"]
["Return-to-provision adjustment","(1.30%)",{"v":0,"d":"0%"}]
["Uncertain tax benefit",{"v":0.008,"d":"0.80%"},"(1.00%)"]
["Expiration of tax attributes","(0.30%)","(1.80%)"]
["Valuation allowance","(9.00%)","(14.70%)"]
["Effective income tax rate reconciliation, percent, total",{"v":0.001,"d":"0.10%"},{"v":0,"d":"0%"}]

{"sheet":"Income Taxes - Schedule of Defe","index":94,"n_rows":19,"n_cols":4,"rows_kept":19}
["Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands","Dec. 31, 2024","Dec. 31, 2023","Dec. 31, 2022"]
["Deferred Tax Assets:"," "," "," "]
["Net operating losses (“NOL”)",{"v":411244,"d":"$ 411,244"},{"v":353839,"d":"$ 353,839"}," "]
["Research and development credits",{"v":4239,"d":"4,239 "},{"v":4239,"d":"4,239 "}," "]
["Accrued liabilities",{"v":25581,"d":"25,581 "},{"v":16646,"d":"16,646 "}," "]
["Capital loss",{"v":0,"d":"0 "},{"v":3420,"d":"3,420 "}," "]
["Amortization",{"v":8803,"d":"8,803 "},{"v":9921,"d":"9,921 "}," "]
["Capitalized R&D expense",{"v":53125,"d":"53,125 "},{"v":74835,"d":"74,835 "}," "]
["Stock-based compensation",{"v":450,"d":"450 "},{"v":418,"d":"418 "}," "]
["Transaction costs",{"v":35,"d":"35 "},{"v":45,"d":"45 "}," "]
["Other",{"v":379,"d":"379 "},{"v":594,"d":"594 "}," "]
["Gross deferred tax assets",{"v":503856,"d":"503,856 "},{"v":463957,"d":"463,957 "}," "]
["Valuation allowance",{"v":-457738,"d":"(457,738)"},{"v":-426003,"d":"(426,003)"},{"v":-361804,"d":"$ (361,804)"}]
["Deferred tax assets, net of valuation allowance",{"v":46118,"d":"46,118 "},{"v":37954,"d":"37,954 "}," "]
["Deferred Tax Liabilities:"," "," "," "]
["Depreciation",{"v":-20174,"d":"(20,174)"},{"v":-14113,"d":"(14,113)"}," "]
["State taxes",{"v":-25944,"d":"(25,944)"},{"v":-23841,"d":"(23,841)"}," "]
["Gross deferred tax liabilities",{"v":-46118,"d":"(46,118)"},{"v":-37954,"d":"(37,954)"}," "]
["Net deferred tax assets (liabilities)",{"v":0,"d":"$ 0"},{"v":0,"d":"$ 0"}," "]

{"sheet":"Income Taxes - Narrative (Detai","index":95,"n_rows":17,"n_cols":4,"rows_kept":17}
["Income Taxes - Narrative (Details) - USD ($) $ in Thousands","Dec. 31, 2024","Dec. 31, 2023","Dec. 31, 2022"]
["Income Tax Contingency [Line Items]"," "," "," "]
["Valuation allowance",{"v":457738,"d":"$ 457,738"},{"v":426003,"d":"$ 426,003"},{"v":361804,"d":"$ 361,804"}]
["Net operating loss carryforwards, no expiration",{"v":1247500,"d":"1,247,500 "}," "," "]
["Federal"," "," "," "]
["Income Tax Contingency [Line Items]"," "," "," "]
["Net operating loss carryforwards",{"v":1328500,"d":"1,328,500 "}," "," "]
["Net operating loss carryforwards, subject to expiration",{"v":80500,"d":"80,500 "}," "," "]
["State"," "," "," "]
["Income Tax Contingency [Line Items]"," "," "," "]
["Net operating loss carryforwards, subject to expiration",{"v":1360200,"d":"1,360,200 "}," "," "]
["State | Research Tax Credit Carryforward"," "," "," "]
["Income Tax Contingency [Line Items]"," "," "," "]
["Tax credit carryforward",{"v":4200,"d":"4,200 "}," "," "]
["Foreign"," "," "," "]
["Income Tax Contingency [Line Items]"," "," "," "]
["Net operating loss carryforwards",{"v":48000,"d":"$ 48,000"}," "," "]

{"sheet":"Income Taxes - Valuation Allowa","index":96,"n_rows":6,"n_cols":3,"rows_kept":6,"merged":[[0,0,1,0],[0,1,0,2]]}
["Income Taxes - Valuation Allowance (Details) - USD ($) $ in Thousands","12 Months Ended"]
[null,"Dec. 31, 2024","Dec. 31, 2023"]
["Deferred Tax Assets, Valuation Allowance [Roll Forward]"," "," "]
["Beginning balance",{"v":426003,"d":"$ 426,003"},{"v":361804,"d":"$ 361,804"}]
["Increase related to current year tax positions",{"v":31735,"d":"31,735 "},{"v":64199,"d":"64,199 "}]
["Ending balance",{"v":457738,"d":"$ 457,738"},{"v":426003,"d":"$ 426,003"}]

{"sheet":"Income Taxes - Schedule of Unre","index":97,"n_rows":7,"n_cols":3,"rows_kept":7,"merged":[[0,0,1,0],[0,1,0,2]]}
["Income Taxes - Schedule of Unrecognized Tax Benefits (Details) - USD ($) $ in Thousands","12 Months Ended"]
[null,"Dec. 31, 2024","Dec. 31, 2023"]
["Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"," "," "]
["Beginning balance",{"v":12972,"d":"$ 12,972"},{"v":8807,"d":"$ 8,807"}]
["Increase related to current year tax positions",{"v":389,"d":"389 "},{"v":4165,"d":"4,165 "}]
["Decrease related to prior year positions",{"v":-3274,"d":"(3,274)"},{"v":0,"d":"0 "}]
["Ending balance",{"v":10087,"d":"$ 10,087"},{"v":12972,"d":"$ 12,972"}]

{"sheet":"Net Loss per Share - Schedule o","index":98,"n_rows":21,"n_cols":3,"rows_kept":21,"merged":[[0,0,1,0],[0,1,0,2]]}
["Net Loss per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, $ in Thousands","12 Months Ended"]
[null,"Dec. 31, 2024","Dec. 31, 2023"]
["Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"," "," "]
["Net loss",{"v":-355847,"d":"$ (355,847)"},{"v":-431744,"d":"$ (431,744)"}]
["Less: Deemed Dividend",{"v":-7576,"d":"(7,576)"},{"v":0,"d":"0 "}]
["Net loss available to common stockholders",{"v":-363423,"d":"(363,423)"},{"v":-431744,"d":"(431,744)"}]
["Net loss available to common stockholders",{"v":-363423,"d":"$ (363,423)"},{"v":-431744,"d":"$ (431,744)"}]
["Class A Common Stock"," "," "]
["Weighted average common shares used in computing net loss per share of Class A and Class B Common Stock:"," "," "]
["Basic (in shares)",{"v":18529525,"d":"18,529,525 "},{"v":240869,"d":"240,869 "}]
["Diluted (in shares)",{"v":18529525,"d":"18,529,525 "},{"v":240869,"d":"240,869 "}]
["Net loss per share of Class A and B Common Stock attributable to common stockholders:"," "," "]
["Basic (in dollars per share)",{"v":-19.61,"d":"$ (19.61)"},{"v":-1792.44,"d":"$ (1,792.44)"}]
["Diluted (in dollars per share)",{"v":-19.61,"d":"$ (19.61)"},{"v":-1792.44,"d":"$ (1,792.44)"}]
["Class B Common Stock"," "," "]
["Weighted average common shares used in computing net loss per share of Class A and Class B Common Stock:"," "," "]
["Basic (in shares)",{"v":18529525,"d":"18,529,525 "},{"v":240869,"d":"240,869 "}]
["Diluted (in shares)",{"v":18529525,"d":"18,529,525 "},{"v":240869,"d":"240,869 "}]
["Net loss per share of Class A and B Common Stock attributable to common stockholders:"," "," "]
["Basic (in dollars per share)",{"v":-19.61,"d":"$ (19.61)"},{"v":-1792.44,"d":"$ (1,792.44)"}]
["Diluted (in dollars per share)",{"v":-19.61,"d":"$ (19.61)"},{"v":-1792.44,"d":"$ (1,792.44)"}]

{"sheet":"Net Loss per Share - Potentiall","index":99,"n_rows":31,"n_cols":3,"rows_kept":31,"merged":[[0,0,1,0],[0,1,0,2]]}
["Net Loss per Share - Potentially Dilutive Shares Excluded From Computation Of Diluted Net Income/(Loss) (Details) - shares","12 Months Ended"]
[null,"Dec. 31, 2024","Dec. 31, 2023"]
["Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"," "," "]
["Antidilutive shares (in shares)",{"v":64483012,"d":"64,483,012 "},{"v":1317738,"d":"1,317,738 "}]
["Shares issuable upon conversion of SPA Portfolio Notes"," "," "]
["Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"," "," "]
["Antidilutive shares (in shares)",{"v":41054586,"d":"41,054,586 "},{"v":1069202,"d":"1,069,202 "}]
["Shares issuable upon conversion of Unsecured Convertible Notes"," "," "]
["Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"," "," "]
["Antidilutive shares (in shares)",{"v":749866,"d":"749,866 "},{"v":0,"d":"0 "}]
["Shares issuable upon exercise of equity classified SPA Portfolio Note warrants"," "," "]
["Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"," "," "]
["Antidilutive shares (in shares)",{"v":15238,"d":"15,238 "},{"v":13906,"d":"13,906 "}]
["Shares issuable upon exercise of liability classified SPA Portfolio Note warrants"," "," "]
["Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"," "," "]
["Antidilutive shares (in shares)",{"v":16720384,"d":"16,720,384 "},{"v":0,"d":"0 "}]
["Ares warrants"," "," "]
["Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"," "," "]
["Antidilutive shares (in shares)",{"v":5776657,"d":"5,776,657 "},{"v":228482,"d":"228,482 "}]
["Stock-based compensation awards – Options"," "," "]
["Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"," "," "]
["Antidilutive shares (in shares)",{"v":2591,"d":"2,591 "},{"v":798,"d":"798 "}]
["Stock-based compensation awards – RSUs"," "," "]
["Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"," "," "]
["Antidilutive shares (in shares)",{"v":161225,"d":"161,225 "},{"v":2885,"d":"2,885 "}]
["Public Warrants"," "," "]
["Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"," "," "]
["Antidilutive shares (in shares)",{"v":2453,"d":"2,453 "},{"v":2453,"d":"2,453 "}]
["Private Warrants"," "," "]
["Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"," "," "]
["Antidilutive shares (in shares)",{"v":12,"d":"12 "},{"v":12,"d":"12 "}]

{"sheet":"Subsequent Events (Details)","index":100,"n_rows":94,"n_cols":23,"rows_kept":94,"merged":[[0,0,1,0],[0,4,0,5]]}
["Subsequent Events (Details) $ / shares in Units, € in Thousands, $ in Thousands",{"$nulls":5},"12 Months Ended"]
[null,"Mar. 31, 2025 USD ($) day shares","Mar. 21, 2025 USD ($) tranche $ / shares","Feb. 11, 2025 USD ($) shares","Jan. 17, 2025 USD ($) $ / shares shares","Jan. 17, 2025 EUR (€) shares","Dec. 31, 2024 USD ($) day trading_day $ / shares shares","Mar. 10, 2025 shares","Jan. 28, 2025 $ / shares shares","Dec. 21, 2024 $ / shares","Sep. 05, 2024 $ / shares","Aug. 31, 2024 shares","Aug. 04, 2024 shares","Jul. 31, 2024 $ / shares shares","Jun. 21, 2024 $ / shares","Feb. 23, 2024 shares","Feb. 05, 2024 shares","Feb. 04, 2024 shares","Dec. 31, 2023 shares","Aug. 25, 2023 shares","Aug. 22, 2023 shares","Feb. 28, 2023 shares","Feb. 27, 2023 shares"]
["Subsequent Event [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Exercise price (in dollars per share) | $ / shares"," "," "," "," "," "," "," "," ",{"v":1.16,"d":"$ 1.16"}," "," "," ",{"v":110400,"d":"$ 110,400"}," "," "," "," "," "," "," "," "," "]
["Authorized shares (in shares)"," "," "," "," "," ",{"v":114245313,"d":"114,245,313 "}," "," "," "," "," "," "," "," "," "," "," ",{"v":11286980,"d":"11,286,980 "}," "," "," "," "]
["Common stock, shares authorized (in shares)"," "," "," "," "," ",{"v":104245313,"d":"104,245,313 "}," "," "," "," ",{"v":104245313,"d":"104,245,313 "},{"v":104245313,"d":"104,245,313 "},{"v":104245313,"d":"104,245,313 "}," ",{"v":11582813,"d":"11,582,813 "},{"v":34748438,"d":"34,748,438 "},{"v":3860938,"d":"3,860,938 "}," ",{"v":1286980,"d":"1,286,980 "},{"v":3860938,"d":"3,860,938 "},{"v":433855,"d":"433,855 "}," "]
["Preferred stock, shares authorized (in shares)"," "," "," "," "," ",{"v":10000000,"d":"10,000,000 "}," "," "," "," "," "," ",{"v":114245313,"d":"114,245,313 "}," ",{"v":12582813,"d":"12,582,813 "}," "," ",{"v":10000000,"d":"10,000,000 "}," "," "," "," "]
["Class A Common Stock"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Subsequent Event [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Common stock, shares authorized (in shares)"," "," "," "," "," ",{"v":99815625,"d":"99,815,625 "}," "," "," "," "," "," "," "," "," "," "," ",{"v":1232292,"d":"1,232,292 "},{"v":1232292,"d":"1,232,292 "}," ",{"v":176042,"d":"176,042 "},{"v":84896,"d":"84,896 "}]
["Series A Preferred Stock"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Subsequent Event [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Purchase price per share (in dollars per share) | $ / shares"," "," "," "," "," "," "," "," "," "," "," "," "," ",{"v":100,"d":"$ 100"}," "," "," "," "," "," "," "," "]
["Common Stock And Preferred Stock"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Subsequent Event [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Authorized shares (in shares)"," "," "," "," "," ",{"v":114245313,"d":"114,245,313 "}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Subsequent Event"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Subsequent Event [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Preferred stock, shares, certificate of designation (in shares)"," "," "," "," "," "," "," ",{"v":1,"d":"1 "}," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Debt instrument. cash fee received, gross proceeds, percentage"," ",{"v":0.08,"d":"8%"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Debt instrument. cash fee received, underlying issued notes, percentage"," ",{"v":0.07,"d":"7%"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Warrants term"," ","5 years"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Exercise price (in dollars per share) | $ / shares"," ",{"v":1.548,"d":"$ 1.548"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Class of warrant or right, threshold percentage of stock price trigger"," ",{"v":1.2,"d":"120%"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Debt instrument, reimbursement expense | $"," ",{"v":200,"d":"$ 200"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Subsequent Event | HSL s.r.l."," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Subsequent Event [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Litigation settlement, amount awarded to other party"," "," "," ",{"v":1185,"d":"$ 1,185"},{"v":1150,"d":"€ 1,150"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Shares issued, price per share (in dollars per share) | $ / shares"," "," "," ",{"v":1.53,"d":"$ 1.53"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Litigation settlement, amount awarded to other party, shares (in shares)"," "," "," ",{"v":774183,"d":"774,183 "},{"v":774183,"d":"774,183 "}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Stock issued during period, issued for settlement, market value, percentage"," "," "," ",{"v":0.05,"d":"5%"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Subsequent Event | Series A Preferred Stock"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Subsequent Event [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Purchase price per share (in dollars per share) | $ / shares"," "," "," "," "," "," "," ",{"v":100,"d":"$ 100"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Subsequent Event | Common Stock And Preferred Stock"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Subsequent Event [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Authorized shares (in shares)"," "," "," "," "," "," ",{"v":139245313,"d":"139,245,313 "}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Subsequent Event | Common Stock"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Subsequent Event [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Common stock, shares authorized (in shares)"," "," "," "," "," "," ",{"v":129245313,"d":"129,245,313 "}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Subsequent Event | Preferred Stock"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Subsequent Event [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Preferred stock, shares authorized (in shares)"," "," "," "," "," "," ",{"v":10000000,"d":"10,000,000 "}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Unsecured Convertible Notes, Due April 25, 2024 - July 8, 2024 | Notes Payable | Related Party | Subsequent Event"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Subsequent Event [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Aggregate principal amount | $",{"v":20000,"d":"$ 20,000"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Notes payable bearing interest rate",{"v":0.1,"d":"10%"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Debt instrument, convertible, threshold consecutive trading days | day",{"v":5,"d":"5 "}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["SPA Loans | Subsequent Event"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Subsequent Event [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Debt conversion, converted amount | $",{"v":18600,"d":"$ 18,600"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Converted interest | $",{"v":1100,"d":"$ 1,100"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["SPA Loans | Subsequent Event | Class A Common Stock"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Subsequent Event [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Shares issued from conversion (in shares)",{"v":17034826,"d":"17,034,826 "}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["SPA Loans | Related Party | Subsequent Event"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Subsequent Event [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Debt conversion, converted amount | $"," "," ",{"v":1500,"d":"$ 1,500"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Converted interest | $"," "," ",{"v":100,"d":"$ 100"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["SPA Loans | Related Party | Subsequent Event | Class A Common Stock"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Subsequent Event [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Shares issued from conversion (in shares)"," "," ",{"v":1352766,"d":"1,352,766 "}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Junior Secured SPA Notes | Notes Payable"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Subsequent Event [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Notes payable bearing interest rate"," "," "," "," "," "," "," "," "," ",{"v":0.1,"d":"10%"}," "," "," "," "," "," "," "," "," "," "," "," "]
["Debt instrument, convertible, threshold consecutive trading days | trading_day"," "," "," "," "," ",{"v":5,"d":"5 "}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Conversion price (in dollars per share) | $ / shares"," "," "," "," "," "," "," "," ",1.16,{"v":5.24,"d":"$ 5.24"}," "," "," "," "," "," "," "," "," "," "," "," "]
["Junior Secured SPA Notes | Notes Payable | Class A Common Stock"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Subsequent Event [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Debt conversion, converted amount | $"," "," "," "," "," ",{"v":1100,"d":"$ 1,100"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Shares issued from conversion (in shares)"," "," "," "," "," ",{"v":1046651,"d":"1,046,651 "}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Junior Secured SPA Notes | Notes Payable | Subsequent Event"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Subsequent Event [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Conversion price (in dollars per share) | $ / shares"," "," "," "," "," "," "," ",5.24," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["2024 Unsecured SPA Notes"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Subsequent Event [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Debt instrument, convertible, threshold consecutive trading days | day"," "," "," "," "," ",{"v":1,"d":"1 "}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["2024 Unsecured SPA Notes | Notes Payable"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Subsequent Event [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Aggregate principal amount | $"," "," "," "," "," ",{"v":7500,"d":"$ 7,500"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Notes payable bearing interest rate"," "," "," "," "," ",{"v":0.1,"d":"10%"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Debt instrument, convertible, threshold consecutive trading days | day"," "," "," "," "," ",{"v":5,"d":"5 "}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Conversion price (in dollars per share) | $ / shares"," "," "," "," "," ",{"v":1.16,"d":"$ 1.16"}," "," ",{"v":1.16,"d":"$ 1.16"}," "," "," "," "," "," "," "," "," "," "," "," "," "]
["2024 Unsecured SPA Notes | Notes Payable | Subsequent Event"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Subsequent Event [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Conversion price (in dollars per share) | $ / shares"," "," "," "," "," "," "," ",{"v":1.16,"d":"$ 1.16"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["2025 Senior Unsecured SPA Notes | Notes Payable | Subsequent Event"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Subsequent Event [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Debt instrument, purchase agreements | $"," ",{"v":41000,"d":"41,000 "}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Payments of debt instrument | $"," ",{"v":39500,"d":"39,500 "}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Debt instrument, converted amount | $"," ",{"v":1500,"d":"$ 1,500"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Number of tranches | tranche"," ",{"v":4,"d":"4 "}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Debt instrument, additional note issued, amount | $"," ",{"v":10000,"d":"$ 10,000"}," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Debt instrument, resale period"," ","45 days"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]